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Abstract
Apple Pomace as a Novel Nutritional Aid for Western Diet-Induced Nonalcoholic Fatty Liver
Disease in Young Female Sprague Dawley Rats

R. Chris Skinner
Apple pomace is a “waste” byproduct of apple processing that causes environmental pollution
and is costly to dispose of. Yet, apple pomace is rich in dietary fibers and antioxidants. Analysis
of apple pomace’s nutritional profile indicates suitability as a potential dietary treatment for nonalcoholic fatty liver disease (NAFLD) and the more severe non-alcoholic steatohepatitis (NASH).
NAFLD is the most prevalent liver disease in the world with prevalence and severity expected to
increase in both adults and children. Currently, there is no approved drug treatment for NAFLD
and therefore, dietary intervention is the primary treatment. The study objectives were to
determine the effect of apple pomace consumption on diet-induced NAFLD, NASH and renal
and bone health using a rodent model. Growing (aged 22-29 d) female Sprague-Dawley rats
(n=8/group) were fed ad libitum diets consisting of AIN-93G, AIN-93G with 10% apple pomace
substitution (AIN/AP), Western diet (45% fat, 34% sucrose), or Western diet with 10% apple
pomace substitution (Western/AP) for 8 weeks. Results showed Western diet consumption
increased (p<0.0001) gonadal adipose weight independent of body weight differences. Rats
consuming Western diet showed histological evidence of hepatic fat infiltration and inflammation
characterizing NAFLD and progression to NASH. Fatty acid analysis by gas chromatography
showed increase (p<0.05) hepatic palmitic, palmitoleic, and oleic acid content in rats consuming
Western diet was attenuated by apple pomace. Gonadal adipose tissue fatty acid analysis
showed rats consuming a Western diet to have significantly reduced palmitic, stearic, and oleic
acid compared to all diet groups. These results suggest saturated and monounsaturated fatty
acids from the adipose tissue are being transported to the liver, resulting in increased hepatic fat
deposition. Additionally, hepatic gene expression by real time-quantitative polymerase chain

reaction (RT-qPCR) showed rats consuming Western diet upregulated hepatic expression of
diacylglycerol O-acyltransferase 2 (DGAT2), which was attenuated by apple pomace. Rats
consuming Western diets also had upregulated nuclear factor kappa-light chain enhancer of
activated B cells (NFκB) and interleukin-6 (IL-6). Further, gonadal adipose tissue expression of
NFκB, IL-6, and tumor necrosis factor alpha (TNFα) was significantly upregulated compared to
all groups contributing to progression of NAFLD to NASH. The results suggest increased
gonadal adipose also increased transport of inflammatory cytokines, resulting in NASH
progression. Apple pomace attenuated Western diet-induced NAFLD due to the high fiber
content in apple pomace increasing (p<0.02) serum bile acids. Caloric substitution with apple
pomace also attenuated Western diet-induced progression to NASH. High polyphenol content in
apple pomace resulted in significantly increased serum total antioxidants and decreased urinary
antioxidants. The calcium and fructose content in apple pomace showed no significant effects in
indices of renal or bone health. Collectively, the study results showed caloric substitution of a
healthy or Western diet with 10% apple pomace attenuated NAFLD, progression to NASH, and
was safe for renal and bone health. Therefore, apple pomace has potential to be repurposed for
human consumption as a sustainable functional food and as a nutritional aid to promote liver
health.
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Introduction
Apples are one of the most popularly consumed fruits in the United States (U.S.). Most
apples produced in the U.S. are processed for apple products, such as: apple juices, ciders, and
more [1]. Apple processing separates the juice from the insoluble portions of the apple,
including: the skin, stem, seeds, calyx, and pulp. This insoluble apple portion is known as apple
pomace and is typically regarded as “waste [2].” Additionally, apple pomace can result in rapid
spoilage and environmental pollution if not swiftly managed, but proper disposal is costly [2].
Currently, it is estimated the U.S. spends $10 million annually on apple pomace disposal and is
expected to rise as the apple processing industry continues to expand [2-4]. However, studies
have shown apple pomace is rich in nutrients associated with positive health outcomes [2,5,6].
Repurposing apple pomace for human consumption could decrease disposal costs and
environmental pollution while providing nutritional value and health benefits.
Apple pomace is rich in several nutrients, including vitamins and minerals, but is
particularly high in dietary fiber and phytochemicals [2,3,7]. Dietary fiber has been shown to
have numerous health benefits, including lowering the risk for metabolic disorders such as nonalcoholic fatty liver disease (NAFLD) [8]. Phytochemicals, phenolics and flavonoids, have also
been shown to play a role in NAFLD [7,9,10]. A synergistic relationship between dietary fiber
and antioxidants exists, as dietary fiber facilitates transport of antioxidants through the intestines
[11,12]. Given apple pomace is high in dietary fiber and antioxidants, and the synergistic
function of the nutrients, whole apple pomace has potential to be repurposed for human
consumption [2].
NAFLD is the most prevalent liver disease worldwide, estimated to effect over 25% of
the U.S. population [13]. Additionally, it is estimated estimated 7% of healthy children and 34%
of obese children have NAFLD, suggesting prevalence will increase [14]. NAFLD is defined as
increased hepatic steatosis which is benign [15]. However, NAFLD can progress to the more
severe non-alcoholic steatohepatitis (NASH). NASH is defined as increased hepatic steatosis in
1

conjunction with inflammation of the liver [16]. An estimated 25% of individuals with NAFLD will
progress to NASH, which increases the risk for liver fibrosis, cirrhosis and cancer [17].
Progression of liver disease is suggested to be a multiple-hit pathogenesis [18]. Diets high in
saturated fatty acids and simple carbohydrates stimulate de novo lipogenesis (DNL) and free
fatty acid (FFA) release from the adipose tissue, resulting in NAFLD [19]. Increases in DNL and
FFA result in increased inflammatory cytokine production and oxidative stress generation,
signifying progression to NASH [20]. Recommended treatment for NAFLD and NASH is to
reduce dietary intake of simple sugars and saturated fats and to increase dietary fiber,
antioxidants, and complex carbohydrates [21-23]. Apple pomace’s high dietary fiber and
polyphenol contents suggests potential for its utilization as a therapeutic aid for NAFLD and
NASH. Further highlighting the need for discovering potential nutrition-based treatments for the
disease, there are currently no approved Food and Administration (FDA) medication for NAFLD
and NASH [24,25].
Despite a favorable nutrient composition as a potential dietary aid for NAFLD and NASH,
apple pomace also contains fructose [2]. Fructose has been reported to promote progression of
NAFLD to NASH and to be detrimental to bone and kidney health [26-28]. Therefore, it is also
necessary to evaluate the safety of apple pomace. Investigating the potential of apple pomace
to be utilized as a safe and sustainable food source for human consumption would not only play
a role in improving health, but also reduces environmental pollution and food waste [2,4].
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Literature Review

1.0.1 A Comprehensive Analysis of the Composition, Health Benefits, and Safety of Apple
Pomace
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1.0.1 Abstract
Apple processing results in peel, stem, seeds, and pulp being left as a waste product known as
apple pomace. This review comprehensively assessed apple pomace composition for nutritional
value and bioactive substances, as well as evaluated potential health benefits, and safety.
Apple pomace is a rich source of health benefiting nutrients including: minerals, dietary fiber,
antioxidants, and ursolic acid, suggesting its potential use as a dietary supplement, functional
food, and/or food additive. Preclinical studies have found apple pomace as well as its isolated
extracts to have several health benefits including; improved lipid metabolism, antioxidant status,
gastrointestinal function, and metabolic disorders (e.g. hyperglycemia, insulin resistance, etc.).
Safety studies have shown apple pomace to be a safe livestock feed additive and pesticide
concentrations to be within safety thresholds established for human consumption. Despite
promising evidence, commercial development of apple pomace for human consumption
requires more research focusing on standardized methods of nutrient reporting, mechanistic
studies, and human clinical trials.

Keywords: apple pomace, fiber, antioxidants, health benefits, safety
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1.0.2 Introduction
Diets high in fruits and vegetables are widely recommended for health benefits. The
Dietary Guidelines for Americans recommends fruits and vegetables make-up one-half of your
plate [1]. Globally, apples are among the most popular and frequently consumed fruits. This is
due to public perception that apples are a healthy food and the availability of apples throughout
the year in a variety of forms [2]. The United States (U.S.) produces ~240 million bushels of
apples, annually. Approximately 33% (~79 million bushels) of apples harvested are processed
into juices, ciders, alcoholic beverages, sauces, canned, dried, and frozen apple slices [3].
However, processing of apples results in 25% of the apple mass (e.g. skin, stem, seeds, and
pulp) being discarded as waste that is referred to as apple pomace [4-6].
Management of apple pomace is a major public health issue as it easily ferments making
it a cause of environmental pollution. Disposal of apple pomace is costly with the U.S. spending
$10 million, annually [5,6]. Therefore, the development of potential commercial applications for
apple pomace is a growing field of research interest. Currently, apple pomace is used as a
livestock feed ingredient, for specific nutrient (dietary fiber, polyphenol, etc.) extraction for
dietary supplements, and food ingredient substitute [7-9]. Given the potential nutrient value,
pollution and financial demands of apple pomace disposal, an economical solution is to utilize
apple pomace as a dietary supplement, functional food and/or food additive for human
consumption. Therefore, the aim of this review is to address the nutritional value, health
benefits, and safety of apple pomace in order to determine its potential for human consumption.

1.0.3 Nutrient Composition of Apple Pomace
In this review, nutrient values are reported as fresh weight (FW) rather than dry weight
since apples and apple products are typically consumed “fresh.” However, Lavelli and Corti [10]
suggested a reduction from 70-85% moisture content to <10% to sustain apple pomace quality
and storage stability. Comparisons for nutrient value between apples and apple pomace were
9

based on values reported in peer-reviewed literature published in the English language and
values available in the United States Department of Agriculture (USDA) data base. Nutrient
compositional study limitations include small sample sizes and confounding factors that
influence nutrient content such as: differences in apple cultivars and varieties, growing
conditions, harvesting, processing techniques, and storage methods and storage length were
not consistently reported in the study description. Future compositional studies evaluating apple
pomace should provide this information and develop standards to allow for comparisons among
studies for nutrient value.

1.0.4 Macronutrients
Diets low in dietary fat have been shown to prevent weight gain and obesity, lower risk of
cardiovascular disease (CVD), cancer, and other chronic diseases [11-14]. An apple contains
0.16-0.18% fat, while apple pomace has been reported to range between 1.1-3.6% (Table 1)
[9,15,16]. Consumption of apple pomace includes seeds, which is the portion of the apple
containing the majority of fatty acids, mostly as linoleic acid (18:2n-6) and oleic acid (18:1n-9)
[9]. Linoleic acid is an essential fatty acid, with some studies suggesting benefits of reduced risk
of atherosclerosis, improved impaired glucose tolerance, and reducing body fat deposition [1720]. Apple pomace, due to a low fat content, is not considered a rich source of these fatty acids.
Additionally, apples are low in protein although the reported amount of protein in apple pomace
is higher likely due to the seeds (Table 1).
Carbohydrates account for ~14% of the nutrient composition of apples [15]. Apple
pomace has a greater carbohydrate content compared to apples (Table 1). Sucrose content in
apple pomace showed a wide range since sucrose is highly variable among apple cultivars
[15,16]. Both apples and apple pomace contain a large percentage of total carbohydrates as
fructose and glucose [9,15]. Higher amounts of fructose and glucose in apple pomace
compared to apples are likely due to the inclusion of the sugar-containing stem and calyx (Table
10

1). Among fruits popularly consumed in the U.S. apples are considered particularly concentrated
in fructose [21]. Free fructose is poorly absorbed and functions similar to dietary fibers, by
escaping absorption in the small intestine and being fermented in the large intestines [22].
Apples also contain complex carbohydrates such as polysaccharides. In a preclinical
study by Chen, et al [23] male Kunming mice (age 45-days old, n=18 animals/group) were
randomly assigned to be fed a high-fat diet (HFD) (45% kcal fat) or a HFD supplemented with
apple pomace polysaccharides at doses of 200, 400, or 800 mg/kg bwt/d for 30 days. Results
showed all doses of apple pomace polysaccharides improved serum triglycerides, total
cholesterol. HDL-C, insulin, and adiponectin compared to mice fed HFD. Doses of 200 and 400,
but not the highest dose of 800 mg/kg bwt/d apple pomace polysaccharide significantly reduced
serum low density lipoprotein-cholesterol (LDL-C). The lowest dose of apple pomace
polysaccharides (200mg/kg bwt/d) showed lower (p<0.05) serum cholesterol, insulin, and
adiponectin compared to HFD fed mice. Additionally, 200 mg/kg bwt/d apple pomace
polysaccharides reduced (p<0.001) serum leptin compared to HFD fed mice. All doses of apple
pomace polysaccharides increased serum hexokinase and glucagon concentrations, indicating
a return to metabolic balance. Additionally, apple pomace polysaccharides supplementation to
rats fed a HFD restored antioxidant capacity to control levels in a dose-dependent manner.
Furthermore, all doses of apple pomace polysaccharides reduced (p<0.05) fasting serum insulin
and liver lipid content compared to mice fed HFD (Table 3) [23-34]. Collectively, study results
showed mice fed HFD supplemented with apple pomace polysaccharides had improved insulin,
glucose metabolism, lipid profile, and antioxidant status. Based on preclinical studies, apple
pomace polysaccharides supplementation may be a potential treatment for diet-induced
metabolic or obesity-related diseases. However, clinical studies are needed to confirm health
benefits for humans.

Dietary Fiber
11

It has been recommended the American population increase their dietary fiber
consumption for various health benefits [15]. However, only about 5% of the U.S. population
achieves the recommended level of dietary fiber consumption [35]. Among the top consumed
fruits in the U.S., apples with skin had one of the highest dietary fiber contents [22]. Since apple
pomace includes the skin, stem, seeds, and calyx, there is a higher fiber content in apple
pomace than an apple. Apple pomace has been reported to contain between 4.4-47.3 g/100g of
fiber [9]. The variability in reported fiber content in apple pomace is likely due to use of different
cultivars of apples and methods of quantifying or extracting dietary fiber. In apple pomace,
insoluble fiber accounts for 33.8-60.0% of total fiber with cellulose accounting for 6.7-40.4% and
lignin for 14.1-18.9% [9]. Soluble fiber accounts for 13.5-14.6% of total fiber in apples. Since the
majority of soluble fiber in apples is in the skin, this results in apple pomace containing a larger
percentage of soluble fiber than apples [36]. In particular, apple pomace contains higher pectin
than apples (Table 1). Due to its high fiber, consumption of 100g of apple pomace provides
approximately half of the recommended daily fiber intake.
Diets high in dietary fiber have been reported to promote gastrointestinal health and to
reduce the risk for diverticular diseases and certain cancers, particularly colorectal cancer
[37,38]. Extraction of fiber-rich colloids from apple pomace was used to investigate fiber as the
specific component in apple pomace responsible for gastrointestinal benefits. Sembries, et al
[24] fed young (age 8 weeks) male Wistar rats (n=12 animals/group) either a standard rodent
diet or a standard rodent diet supplemented with 5% apple pomace fiber-rich colloid for six
weeks. Fiber-rich colloids from apple pomace increased microflora fermentation indicated by
significantly higher short chain fatty acids (SCFA), acetate and propionate, in the cecum. Rats
provided diet supplemented with apple pomace-rich colloid also had increased (p<0.001) bile
acid excretion in the feces. Additionally, consumption of fiber-rich colloids from apple pomace
resulted in significant decreased weight gain in the absence of reduced food consumption
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(Table 3). The authors attributed this to increased food passage rate in the gut due to the high
fiber content of the apple pomace.
High dietary fiber consumption has also been linked to reduced risk of CVD [39]. Fiberrich colloids isolated from apple pomace was used to investigate fiber as a specific component
in apple pomace responsible for CVD health benefits [25]. Apple pomace was mixed with hot
water, and colloids were extracted from the apple pomace juice mixture. Young male Wistar rats
(age 6 weeks) were randomly assigned (n=10 animals/group) to be fed a standard rodent diet
containing (5% diet weight) fiber-rich colloids isolated from different apple pomace extraction
juice from different apple varieties (Boskoop, Werder Frucht, Glindow, Germany). After six
weeks, feeding apple pomace fiber-rich colloids significantly reduced serum total cholesterol
and low density LDL-C, while increasing serum high density lipoprotein-cholesterol (HDL-C).
The excretion of bile acid and neutral sterols was also increased (p<0.05) in rats fed fiber-rich
colloids (Table 3). Dietary fiber by acting as a bile sequestrant improves serum lipids and
lipoproteins [25].
The main fiber constituent found in apple pomace is pectin [40]. Apple pomace contains
10-15% pectin (dry weight) making it a good source of this insoluble fibre [41]. Pectin has been
recommended to be the source of 30-50% of total daily dietary fiber intake due to its reported
health benefits. Pectin has been shown to lower cholesterol absorption and to lower plasma and
liver triglycerides [42]. In an in vitro study, Kumar and Chauhan [42] extracted pectin from apple
pomace to evaluate it as an inhibitor of pancreatic lipase, which is the primary enzyme
responsible for hydrolyzing dietary triglycerides. Pectin extracted from apple pomace resulted in
a 94.3% inhibition of pancreatic lipase indicating purified pectin from apple pomace may be a
potential anti-obesity treatment by reducing calories through inhibition of fat absorption.

1.0.5 Micronutrients
Minerals
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Micronutrients of concern in the American diet includes potassium and calcium [1].
Consumption of potassium (e.g. fruits and vegetables) lowers blood pressure [43]. According to
Koutsos, et al [44] apples contain 107 ± 2.21 mg of potassium/100g FW. Based on a survey of
popularly consumed fruits in the U.S., apples were among the fruits lowest in potassium,
however apple pomace contains more potassium (Table 2) [9,15,45-49]. Calcium and
phosphorus are important for bone health with adequate intake reducing risk of osteoporosis
[9,50]. Oranges are the richest source of calcium among commonly consumed fruits in the U.S.
[22,48]. Apples are lower but apple pomace provided more calcium than oranges (Table 2). Of
popularly consumed fruits in the U.S., bananas contain the most phosphorous. Apples are
lower, but when processed into pomace results in higher phosphorous content making apple
pomace a richer source of phosphorus than other popularly consumed fruits in the U.S. (Table
2). The mechanisms by which bone health is improved by fruits and vegetables have not been
thoroughly investigated. The acid-base hypothesis postulates acid load is buffered in part by
bone tissue, leading to bone resorption and reduced bone density [51]. Fruits and vegetables
are a good source of alkaline precursors such as potassium, calcium as well as magnesium.
These minerals neutralize the acidic effects of low pH foods derived from the diet [52]. Apples
(5.0 ± 0.7 mg/100g) provide a modest amount of magnesium with the amount in apple pomace
(176 ± 157.5 mg/100g) being much higher (Table 2).
In terms of human health, food sources that increase iron consumption are of interest,
since iron deficiency anemia is the most common nutrient deficiency worldwide [53]. Fruits are
not considered a rich source of iron. However, the amount of iron in apple pomace was higher
than in apples. Zinc deficiency is another common nutrient deficiency [54]. Zinc content is also
higher in apple pomace compared to apples (Table 2). Compared to the most popularly
consumed fruits in the U.S., apples only provided modest amounts of dietary minerals. On the
other hand, apple pomace provides significantly more dietary minerals likely due to inclusion of
peel [9,55]. Gorinstein, et al [56] reported apple peels to have higher amounts of sodium,
14

potassium, calcium, magnesium, and iron than in whole apples. Compositional evaluation
indicates potential use of apple pomace as a supplement to increase dietary mineral intake.

Vitamins
Vitamins C and E are non-enzymatic antioxidants and have been shown to be potent
scavengers of reactive oxygen species (ROS). Previous studies have reported apples to be a
rich source of vitamins C and E [57]. However, when compared to other popular consumed
fruits in the U.S., apples were lower in vitamin C content (0.057 mg/g). Corrected for total
antioxidant activity contributed by vitamin C, apples (97.23 μmol of vitamin C equivalents/g)
ranked second after cranberries (176.98 μmol of vitamin C equivalents/g). Although apples
contain less vitamin C than other fruits, antioxidant activity was still higher. This finding has
physiological significance, as the high antioxidant bioactivity index of apples was shown to have
anti-proliferative activity on cancer cells, second only to cranberries [58]. Apple pomace was
reported to have 22.4 mg/100g of vitamin C [59].
Vitamin E is found to be abundant in seeds [57]. Apple pomace which contains seeds
was reported to have 5.5 mg/100g of vitamin E [59]. Lu and Foo [60] analyzed the free radical
scavenging abilities of apple pomace. Vitamin C (EC50=0.35) had the second highest free
radical scavenging activity in apple pomace and vitamin E (EC50=0.30) ranked third. Phloridzin,
a phytochemical, had the highest free radical scavenging activity (EC50=0.60). Phloridzin
present in apple pomace is absent in other pomace sources such as pears [61]. In addition to
antioxidant vitamins, apple pomace also contains phytochemicals with antioxidant properties
that may reduce the risk of various diseases.

Phytochemicals
Diets high in phytochemicals decrease risk of diseases associated with oxidative stress
and inflammation [62,63]. Five major polyphenolic groups have been found in apples: flavanols,
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flavonols, hydroxycinnamates, dihydrochalcones, and anthocyanins [64,65]. Some of the most
popularly consumed apple varieties including: Fuji, Red Delicious, and Gala were reported to be
high in phenolics and flavonoids and supports data showing apples inhibit lipid peroxidation and
scavenge free radicals, ex vivo [66,67]. Total antioxidant activity of apples is reported to be
~100 μmol vitamin C equivalents/g fruit, which was second only to cranberries in a study of
popularly consumed fruits in the U.S [66].
The processing of fruits has been found to alter nutrient composition and content of fruit
constituents [68]. However, polyphenolic antioxidants present in apples are also abundant in the
apple pomace. Polyphenols are predominantly located in the skin and therefore, most
polyphenols remain in the pomace [69]. Polyphenolic compounds found in apple pomace
include: catechin, p-Coumaric acid, caffeic acid, and ferulic acid and have been shown to have
significantly higher scavenging activities than antioxidant vitamins E and C indicating apple
pomace’s potential as a source of dietary antioxidants [9,60]. Apple pomace also contains
polyphenols: flavanols, flavonols, hydroxycinnamates, and dihydrochalcones [61]. Of the
flavonoids, quercetin and its glucosides are the most abundant flavanoids in apple pomace, and
have been linked to the prevention of several diseases [66].
Saucier and Waterhouse [70] isolated polyphenols from apple pomace processed from
Gala apples and evaluated antioxidant activity. Results showed apple pomace polyphenols had
2 to 3 fold greater 1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging and 10 to 30 fold
greater superoxide scavenging activity than vitamins C or E. In another study [71], polyphenols
were isolated from five apple pomace from six common Spanish apple cultivars (Limon Montes,
Meana, Durona de tresali, de la Riega, Perezosa, and Carrio). DPPH and ferric reducing power
(FRAP) assays were used to determine the antioxidant capacities of apple pomace from
different apple cultivars. Results showed apple pomace to be a rich source of polyphenols for all
cultivars. Certain cultivars showed greater antioxidant activity. Carrio had the highest (p<0.05)
DPPH and FRAP values. de la Riega and Meana, Limon Montes cultivars had higher DPPH
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values compared to other cultivars. Additionally, the study found the antioxidant activity of apple
pomace can be predicted by its content of phloridzin, procyanidin B2, rutin + isoquercitrin,
protocatechuic acid, and hyperin. High levels of these phytochemicals indicate more antioxidant
activity [71]. Apple pomace consists 95% skin, which contains a substantial amount of
polyphenols, including the polyphenolic compounds: cinnamic acid, epicatechin, caffeic acid,
and procyanidin [9,60]. Other chemical compounds found in the skin of apples may also have
potential beneficial health effects.

Ursolic Acid
The cuticle forms a protective layer on the surface of the skin of the apple and is
composed of two main components: cutin and wax [72]. The wax on the cuticle layer known as
the epicuticular wax protects against damage caused by insects and other pathogens and has
been suggested to have antioxidant properties [73,74]. The main epicuticular wax in apples is
ursolic acid [72]. Ursolic acid exists as several isomers including oleanolic acid [75]. Both ursolic
and oleanolic acid have been reported to have antioxidant, anti-inflammatory, anti-cancer, and
anti-hepatotoxic activities [76-82].
Apple pomace has been proposed to be a good source of ursolic acid [83,84]. Frighetto,
et al [75] measured ursolic acid content in the skin of different apple cultivars: Fuji, Gala, Smith,
and Granny Smith. Results found Smith apples had the highest content of ursolic acid (0.82
mg/cm2) followed by Fuji (0.77 mg/cm2), Granny Smith apples (0.49 mg/cm2), and Gala (0.21
mg/cm2). The authors concluded apple pomace could have potential benefits since apple
pomace includes the entire skin of the apple, and therefore, would be expected to provide large
amounts of ursolic acid. Grigoras, et al [85] evaluated ursolic acid isomers in apple pomace
processed from four apple cultivars: Gala variety Royal Gala Tenroy, Golden variety Golden,
Granny Smith, and Pink Lady variety Cripps Pink. Identification using high-performance liquid
chromatography (HPLC) showed apple pomace contained ursolic acid, and oleanolic acid,
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which was consistent with finding reported in apples. Furthermore, apple pomace from Gala
apples was shown to have readily extractable ursolic acid [86]. The presence of ursolic acid in
apple pomace provides further evidence in support of health benefits of apple pomace for
human consumption.
Overall, compositional analysis of apple pomace found several compounds present in
high concentration with beneficial effects that including attenuating metabolic dysfunction and
oxidative stress. This provides evidence in support of commercial development of compounds
isolated from apple pomace such as: total dietary fibers, pectin, and apple pomace
polysaccharides as a dietary supplement, functional food and/or food additive for human
consumption. Currently, extracted isolated compounds from apple pomace are being used for
human dietary supplements. However, extraction and purification of specific apple pomace
ingredients can be technologically challenging and costly. Also, the combination of compounds
in apple pomace may have synergistic effects. Therefore, the health benefits of whole apple
pomace consumption is reviewed in the next section.
1.0.6 Health Benefits of Apple Pomace Consumption
Ravn-Haren, et al [26] compared plasma lipid profiles of individuals consuming apple
pomace, apples or apple juice. Subjects were healthy non-smoking, non-obese men and
women (age 18-69 years, n=34) who did not use vitamin or mineral supplements. The
experimental design was a randomized single-blinded 5 x 4 weeks crossover study consisting of
five diet treatments, including: a restricted diet period low in pectin and polyphenols, and four
periods where the restricted diet was supplemented with either, apple pomace (22 mg/day),
apples (550 g/day), cloudy (fiber containing) apple juice (500 ml/day), or clear apple juice (500
ml/day).
Study results showed pectin consumption was correlated (r2=0.983) to reduced plasma
cholesterol concentration. Apple pomace consumption for four weeks had no significant effect
on serum total cholesterol, LDL-C, HDL-C, and bile acid concentration. This may be attributed to
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less pectin in apple pomace (2.12 g/day) than apples (2.87 g/day). Subjects consuming apple
pomace reported a trend (p<0.066) for decreased heart rate, blood pressure, serum alanine
amino transferase, C-reactive protein, insulin-like growth factor 1, and insulin like growth factor
binding protein 3. A significant health benefit of apple pomace consumption was improved
gastrointestinal health indicated by decreased (p<0.05) lithocholic acid excretion (Table 3).
Consumption of clear apple juice, which lacks dietary fiber, had no significant effect on
gastrointestinal function. Therefore, authors suggested the fiber (pectin) content of apple
pomace was the component responsible for improved intestinal health. However, the study
included subjects that ranged widely in age, inconsistent adherence to the study’s dietary
guidelines, the apple pomace group consumed the least fructose despite higher fructose
content. Additionally, lower pectin content was reported when most studies found significantly
higher pectin content in apple pomace compared to apples (Table 1).
In a further analysis of the Ravn-Haren, et al [26] study, Rago, et al [27] performed
untargeted metabolomics on plasma collected from subjects. Apple pomace consumption
decreased aromatic amino acids, which has been associated with gut microbial fermentation
and to insulin sensitivity. Additionally, apple pomace decreased plasma medium- and shortchain acylcarnitines, primary bile acids, deydropiandrosterone sulphate, and lysophospholipids,
which are associated with cholesterol transport from the liver. The authors concluded apple
pomace consumption can benefit cholesterol levels, insulin sensitivity, and gut microbial
functionality. However, the study also found apple pomace consumption increased plasma uric
acid (Table 3). Caliceti et al [87] reported a direct relationship between fructose intake and
circulating levels of uric acid, which is the final product of purine metabolism. Recent preclinical
and clinical evidence suggests that chronic hyperuricemia is an independent risk factor for
hypertension, metabolic syndrome, and cardiovascular disease [88-90]. It is also potentially an
independent risk factor for chronic kidney disease, type 2 diabetes, and cognitive decline [90-
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92]. Since fructose content is higher in apple pomace than apples (Table 1), health implications
of fructose content in apple pomace should to be further investigated.
Few studies have investigated the health benefits of apple pomace consumption by
humans despite preclinical studies reporting health benefits on lipid metabolism, body weight,
gut health, and glucose regulation as well as on antioxidant activity [9]. Cho, et al [28]
investigated the effect of feeding rats a HFD supplemented with apple pomace on body weight
and circulating lipids and lipoproteins. Weanling male Sprague-Dawley rats were randomly
assigned (n=8 animals/group) to diet groups including: HFD (15% by diet weight, consisting of
8% lard and 7% soybean oil) to induce obesity, a HFD supplemented with 10% (diet weight)
apple pomace, or a standard rodent diet. At the end of nine week feeding study, results showed
rats fed HFD supplemented with 10% apple pomace significantly reduced body weight and body
fat percentage, and improved serum lipid profiles indicated by lower (p<0.05) serum LDL-C and
higher (p<0.05) serum HDL-C compared to rats fed HFD. The authors concluded reduced body
weight and improved serum lipid profile in rats fed HFD supplemented with 10% apple pomace
was due to altered lipid metabolism indicated by reduced liver cholesterol and triglyceride
content, and higher fecal total cholesterol and triglyceride excretion (p<0.05) (Table 3).
Significantly higher fecal lipid excretion and improved lipid absorption and metabolism in rats fed
HFD supplemented with 10% apple pomace was attributed to higher fiber intake.
Bobek et al [29] reported similar effects of improved lipid profile. Weanling male Wistar
rats were randomly assigned (n=20 rats/group) to be fed either a cholesterol diet (0.3% diet
weight) or a cholesterol diet supplemented with 5% (diet weight) apple pomace for 10 weeks.
Results showed rats fed cholesterol diet supplemented with 5% apple pomace reduced (p<0.05)
liver cholesterol content by 11% compared to rats fed cholesterol diet. Rats fed diet
supplemented with apple pomace reduced (p<0.05) liver HMG-CoA reductase activity (a rate
controlling enzyme for de novo cholesterol synthesis), reduced plasma levels of conjugated
dienes, and increased (p<0.01) the fractional catabolic rate of plasma cholesterol, but did not
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significantly reduce plasma total cholesterol (Table 3). These results were attributed to the
ability of fiber to bind to bile acids. In addition, antioxidant status was determined. Cholesterol
diets supplemented with apple pomace significantly reduced antioxidant enzymes: SOD,
catalase, and GPx activity in erythrocytes (Table 3). The authors suggested decreased
erythrocyte antioxidant enzyme activity was due to an increase in vitamins C, E, and A, as well
as β-carotene, retinol, phytochemicals, and flavonoids from consumption of the apple pomace.
Based on the results the authors concluded apple pomace plays a significant role in antioxidant
defense systems. However, the study did not support the proposed mechanism by measuring
antioxidant vitamins or phytochemical content of apple pomace.
A preclinical study investigated polyphenol and fiber rich apple pomace on antioxidant
status and gastrointestinal physiology. Juskiewicz, et al [30] conducted a feeding study using
unprocessed apple pomace and apple pomace in which the polyphenol content was significantly
reduced by ethanol extraction, referred to as processed apple pomace. Male Wistar rats (age 35
days) were randomly assigned (n=8 animals/group) into three groups consisting of a standard
rodent diet (control) or a standard control diet supplemented with either 15% (diet weight)
unprocessed apple pomace or 14% (diet weight) processed apple pomace. Results showed
erythrocyte SOD was significantly higher in unprocessed apple pomace. Both apple pomace
groups significantly increased serum antioxidant capacity of water-soluble substances
compared to control. However, only unprocessed apple pomace significantly increased serum
antioxidant capacity of lipid-soluble substances. Additionally, unprocessed apple pomace
decreased (p<0.05) liver thiobarbituric acid reactive substances (TBARS) compared to control
(Table 3). As expected, unprocessed apple pomace which is rich in polyphenols showed greater
improvements in antioxidant status.
The effect of apple pomace on gastrointestinal health was determined by measuring
digestibility and gastrointestinal function markers. Nitrogen was used as a measure of
digestibility of the apple pomaces by measuring nitrogen intake compared to nitrogen excreted
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in the feces and urine. Nitrogen intake did not differ among groups, but both apple pomace
groups decreased (p<0.05) fecal nitrogen compared to control. Only unprocessed apple
pomace significantly decreased nitrogen in the urine. Nitrogen digestibility was significantly
decreased in both apple pomace groups, but nitrogen utilization was not altered. Both apple
pomace groups significantly increased cecum tissue weight, digesta, dry matter percentage, pH,
and ammonia in the cecum compared to control. Unprocessed apple pomace significantly
decreased digesta β-glucuronidase, an enzyme catalyzing the breakdown of complex
carbohydrates, compared to control while processed apple pomace showed greater microbiota
glycolytic activity indicated by significantly decreased digesta β-glucuronidase and βglucosidase. Rats fed unprocessed apple pomace also had the lowest (p<0.05) digesta pH in
the colon. Both apple pomace groups promoted fermentation indicated by significantly
decreased fecal pH and higher cecal digesta SCFA compared to control. Although, only
processed apple pomace decreased fecal pH at the end of the 28 days study (Table 3).
Collectively, the results suggested both unprocessed and processed apple pomace improved
intestinal health through beneficial decreases in gut enzymes without significantly impacting
nitrogen utilization. Also, unprocessed apple pomace favorably modified antioxidant status.
In another study examining the potential role of apple pomace on gastrointestinal health,
Kosmola, et al [31] randomly assigned young (age 4 weeks) male Wistar rats (n=8
animals/group) to be fed standard rat diet (control) or standard rat diet supplemented with apple
pomace (0.23% w/w), flavonoid-reduced (0.10 % w/w) apple pomace, or flavonoid-deprived
(0.01 % w/w) apple pomace. Following four weeks, gastrointestinal fermentation and health
were evaluated. Resulted showed all apple pomace groups had increased intestinal
fermentation, significantly higher fecal SCFA, and decreased cecum pH compared to control.
However, rats fed apple pomace had significantly increased cecum tissue weight compared to
control indicating greater ability to metabolize energy dense foods and had the lowest βglucuronidase which has been linked to a decreased risk for colon cancer [93]. Whereas,
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flavonoid-reduced apple pomace supplementation significantly increased glycolytic activity of
cecal microbiota and beneficially modified the ratio of cecal SCFA and branched-chain fatty
acids compared to control. Further, flavonoid reduction of apple pomace resulted in significantly
decreased cecal ammonia and colonic pH compared to control (Table 3). The authors
concluded apple pomace consumption improved gastrointestinal health with flavonoids in apple
pomace showing improved local interactions in the digestive tract.
When using animal models to study digestive health, the pig has advantages of similar
digestive and associated metabolic processes to humans. The pig is an omnivorous animal with
comparable nutritional requirements to humans and also has a similar intestinal microbial
ecosystem [94]. Sehm, et al [32] fed young (age 24 days old) male piglets (Pietráin × (Deutsche
Landrasse × Deutsches Edelschwein) a standard swine diet or a standard swine diet
supplemented with 3.5% (by weight) apple pomace for six weeks (n=39 pigs/group). Results
showed apple pomace supplementation had no significant effect on energy intake, feed uptake,
and average daily weight gain. However, apple pomace increased villi breadth in the jejunum
(p<0.01) and ileum (p<0.001) suggesting improved nutrient absorption. Apple pomace also
reduced (p<0.007) gut-associated lymphoid tissue (Table 3), which plays a role in the immune
function of the gastrointestinal tract, indicating apple pomace may offer anti-inflammatory
capabilities. Based on the results, the authors concluded apple pomace improved
gastrointestinal health.
Apple pomace was compared to other fruit byproducts as a source of fiber with potential
benefits for lipid metabolism, intestinal health, and glucose regulation. Macagnan, et al [33]
compared apple pomace to two other common fruit byproducts; orange bagasse and passion
fruit peel. Weanling male Wistar rats (n=8 animals/group) were randomly assigned to four
groups: supplemented with cellulose (50 g/kg) as a control, apple pomace (68.8 g/kg), orange
bagasse (99.6 g/kg), or passion fruit peels (86.2 g/kg). Different amounts of the fruit byproducts
were used to balance macronutrient and energy amounts among diets. After 34 days of feeding,
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food consumption, weight gain, and feed efficiency ratio did not differ among diet groups. All
fruit byproducts had significantly higher apparent digestibility of digestive fiber compared to
cellulose Apple pomace and orange bagasse had significantly increased fecal nitrogen
percentage, a marker of diet digestibility, compared to passion fruit peels and control (Table 3).
All fruit byproducts significantly decreased dry fecal production and increased fecal moisture
content. However, none significantly altered gastrointestinal transit time. Apple pomace had no
effect on intestinal fermentation, but the other fruit byproducts promoted intestinal fermentation
indicated by reduced (p<0.05) fecal pH. However, apple pomace had the highest (p<0.05) fecal
lipid percentage. This in turn, was expected to influence circulating lipids. All fruit byproducts
had significantly reduced serum triglycerides and liver LDL-C, but did not alter serum total
cholesterol (Table 3). Liver fat percentage was not significantly altered by any of the diet groups.
Regarding glucose regulation, all fruit fiber groups significantly decreased area under the
curve for glucose (Table 3). Orange bagasse and passion fruit peel, but not apple pomace
significantly reduced postprandial fasting glucose compared to cellulose. Only orange bagasse
significantly decreased glycemic peak. Other studies reported apple pomace consumption
improved blood glucose. Juskiewicz, et al [30] reported unprocessed polyphenol rich apple
pomace reduced serum glucose. Kosmala, et al [31] found feeding apple pomace and flavonoidreduced apple pomace, but not flavonoid-deprived apple pomace reduced serum glucose
(Table 3). All food byproducts studied were similar in terms of digestibility, gastric transit, and
lipid metabolism alterations. Orange bagasse appeared to be the most efficient at glycemic
control, which may be related to polyphenol content, as high polyphenol foods have been shown
to inhibit glucose absorption [95]. Collectively, the results indicate the importance of polyphenols
rich fiber as the compound in apple pomace influencing glucose regulation.
Ma, et al [34] investigated apple pomace combined with rosemary extract, a popular
flavoring herb, on fructose consumption-induced insulin resistance. Male Sprague Dawley rats
(age 7 weeks) were randomly assigned into two initial groups for the first 13 weeks of the study:
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water control (n=6 animals) or 10% (w/v) fructose in the drinking water (n=27). Following 13
weeks, the fructose group was divided into three groups (n=9 animals/group) fructose control,
fructose with 100 mg/kg of apple pomace and rosemary extract, and fructose with 500 mg/kg of
apple pomace and rosemary extract. At the end of five weeks, the higher dose of 500 mg/kg
apple pomace and rosemary extract significantly decrease fasting plasma glucose compared to
fructose control. Fasting plasma insulin, homeostasis model assessment of insulin resistance
(HOMA-IR) and adipose insulin resistance (Adipo-IR) were significantly decreased at both
doses of apple pomace and rosemary extract compared to fructose control. High dose (500
mg/kg) apple pomace and rosemary extract improved insulin resistance. Gastrocnemius
sarcolemmal CD36 contributes to insulin resistance by facilitating fatty acid uptake and downregulation of glucose transporter-4 (GLUT-4). Rats fed the high dose (500 mg/kg) of apple
pomace and rosemary extract significantly reduced gastrocnemius sarcolemmal CD36 and
GLUT-4 stain intensity compared to fructose control (Table 3). The authors concluded high dose
apple pomace and rosemary extract improved fructose consumption-induced insulin resistance
by attenuation of impaired CD36 cells and GLUT-4 transporter.
Collectively, human and animal study results showed apple pomace consumption
improved lipid metabolism, blood lipid profile, and metabolic dysfunction (e.g. hyperglycemia,
insulin resistance) induced by unhealthy diets (e.g. high in fat, high in fructose), as well as
antioxidant status and gastrointestinal health and therefore, warrants further research towards
development of apple pomace for human consumption. Of the preclinical studies investigating
potential health benefits of apple pomace consumption, all used animal models consisting of
growing or young adult males. Most feeding studies were of short-duration (4-10 weeks).
Typical of animal feeding studies, doses of apple pomace or purified apple pomace ingredients
were higher than typically consumed or achievable by humans and therefore, translational
dosing studies are needed. Evidence regarding the potential of health benefits of apple pomace
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for human consumption is promising. However, no studies have specifically addressing the
safety of apple pomace for human consumption.

1.0.7 Safety of Apple Pomace Consumption
The safety of apple pomace for human consumption has not been comprehensively
reviewed and few studies exist regarding potential health risks of consuming apple pomace. A
commercial use for apple pomace has been as a feed additive for livestock animals (e.g. cattle
and goats). Studies found apple pomace to be a suitable feed additive for livestock by providing
adequate nutrients with no detriments to protein digestion, growth, pregnancy outcome, and
milk production [96-99]. However, ruminants are not translational animal models and nutritional
inadequacies resulting from apple pomace intake is not a major concern for humans. Issues of
greater concern for apple pomace consumption by humans is presence of natural toxins in
apple seed and pesticide exposure.
The cyanogenic glycoside, amygdalin is a naturally-occurring plant toxin. When apple
tissues are disrupted amygdalin interact with endogenous digestive enzymes resulting in the
release of hydrogen cyanide. Consumption of cyanogenic plants can result in acute cyanide
poisoning with symptoms including: headaches, dizziness, hypotension, loss of consciousness,
coma, and death [100-102]. Bolarinwa, et al [100] analyzed apple seed amygdalin levels in 15
varieties of apples. Results found Golden Delicious (3.91 ± 0.49 mg/g), Royal Gala (2.96 ± 0.12
mg/g), and Red Delicious (2.80 ± 0.50 mg/g) had the highest seed amygdalin content. Braeburn
(1.19 ± 0.12 mg/g) and Egremont Russet (0.95 ± 0.22 mg/g) had the lowest seed amygdalin
content (Table 4) [100,103-115]. Variations in amygdalin content can be attributed to different
cultivars and environmental differences. The authors suggested that amygdalin content found in
apple seeds was high and consumption of apple seeds could be a cause for concern.
Opyd, et al [103] fed male Wistar rats (age 8 weeks) apple seeds isolated from apple
pomace to determine if the amygdalin content of apple seeds included in the pomace impacted
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health. Rats were randomly divided (n=10 animals/group) into three groups consisting of a high
saturated fat (7% lard, 1% cholesterol) and high fructose (68.75%) (HSHF) diet, HSHF
supplemented with 0.24% (the equivalent of 160 mg/kg) amygdalin, or HSHF supplemented
with 18.4 % apple seeds (amygdalin content=0.24%). Following 14 days, apple seed
supplementation significantly reduced dietary intake and body weight compared to control and
amygdalin diet groups. Additionally, protein digestibility and nitrogen retention were decreased
(p<0.001). Apple seed supplementation significantly increased cecum tissue mass and digesta
mass, increased microbial enzyme activity, and increased (p<0.001) digesta SCFA compared
control and amygdalin diet groups. Serum glucose, triglycerides, and total cholesterol were not
significantly affected by apple seed supplementation, but HDL-C was increased (p=0.015)
compared to control. Apple seed supplementation also increased (p=0.002) serum antioxidant
capacity of water-soluble substances compared to control and amygdalin and significantly
decreased liver TBARS compared to control. The authors concluded amygdalin content of apple
seeds did not negatively impact markers of digestion, blood lipids, and improved antioxidant
status of rats. Results indicated apple pomace which contain apple seeds to be safe for
consumption.
The National Institutes of Health Toxicology Data Network reported the lethal dose of
hydrogen cyanide to be 50-300 mg. The potential amount of hydrogen cyanide released from
apple seeds is 0.6 mg of hydrogen cyanide/g, which would require consumption of 83-500 apple
seeds for acute cyanide poisoning [104]. At most, an apple can contain 10 seeds and
depending on apple size ~1-2 apples are needed to produce 100g of apple pomace. Therefore,
an individual would need to consume nearly 800g of apple pomace for potential acute cyanide
poisoning [116,117].
Another potential adverse effect of apple pomace consumption by humans is pesticide
exposure since apple crops are heavily sprayed with pesticides, which includes fungicides and
plant growth regulators [9]. Lead arsenate pesticides were once popularly used in apple and
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other fruit orchards. Although many countries including the U.S. have ban the use of lead
arsenate and arsenic-based pesticides, arsenic and lead can persist in soil for years [118]. The
media has alerted consumer to presence of arsenic in food, most notably in apple juice [119].
No studies have investigated apple byproducts; however, it has been reported arsenic primarily
remains in soil, roots, and leaves [120,121]. Additionally, food processing has been suggested
to be effective for reducing pesticide residue [122,123]. Washing fruit and other produce has
been shown to be effective [124]. Washing apples with 10 mg/ml sodium bicarbonate for 12-15
minutes reduced the pesticides phosmet and thiabendazole levels in apples by 95.6% and 80%,
respectively. Using bleach, a common washing method, did not effectively remove pesticides
[125]. However, washing may not be sufficient for systemic pesticides, such as neonicotinoids
which translocate to all parts of the plant including the fruit [126]. Neonicotinoids have been
found to penetrate apple flesh with 24 hours of topical application, indicating potential for
neonicotinoid residues in apple pomace [106].
To assess health risk of pesticides on humans, the Environmental Protection Agency
(EPA) uses reference dose (RfD) which is an estimated measurement of daily human oral
exposure to acute or chronic dose that produces no adverse short-term or lifetime health risks
based on animal studies as well as % population adjusted dose (% PAD) which is based on RfD
and adjusts for additional susceptibility (e.g. infants, children, pregnancy) with values less than
100% PAD considered safe [127,128].
Apples contained low amounts of neonicotinoids (<0.001 mg/kg) however, acetamiprid
were more frequently detected in apples than other fruits and vegetables, based on the USDA
Pesticide Data Program from 2004-2011 [106]. In a mouse study, oral ingestion of 30
mg/kg/day of acetamiprid for 35 days resulted in significantly decreased testis, epididymis,
seminal vesicle, and prostate weights compared to mice provided no acetamiprid. Histological
evaluation showed acetamiprid damaged Leydig cells indicated by increased (p<0.05) testicular
p38 MAPK, a marker of stress and inflammation, and decreased testicular antioxidants:
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catalase, GPX and SOD. Sperm count, viability and motility, rate of intact acrosomes, and
serum testosterone were significantly decreased by acetamiprid ingestion (Table 4). Based on
the results acetamiprid reduced male fertility [105].
Chen, et al [106]. analyzed specific neonicotinoid residues in fruits and vegetables using
liquid chromatography-mass spectrometry. Analysis of apples included several varieties,
including: Cortland, Granny Smith, Fuji, Red Delicious, Golden Delicious, Gala, Honey Crisp,
and Macintosh. Results found apples to have negligible amounts of most neonicotinoids with the
exceptions of Granny Smith and Honey Crisp reporting high concentrations of acetamiprid of
0.0407 and mg/kg and 0.1007 mg/kg, respectively (Table 4). Based on these doses reported in
apples, results indicate a low risk for acetamiprid toxicity in humans since acute RfD for
acetamiprid is 0.10 mg/kg/day and the chronic RfD is 0.07 mg/kg/day, with % PAD ranging from
10-40% [107]. Based on the levels of toxicity reported for neonicotinoids in the mouse study by
Zhang, et al [105] ~30 mg/kg of neonicotinoids would need to be consumed for acute toxicity in
humans (Table 4).
Fungicides are another widely used chemical that results in better fruit yield and quality.
However, fungicides are environmentally mobile through wind and rain runoff and can be toxic
to humans [129]. Depending on dose, fungicides vary in adverse side effects in humans from
allergies to cancer [130]. Lozowicka [108] evaluated fungicide residues in a variety of fruits
using spectrophotometric and chromatographic techniques. Fungicide residue was found on
52% of 974 sampled fruits, including apples. However, 1.3% of fruits, including apples (n=696),
sampled exceeded the maximum residue level of pesticides. Dithiocarbamates, the most
widespread fungicide in the world, occurred most frequently in apples. In order to assess safety,
the author calculated both the long-term risk using hazard index, a measure of the maximum
amount of pesticide intake and safety and acute reference dose, which estimates 24 hours daily
oral exposure without long-term risk. A hazard index and an acute reference dose over 100%
indicates potential risk to the consumer. Short-term and long-term risks associated of all
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pesticides found on apples did not pose a health risk since hazard index and acute reference
dose values ranged from 0 to 4.65% (Table 4). The authors concluded long-term risks
associated with consuming fungicides from apples are low in children and adults based on their
risk estimates of consumed pesticides compared to acceptable daily intakes.
Liu, et al [109] analyzed fungicide residue in fresh apples (n=24) using HPLC. Of the
apples (n=24) sampled 50% had detectable fungicide residue. Three classes of fungicides
found in apples were thiophanate, carbendazim, and pyrimethanil. Liu, et al [113] reported
thiophanate residues in apples were within established maximum allowed residue levels (2
mg/kg). Additionally, the EPA states all foods known to have carbendazim and thiophanate
including apples have low % PAD [113,131]. However, apples were found to have the highest
amount of pyrimethanil among all surveyed fruits that included: grapes, watermelons, bananas,
blueberries, and peaches. Since no maximum residue levels have been established for
pyrimethanil and carbendazim conclusions cannot be drawn. However, the EPA’s data on
cyprodinil, a similar fungicide to pyrimethanil found minimal acute and chronic risk with the
highest % PAD being 5.8% [110,113]. The authors also calculated acute and chronic risk of
pesticide exposure and found negligible acute or chronic risk for thiophanate. According to the
authors long-term risk from fungicide exposure from apple consumption was negligible.
Plant growth regulators are also commonly used in apple growth and orchard
maintenance to defend against fruit drop and delay ripening [132]. Maiti, et al [111] studied
residues of naphthaleneacetic acid, a commonly used plant growth regulator, in apples by
HPLC method. Seven samples were analyzed as whole apples, apple skin only, and apple
without the skin. Apple skin showed the highest levels of naphthaleneacetic acid (0.433 mg/kg).
Naphthaleneacetic acid content in whole apple and apples without skin ranged from 0.042
mg/kg to 0.285 mg/kg (Table 4). No maximum permissible concentration for humans has been
established The EPA states naphthaleneacetic acid to poses no acute or chronic health risks
and levels in foods so low that no measurements are necessary [112]. Liu, et al [113] analyzed
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fresh fruits in China (the country producing the most apples worldwide) for plant growth
regulators residue using HPLC reported no detectable plant growth regulators residues (Table
4). Diphenylamine is a plant growth regulator commonly used to control browning during apple
storage. Lozowicka [108] reported diphenylamine to be present on 14.6% of apple samples
analyzed (n=696), however dose was not reported. The EPA reports animal studies on
diphenylamine studies have shown it to be slightly toxic through oral, dermal, and inhalation
route, causing increased bladder tumors in male and female mice, as well as reticulum cell
sarcomas in mice. However, the EPA has found diphenylamine to pose a low risk for toxicity,
setting a tolerance level of 10ppm for apples and 30ppm for apple pomace (Table 4) [114]. The
USDA has a database of pesticides detected in various foods, the highest concentration at
which the pesticides were detected, and the established EPA Tolerance Level for the pesticide.
The most recently published data on the USDA database is from 2015, with n=708 apples being
sampled and tested for 223 pesticides. No pesticide was found to be over the EPA’s established
Tolerance Levels. These results indicate apples and in turn, apple pomace likely does not
contain levels of pesticides harmful to human health [115].
Collectively, studies results showed apple pomace to be a safe feed additive for
livestock and pesticide content in apples to be within accepted safe standards for human
consumption. Previous studies on feeding apple pomace to rodents and humans have not
shown health detriments. However, it should be noted that no studies directly evaluated
potential risks associated with pesticide residues in apple pomace. Although apples contain
naturally toxic substances (e.g. amygdalin), the amount of apple pomace that must be
consumed to result in acute toxicity would be nearly 2 lbs. Therefore, apple pomace appears to
be safe for human consumption. However, more studies are needed on the safety of apple
pomace for human consumption to ensure various pesticides and harmful compounds are not
retained at toxic levels in apple pomace.
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1.0.8 Potential Food Uses
Apple pomace is being studied for extraction and isolation of nutrients such as dietary
fiber and polyphenols for use as purified food ingredients. Dietary fibers extracted from apple
pomace and used as a replacement for fat in cookies resulted in changes in cookie size, shape,
and color but maintained a pleasing texture for consumption [133]. Others have investigated
apple pomace as an ingredient in baked goods. Apple pomace was incorporated into cakes to
increase dietary fiber and polyphenol content. Cakes prepared with 25% apple pomace wheat
flour blend resulted in 14.2% total dietary fiber content compared to 0.47% in wheat flour.
Additionally, 25% apple pomace blend increased polyphenols by 50%. Results showed
incorporating apple pomace as an ingredient in cakes improved its nutritional profile [134].
Masoodi, et al [8] utilized apple pomace as a source of dietary fiber in wheat bread. Blends were
made by incorporating 2, 5, 8, and 11% apple pomace into wheat flour. Sensory evaluation
found up to 5% apple pomace in wheat bread maintained favorable texture, color, general
appearance, taste and odor. Unrefined dried powered apple pomace was evaluated in an
ingredient pie filling and oatmeal cookies. Apple pomace added at 10-20% total formula of pie
filling resulted in no differences in sensory attributes except for texture. Apple pomace added to
oatmeal cookies at 30, 40, and 50% weight resulted in flavor changes. However, both products
were rated as moderately liked [135]. Issar, et al [136] utilized apple pomace to develop a fiberenriched yogurt. Apple pomace was added at 2.5, 5, 7.5 and 10% to whole milk then inoculated
with starter culture. Fiber ranged from 2.42 to 9.94% with optimal sensory attributes of color,
flavor, texture, and overall acceptability reported with 5% apple pomace. To our knowledge no
studies have evaluated apple pomace as an edible food. Apple pomace has high potential to be
reconstituted into a food product due to its favorable nutritional profile and reported sweet taste
and smell [9,135,137]. However, apple pomace would need to be dried due to its high moisture
content and propensity for rapid spoilage [9]. Following drying, apple pomace could potentially

32

be reconstituted into snack bars, granolas, flavoring powders, toppings, and other innovative
food products.

1.0.9 Conclusion
Apple pomace is a byproduct of the apple processing industry that is typically regarded
as waste and presents a public health issue as its disposal is difficult and costly. As reviewed in
this paper, nutrient composition of apple pomace showed higher content of dietary fiber,
essential fatty acid, protein, several dietary minerals important to human health, several classes
of dietary antioxidants, and ursolic acid as compared to apples and other popularly consumed
fruits in the U.S., making it a potentially nutritious for human consumption.
Collectively, preclinical study results reported health benefits of improved lipid
metabolism, antioxidant capacity, and digestive health indicating apple pomace’s potential as a
dietary supplement, food additive or functional food for human consumption. Studies have
shown no deleterious effects in livestock from consumption of apple pomace as a feed additive
and research on pesticide content in apples has shown safe levels for short- and long-term
human consumption. However, further mechanistic, translational dose, and clinical studies on
both health benefits as well as safety of apple pomace for human consumption are required.
Apple processing is a continually growing industry, as ciders and juices are in high demand,
resulting in apple pomace being readily available. Therefore, re-purposing apple pomace as a
commercial product for human consumption can result in an environmental and economical
solution to apple waste generated by industrial processing of apples.
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Table 1. Comparison of the nutrient composition of whole apples versus apple pomace
Constituents (Fresh weight)
Whole Apple1
Apple Pomace2
Macronutrients (%)
Fat
0.16-0.18
1.1-3.6
Protein
0.24-0.28
2.7-5.3
Total Carbohydrate
13.81
44.5-57.4
Simple Carbohydrates (%)
Fructose
5.8-6.0
44.7
Glucose
2.4-2.5
18.1-18.3
Complex Carbohydrates (%)
Total Fiber
2.1-2.6
4.4-47.3
Insoluble Fiber
1.54
33.8-60.0
Soluble Fiber
0.67
13.5-14.6
Pectin
0.71-0.93
3.2-13.3
Major Minerals (mg/100g)
Sodium
0.9-1.1
185.3
Potassium
104.8-109.2
398.4-880.2
Calcium
5.7-6.3
55.6-92.7
Phosphorus
10.7-11.3
64.9-70.4
Magnesium
4.9-5.1
18.5-333.5
Trace Elements (mg/100g)
Iron
0.11-0.13
2.9-3.5
Zinc
0.0036-0.0044
1.4
Copper
0.026-0.028
0.1
Manganese
0.033-0.037
0.4-0.8
Values are the ranges reported for n=6-38 samples. A single value indicates an n=1 sample.
1
Values for whole apples are based on the USDA database.[1] 2Values for apple pomace are
based on Bhushan, et al.[2] and Queji, et al.[3]
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Table 2. Mineral values in commonly consumed fruits in North America.
Dietary
Minerals
Apples1
Bananas1
Pears1
Grapes1
Oranges1 Blueberries1 Apple Pomace2
mg/100 g Fresh
Weight
Sodium
1 ± 0.07
1 ± 0.40
1 ± 0.20
0.4 ± 0.44
0 ± 0.03
0.16 ± 0.35
185.3 ± 0.00
Potassium
107 ± 2.21
358 ± 1.91
116 ± 3.61
191 ± 27.52 181 ± 1.40
77 ± 5.45
639.3 ± 240.9
Calcium
6 ± 0.34
5 ± 0.05
9 ± 0.41
14 ± 1.72
43 ± 2.24
6 ± 0.79
74.1 ± 18.5
Phosphorus
11 ± 0.34
22 ± 0.17
12 ± 0.23
10 ± 0.61
14 ± 0.44
12 ± 0.51
67.6 ± 2.8
Magnesium
5 ± 0.07
27 ± 0.48
7 ± 0.07
5 ± 0.18
10 ± 0.17
6 ± 0.20
176.0 ± 157.5
Iron
0.12 ± 0.01 0.26 ± 0.001 0.18 ± 0.03
0.29 ± 0.06
0.1 ± 0.04
0.28 ± 0.11
3.2 ± 0.3
Zinc
0.04 ±0.004 0.15 ± 0.001 0.10 ± 0.004 0.04 ± 0.01
0.07 ± 0.00
0.16 ± 0.02
1.4 ± 0.00
Values report as mean ± SE for n=1-212 samples.
1
Values for apples, bananas, pears, grapes, oranges, and blueberries are from USDA.[1,4-8] 2Apple pomace values are from
Bhushan, et al.[2]
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Table 3. Studies of apple pomace constituents and whole apple pomace effects on health.
Reference
Dietary study characteristics
Results
Apple Pomace
Constituents
Chen, et al. (2017) [23]

Male Kunming mice age 45d
n=18 animals/group
45% HFD with 200, 400, or
800 mg/kg bwt/d apple
pomace polysaccharide
extract for 30 days

200 mg/kg bwt/d
↓ serum cholesterol
↓ serum insulin
↓ serum adiponectin
↓ serum leptin
200 and 400 mg/kg bwt/d
↓ serum LDL-C
All doses
↓ fasting serum insulin
↓ serum hexokinase and glucagon
↓ liver lipid
↑ serum antioxidant capacity dose-dependent

Sembries, et al. (2006)
[24]

Male Wistar rats age 8 weeks
n=12 animals/group
Standard rodent diet with 5%
apple pomace fiber-rich
colloid for 6 weeks

↑ cecum SCFA, acetate, and proprionate
↑ fecal bile acid excretion
↓ body weight

Sembries, et al. (2004)
[25]

Male Wistar rats age 6 weeks
n=10 animals/group
Standard rodent diet + 5%
apple pomace fiber-rich
colloids for 6 weeks

↓ serum CHL
↓ serum LDL-C
↑ serum HDL-C
↑ fecal bile acid and neutral sterol excretion

Men and women age 18-69
years (n=34)
Polyphenol and pectin
restricted diet + 22 mg/day

NS lipid profile and bile acid
↓ fecal lithocholic acid excretion

Apple pomace
Human Studies
Ravn-Haren, et al. (2015)
[26]
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apple pomace for 5 x 4
weeks crossover

Rago, et al. (2015) [27]

Preclinical Studies
Cho, et al. (2013) [28]

Bobek, et al. (1998) [29]

Juskiewicz, et al. (2012)
[30]

Men and women age 18-69
years (n=34)
Polyphenol and pectin
restricted diet + 22 mg/d
apple pomace for 5 x 4
weeks crossover

Plasma measurements:
↓ aromatic amino acids
↓ medium- and short-chain acylcarnitines
↓ primary bile acids
↓ deydropiandrosterone sulphate, and lysophospholipids
↑ uric acid

Male Sprague Dawley rats
age 3 weeks (n=8
animals/group)
15%HFD + 10% apple
pomace for 9 weeks

↓ body weight and fat
↓ serum LDL-C
↑ serum HDL-C
↓ liver CHL and TG
↑ fecal CHL and TG

Male Wistar rats age 3 weeks
n=20 animals/group
0.3% CHL + 5% apple
pomace for 10 weeks

↓ liver CHL
↓ liver HMG-CoA reductase
↓ plasma conjugated dienes
↑ fractional catabolic rate of plasma CHL
↓ erythrocyte SOD, catalase, GPx activity

Male Wistar rats age 35 d
n=8 animals/group
Standard diet + 15%
unprocessed or 14%
processed apple pomace for
28 d

Unprocessed apple pomace
↑ erythrocyte SOD
↑ serum antioxidant capacity of fat and water-soluble
substances
↓ urine nitrogen
↓ digesta β-glucosidase
↓ serum glucose
↓ liver TBARS
Processed apple pomace
↑ antioxidant capacity of water-soluble substances
↓ digesta β-glucosidase and β-glucuronidase
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↓ colon digesta pH
↓ fecal pH
All apple pomace groups
↓ fecal nitrogen
↓ nitrogen digestibility
↑ cecum tissue weight, digesta, dry matter, pH, ammonia
↑ cecal digesta SCFA

Kosmala, et al. (2011) [31]

Male Wistar rats age 4 weeks
n=8 animals/group
Standard diet + 0.23% (w/w)
whole apple pomace, 0.10%
(w/w) flavonoid-reduced
apple pomace, or 0.01%
(w/w) flavonoid-deprived
apple pomace for 4 weeks

Whole apple pomace
↑ cecum tissue weight
↓ β-glucuronidase
↓ serum glucose
Flavonoid-reduced apple pomace
↑ cecal microbiota glycolytic activity
Modified cecal SCFA:BCFA ratio
Flavonoid-deprived
↓ cecal ammonia
↓ colonic pH
↓ serum glucose
All apple pomace groups
↑ intestinal fermentation
↑ fecal SCFA
↓ cecum pH

Sehm, et al. (2007) [32]

Male Pietráin × (Deutsche
Landrasse ×Deutsches
Edelschwein) piglets age 24d
n=39 animals/group
3.5% apple pomace for 6
weeks

NS feed/energy intake, weight gain
↑ jejunum and ileum villi breadth
↓ gut-associated lymphoid tissue

Macagnan, et al. (2015)
[33]

Male Wistar rats age 3 weeks
n=8 animals/group
Standard diet + 68.8 g/kg of

↑ apparent digestibility
↑ fecal nitrogen
↓ dry fecal production
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apple pomace for 34 d

↑ fecal moisture content
↑ fecal lipid
↓ serum TG
↓ liver LDL-C
↓ AUC for glucose

Ma, et al. (2016) [34]

Male Sprague-Dawley rats
500 mg/kg apple pomace
age 7 weeks
↓ fasting plasma glucose
n=6-9 animals/group
↓ gastrocnemius sarcolemmal CD36 and GLUT-4 stain
10% fructose in water +
intensity
standard diet with 100 mg/kg Both apple pomace groups
or 500 mg/kg apple pomace
↓ plasma insulin, HOMA-IR, and Adipo-IR
+ rosemary extract for 5
weeks
Abbreviations and symbols: ↓, decrease; ↑, increase; Adipo-IR, adipose tissue insulin resistance; AUC, area under the curve; BCFA,
branched-chain fatty acid; CHL, cholesterol; HDL-C, high density lipoprotein-cholesterol; GPx, glutathione peroxidase; HFD, high fat
diet; HOMA-IR, homeostatic model assessment for insulin resistance; LDH, lactate dehydrogenase; LDL-C, low density lipoproteincholesterol; NS non-significant; SCFA, short-chain fatty acids; SOD, super oxide dismutase; TBARS, thiobarbituric acid reactive
substances; TG, triacylglycerol.
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Table 4. Studies on safety of apple and apple constituents and pesticide safety information.
Reference
Safety study characteristics
Results
Amygdalin
Bolarinwa, et al. (2014) [100]
Seeds from 15 apple varieties
↑ amygdalin (2.80-3.91 mg/g) in Golden
Delicious, Royal Gala, and Red Delicious
↓ amygdalin (0.95-1.19 mg/g) Braeburn and
Egremont Russet
Opyd, et al. (2017) [103]

Male Wistar rats age 8 weeks
n=10 animals/group
High-saturated fat (7% lard, 1%
CHL) and high-fructose (68.75%)
diet with 0.24% amygdalin or
18.4% apple seeds (0.24%
amygdalin)

Amygdalin dose equivalent to 160 mg/kg
Apple Seeds
↓ food consumption
↓ body weight
↓ protein digestibility and nitrogen retention
↑ cecum and digesta mass
↑ cecum microbial enzyme activity
↑ digeta SCFA
↑ serum HDL-C
↑ serum antioxidant capacity of watersoluble substances
↓ liver TBARS

NIH (2017) [104]

Toxicology Database

Hydrogen cyanide LD=50-300 mg
= need to consume ~800g apple pomace

Male Kungming mice age 8
weeks
n=10 animals/group
Oral ingestion of 30 mg/kg bwt/d
acetamiprid for 35 d

~30 mg/kg = toxicity in humans
↓ testis, epididymis, seminal vesicle,
prostate weight
↑ Leydig cell damage
↑ testicular p38 MAPK
↓ testicular catalase, GPX, and SOD
↓ sperm count, viability, and motility, rate of
intact acrosomes
↓serum testosterone

Pesticides
Neonicotinoids
Zhang, et al. (2011) [105]
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Chen, et al. (2014) [106]

8 apple varieties

↑ acetamiprid Granny Smith (0.407 mg/kg)
and Honey Crisp (0.1007 mg/kg)

EPA (2002) [107]

Acetamiprid Fact Sheet

Acute RfD=0.10 mg/kg/d
Chronic RfD=0.07 mg/kg/d
% PAD=10-40

Apples n=696

Dithocarbamate residue found most
frequently on apples
Risk at 100%
Hazard index and acute reference dose 04.65%

Apples n=24

Thiophanate (2 mg/kg) and found within
allowed residue levels
Thiophanate and carbendazim low % PAD
↑pyrimethanil compared to other fruits
EPA (1998)[29] states cyprodinil (similar to
pyrimethanil) % PAD=5.8

Apples n=7
Whole apples
Apples without skin
Apple skin

↑ Naphthaleneacetic acid residue on apple
skin (0.433 mg/kg)
Naphthaleneacetic acid in whole apples and
without skin (0.042-0.285 mg/kg)
EPA (2007)[31] states naphthaleneacetic
acid poses no acute or chronic health risks

Liu, et al. (2016) [113]

Apples n=24

No detectable PGR residue

Lozowicka (2015) [108]

Apples n=696

Diphenylamine found on 14.6% of apples
EPA(1998)[33] states low risk for toxicity
Tolerance level of 10 ppm (apples) and 30
ppm (apple pomace)

Fungicides
Lozowicka (2015) [108]

Liu, et al. (2016) [109]

Plant Growth Regulators
Maiti, et al. (1988) [111]
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USDA Database (2015) [115]

Apples n=708

223 pesticides tested for
All below EPA tolerance level
Abbreviations and symbols: ↓, decrease; ↑, increase ; EPA, Environmental Protection Agency; NIH, National Institutes of Health; NS,
non-significant; PGR, plant growth regulator; ppm, parts per million; RfD, reference dose; % PAD, % population adjusted dose;
TBARS, thiobarbituric acid reactive substances; USDA, United States Department of Agriculture.
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1.1 Diet-induced non-alcoholic fatty liver disease: a brief review
Non-alcoholic fatty liver disease (NAFLD) is the most prevalent liver disease worldwide
with prevalence also rising in children [1,2]. NAFLD is defined as hepatic steatosis not caused
by alcohol consumption and is often linked to overconsumption of saturated fat and simple
carbohydrates as well as obesity [3-5]. NAFLD can progress to the more severe non-alcoholic
steatohepatitis (NASH), which includes inflammation in addition to steatosis [6]. As the disease
progresses from NAFLD to NASH, mortality and systemic complications increase [7,8].
Approximately 25% of the world’s population is reported to have NAFLD, with 25% of these
individuals having the more severe NASH [9]. However, prevalence may be higher since liver
biopsy is most accurate diagnostic for the disease is costly and invasive [10]. As the obesity
epidemic continues, cases of NAFLD and NASH, with current predications forecasting a
potential liver disease crisis [9,11].
1.1.1 Etiology
NAFLD has been suggested to be the hepatic manifestation of metabolic syndrome [12].
Poor diet and lack of physical exercise are factors in NAFLD development [1]. NAFLD
prevalence is particularly high in Western countries, due to “Western diets” defined as diets high
in saturated fat and simple carbohydrates [13,14]. A multiple-hit model has been proposed to
explain NAFLD progression, with the first hit being accumulation of fat in the liver and the
second hit being the onset of inflammation [4].
Accumulation of hepatic fat results from dysregulation of hepatic lipid metabolism.
Overconsumption of saturated fat and simple carbohydrates results in increased i lipogenesis
(DNL) through the stimulation of genes involved in the DNL cascade [15,16]. Transcription
factors sterol regulatory binding protein-1c (SREBP-1c) and carbohydrate element response
binding protein (ChREBP) stimulate fatty acid synthase (FAS) to catalyze the synthesis of
saturated fatty acids (SFAs) [15]. These SFAs can then be further desaturated to
monounsaturated fatty acids (MUFAs) by stearoyl-CoA desaturase (SCD-1), which are more
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readily used for triglyceride synthesis [15,17]. Esterification is catalyzed by diacylglycerol O-acyl
transferase-2 (DGAT2), resulting in the accumulation of hepatic triglycerides [18]. Triglycerides
can accumulate in the liver or enter circulation via activation by microsomal triglyceride transport
protein (MTTP), which stimulates very-low density lipoprotein (VLDL) production and
subsequent circulation (Figure 1) [19].
Rise in circulating VLDL impairs bile acid homeostasis [20]. Typically, bile acids assist in
digestion and absorption of fats and fat-soluble vitamins, cholesterol homeostasis, and
eliminates waste from the body [20, 21]. Bile acids also act as metabolic signaling molecules,
with normal reabsorption critical for triglyceride and glucose metabolism homeostasis [21].
Individuals with NAFLD have elevated bile acid production which contributes to elevated levels
of circulating fatty acids and glucose that eventually leads to increased fat deposition and a
proinflammatory state [22-24]. Additionally, bile acid dysregulation along with increased DNL
can increase circulating free fatty acids [25]. Increases in MUFAs have been shown to
increased triglyceride production and storage [26]. While increases in SFAs has been linked to
increased inflammation, a second hit in the NAFLD cascade [27].
Increases in SFAs has been shown to stimulate inflammatory gene expression, through
activation of transcription factor nuclear factor kappa-light enhancer of activated B cells (NFκB)
[28]. NFκB activates downstream inflammatory cytokines, such as IL-6 and TNF-α, resulting in
increased hepatic inflammation [4,29]. This inflammatory cascade is not limited to the liver, as
adipose tissue is also implicated in the inflammatory process. Alterations in fatty acid and
glucose metabolism result in in adipose tissue lipogenesis leading to alterations in adipose
tissue fatty acid profiles and inflammation status, further exacerbating increased hepatic DNL
[30-32]. Inflammatory cytokines, upregulated by SFA, are transported to the liver, further
promoting inflammation [4,30]. Inflammation coupled with increased reactive oxygen species
(ROS) generation from free fatty acid metabolism promotes NAFLD progression to the more
severe NASH (Figure 2) [6].
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Further complicating this progression, polyunsaturated fatty acids (PUFAs) can also
exacerbate inflammation and lipid peroxidation in NASH [14,33]. Overconsumption of the n-6
PUFA, linoleic acid can result in increased inflammation and exacerbate liver disease [34].
Current recommendation are for the ratio of linoleic acid to n-3 PUFA α-linolenic acid to be
approximately 1:1. The Western diet has a linoleic:α-linolenic acid ratio of 15:1 [14,34]. This
essential fatty acid imbalance increases metabolism of linoleic acid to arachidonic acid [35].
Arachidonic acid can be further metabolized by cyclooxygenases to bioactive compounds, 2
series prostaglandins and thromboxanes or to 4 series leukotrienes by lipooxygenases [36,37].
Further, the ratio of n-6:n-3 has been shown to be the most important determinant of cell
membrane composition, with an increase in n-6 consumption leading to a proinflammatory state
[38].
Increases in inflammatory cytokines from the liver and adipose tissue can be circulated
to the kidney, resulting in renal inflammation and vascular dysfunction [4,39]. Increased uric acid
production, due to overconsumption of sucrose and fructose, further exacerbates inflammation
and increases risk of developing kidney stones, gout, and other renal diseases [40-42] [43,44].
Additionally, recent research suggests as NAFLD progresses it can result in detriments to bone
health. Individuals with NAFLD have been shown to have decreased bone mineral density, and
to increase the risk of osteoporosis [45-47]. Chronic inflammation increases in inflammatory
cytokines, and decreased antioxidant defense have been suggested as a link between NAFLD
and decreased bone mineral density [47].
NAFLD is reversible with lifestyle modifications. However, as NAFLD progresses from
simple steatosis to NASH reversibility decreases [6]. Continual consumption of a diet high in
saturated fat and simple carbohydrates without intervention can lead to the onset of NASH, and
eventual cirrhosis [6,48]. Cirrhosis of the liver is defined as hepatic steatosis, inflammation, and
fibrosis [49]. Cirrhosis is advanced stage liver disease that is irreversible and significantly
increases risk of mortality [49,50]. Currently, no Food and Drug Administration approved drugs
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exist for NAFLD treatment, medications are recommended to slow progression of cirrhosis,
along with lifestyle modifications [51]. Cirrhosis of the liver also further increases the risk for
chronic kidney disease, osteoporosis, and development of hepatocellular carcinoma [5,6,52,53].
Drug and lifestyle interventions slows the progression of cirrhosis, however liver transplant the
only effective remedy [49]. NAFLD prevalence is increasing and onset is occurring in younger
individuals with potential of a liver transplant epidemic in the future [7]. Therefore, diagnosis of
NAFLD in its early stages in essential for improving outcomes and reducing potential burdens
associated with late-stage liver disease.

1.1.2 Diagnosis
NAFLD and NASH are diagnosed by liver biopsy and histological evaluation of the liver
for steatosis, inflammation, and hepatocellular ballooning, or enlargement of hepatocytes [54].
Histological grading for steatosis is divided into four scores: a score of 0 indicates no sign of fat
infiltration, a score of 1 indicates fat infiltration in <33% of hepatocytes, a score of 2 indicates fat
infiltration in 33-66% of hepatocytes, and a score of 3 indicates fat infiltration in >66% of
hepatocytes [55]. Similarly, inflammation is categorized by grading. Inflammation grades are
divided into lobular inflammation, chronic portal inflammation, and cell ballooning. Liver lobular
inflammation is scored as: 0 being no sign of inflammation, 1 being <2 signs of lobular
inflammation present, 2 being 2-4 signs of lobular inflammation present, and 3 being >4 signs of
lobular inflammation present. Chronic portal inflammation is scored as a 0, 1, or 2, being none,
mild, or severe respectively. Ballooning is scored similarly, with 0 being none, 1 being few, and
2 being many [54,56]. Fibrosis is scored as: 0 being no fibrosis, 1 being fibrosis in the
presinusoidal or portal region, 2 being fibrosis in the presinusoidal and portal region, 3 being
bridging of fibrosis, and 4 being cirrhosis [57].
While liver biopsies provide the most reliable method for diagnosing NAFLD and NASH,
the procedure is invasive, costly, and only performed when an individual is suspected of having
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liver disease [58]. Researchers have criticized pitfalls in using liver biopsies and histology for
diagnosis due to inability for early NAFLD detection and potential confounders causing liver
damage separate from diet (i.e. alcohol and drugs) [59]. Therefore, other methods are also
used to diagnosis liver disease. Serum measurement of alanine aminotransferase (ALT) and
aspartate aminotransferase (AST) are used as biological indicators of liver injury [60]. ALT and
AST are enzymes that catalyze reactions important for transamination and elevated levels can
indicate liver damage [61]. However, studies have shown serum ALT and AST levels to be
normal in up to 60% of individuals with NAFLD and NASH, indicating the value of these
enzymes for diagnosing and are insufficient [62]. Other measurements used to complement ALT
and AST measures include: insulin resistance using homeostatic model assessment (HOMA),
fasting glucose, triglycerides, cholesterol, as well as blood pressure and abdominal
circumference [57]. New imaging tools are being developed to diagnose NAFLD. Abdominal
ultrasounds are being widely used to aid diagnosis of NAFLD; however, few studies have
investigated their accuracy [63]. Therefore, histological evaluation remains ‘the gold standard’
for determining NAFLD and disease progression.

1.1.3 Treatment
In the absence of Food and Drug Administration approved drugs that specifically treat
NAFLD, lifestyle changes are the primary treatment for liver disease [64,65]. Weight loss diet
modification to achieve a healthier weight is recommended to treat NAFLD. Other dietary
recommendations are to decrease saturated fat, sucrose, and fructose consumption.
Decreasing overconsumption of saturated fat and simple sugars reduces DNL and inflammation
[1]. Additionally, increased consumption of n-3 fatty acids, as well as complex carbohydrates,
dietary fiber, and antioxidants have been suggested as treatments for NAFLD [33,65,66].
Increasing consumption of n-3 fatty acids, particularly eicosapentaenoic acid (EPA) and
docosahexaenoic acid (DHA), has been shown to decrease expression of SREBP-1c and
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ChREBP resulting in decreased circulating free fatty acids, DNL and hepatic fat storage.
Supplementing with long-chain n-3 fatty acids has also been shown to reduce inflammation and
oxidative stress through modulation of inflammatory cytokines, particularly IL-6 and TNF-α [67].
Studies have yet to elucidate the optimal n-3 PUFA to treat NAFLD [67,68].
Dietary fiber also has health benefits associated with reducing NAFLD. Soluble dietary
fiber binds to LDL- and VLDL-cholesterol decreases circulating cholesterol [69,70]. Soluble fiber
consumption also produces short-chain fatty acids. Short chain fatty acids have been shown to
decrease hepatic inflammation, lipid deposition, and to increase lipid metabolism [71]. Dietary
fiber also bind to bile acids resulting in a decrease in circulating bile acids, ameliorating
increased bile acids caused by NAFLD [69,72]. Additionally, increasing antioxidant intake has
been suggested for NAFLD since individuals with liver disease have been shown to have
increased inflammation, ROS, and lipid peroxidation [4,25]. Antioxidants stabilize free radicals
by donating electrons ameliorating the impact of free radicals on ROS and inflammation [73].
Although a plethora of studies have been conducted on various dietary antioxidants, results
have produced inconsistences in regarding effectiveness [74-76]. Studies suggest antioxidants
may have the greatest efficacy when combined with dietary fiber [75,77].
Studies have been conducted utilizing insulin sensitizing drugs, LDL-cholesterol
reducing drugs, and bile acid targeting drugs have produced inconsistent results [7,76,78,79].
However, as discussed diet was able to favorably modulate the proposed drug targets for
treating NAFLD [66]. Using functional food to treat of NAFLD has recently gained attention.
Functional foods are defined as foods that beneficially affect one or more target functions in the
body beyond adequate nutritional effects. Functional foods can be whole foods such as an
apple or isolated components antioxidant compounds derived from apples [73]. Recent studies
on the role of functional foods, particularly antioxidant and probiotic foods, as a treatment
NAFLD have produced favorable results indicating potential for use as a treatment for NAFLD
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[80-84]. Although new drugs and physiological targets continue to be studied, lifestyle
modification remains the standard for treating individuals diagnosed with NAFLD.

1.1.4 Conclusions
NAFLD is the most prevalent liver disease in the world, with projections estimating a
potential liver disease epidemic [9,39]. NAFLD is primarily a lifestyle disease with increased
saturated fat and simple carbohydrate consumption and physical inactivity central to disease
etiology [4]. Onset of NAFLD is characterized by steatosis caused by alterations in lipid
metabolism leading to increased DNL and alterations to bile acid homeostasis subsequently,
followed by progression to NASH due to increased inflammation and ROS [4,21,85]. As NAFLD
progresses to the more severe NASH, the disease becomes more difficult to manage.
Eventually, untreated NASH can lead to cirrhosis, an incurable liver disease requiring liver
transplant [6]. The continual increase in NAFLD prevalence, with onset occurring at a younger
age, gives credence to a potential liver transplant epidemic [9]. Therefore, improved diagnosis
and treatment of NAFLD are essential.
Difficulties with diagnosing NAFLD has shifted focus to finding novel and effective
treatments. Currently, no drugs are approved to treat NAFLD and therefore, lifestyle
modification are primary treatment [64]. Dietary recommendations include decreasing saturated
fat and simple carbohydrate intake and increasing complex carbohydrate and antioxidant intake
[86]. Fruits, such as apples are high in dietary fiber and antioxidant compounds indicating its
potential as a nutrition aid in the prevention and treatment of NAFLD [87,88]. Apple pomace, a
waste byproduct from apple processing, should also be considered. When compared to apples,
fiber content and antioxidant polyphenol content were higher in apple pomace [89,90].
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Figure 1. Illustration of de novo lipogenesis, lipid storage, and transport pathway. Adapted from
Browning, et al [91]. Abbreviations: ACC, acetyl co-A carboxylase; ACL, ATP citrate synthase;
ApoB, apolipoprotein B; ChREBP, carbohydrate response element bind protein; CPT-1,
carnitine palmitoyltransferase 1; diacylglycerol O-acyltransferase 2; FAS, fatty acid synthase;
FFA, free fatty acids; HSL, hormone sensitive lipase; LCE, long chain fatty acyl elongase; SCD,
stearoyl-CoA desaturase; SREBP1c; sterol regulatory element binding protein 1c; VLDL, very
low-density lipoprotein [6].
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Figure 2. Depiction of the multiple hit theory of liver disease progression. Abbreviations: FFA,
free fatty acids; NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis
[92].

76

2.0 Study Objectives and Hypotheses
Study 1
Objective: To investigate the effect of 10% caloric substitution with apple pomace on features
of Western diet-induced non-alcoholic fatty liver disease in growing female rats.
Hypothesis: Caloric substitution with apple pomace will attenuate features of non-alcoholic fatty
liver disease in growing female rats consuming a Western diet.

Study 2
Objective: To determine the effect of 10% caloric substitution with apple pomace on features of
Western diet-induced non-alcoholic steatohepatitis in growing female rats.
Hypothesis: Caloric substitution with apple pomace will attenuate features of Western dietinduced non-alcoholic steatohepatitis in growing female rats.

Study 3
Objectives: To determine the effect of 10% caloric substitution with apple pomace on renal and
bone health in growing female rats consuming ‘healthy’ and Western diets.
Hypothesis: Caloric substitution with apple pomace will not have detriment renal or bone health
in growing female rats consuming ‘healthy’ or Western diets.

Overall Hypothesis: A 10% caloric substitution with apple pomace will attenuate Western dietinduced onset of non-alcoholic fatty liver disease and progression to non-alcoholic
steatohepatitis and will be safe for consumption, regardless of diet quality in growing female
rats.
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3.1 Abstract
Apple pomace, a waste byproduct of processing, is rich in several nutrients, particularly
dietary fiber, indicating potential benefits for diseases attributed to poor diets, such as nonalcoholic fatty liver disease (NAFLD). NAFLD affects over 25% of United States population and
is increasing in children. Increasing fruit consumption can decrease NAFLD. The study objective
was to replace calories in standard or Western diets with apple pomace to determine effects on
genes regulating hepatic lipid metabolism and on risk of NAFLD. Female Sprague-Dawley rats
were randomly assigned (n=8 rats/group) to isocaloric diets of AIN-93G and AIN-93G/10% w/w
apple pomace (AIN/AP) or isocaloric diets of Western (45% fat, 33% sucrose) and Western/10%
w/w apple pomace (Western/AP) diets for 8 weeks. There were no significant effects on hepatic
lipid metabolism in rats fed AIN/AP. Western/AP diet containing fiber-rich apple pomace
attenuated fat vacuole infiltration, elevated monounsaturated fatty acid content, and triglyceride
storage in the liver due to higher circulating bile and upregulated hepatic DGAT2 gene
expression induced by feeding a Western diet. The study results showed replacement of
calories in Western diet with apple pomace attenuated NAFLD risk. Therefore, apple pomace
has potential to be developed into a sustainable functional food for human consumption.

Keywords: apple pomace, NAFLD, Western diet, DGAT2, bile acids, food waste, sustainability
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3.2. Introduction
One-third of apples harvested in the United States (USA) are processed into apple
products [1]. Apple pomace is a byproduct of apple processing that includes: skin, stem, seeds,
core, and calyx [2]. Apple pomace presents an environmental and public health issue due to its
rapid spoilage and fermentation. Moreover, apple pomace disposal is expensive with annual
costs being estimated at $10 million in the USA [3,4]. Yet, apple pomace is a rich source of
various nutrients (e.g., phytochemicals, vitamins, dietary minerals), but it is particularly high in
non-digestible carbohydrates and dietary fibers, indicating potential benefits for reducing
metabolic dysfunction, such as non-alcoholic fatty liver disease (NAFLD) [5].
NAFLD is characterized by dysregulated lipid metabolism and liver steatosis. It is the
most prevalent liver disease worldwide with reports of over 25% of the population having
NAFLD [6]. Global prevalence in children is estimated to be between 7.6–34.2% [7]. Further,
liver steatosis has also been diagnosed in non-obese patients [8]. Diets that are high in fat and
sucrose, which characterize Western diets, have been shown to induce NAFLD [9,10]. High
carbohydrate consumption has been linked to NAFLD progression by upregulating the
expression of key gene transcription factors that are involved in hepatic de novo lipogenesis
(DNL), such as sterol regulatory element-binding protein-1c (SREBP-1c) and carbohydrate
response element binding protein (ChREBP) [11]. SREBP-1c and ChREBP stimulate fatty acid
synthase (FAS) to catalyze the synthesis of saturated fatty acids (SFAs). In turn, SFAs can be
desaturated to monounsaturated fatty acids (MUFAs) by stearoyl-CoA desaturase-1 (SCD-1).
Promoting fatty acid esterification by diacylglycerol O-acyl transferase-2 (DGAT2) stimulates
hepatic triglyceride synthesis that can contribute to hepatic steatosis and production of
triglyceride-rich very low density lipoproteins (VLDLs), which characterizes NAFLD [12].
Currently, there are no approved drugs for the treatment of NAFLD; therefore,
management of NAFLD relies on proper diet and lifestyle changes [13]. Despite a paucity of
studies, apple pomace has been shown to reduce metabolic risk factors, such as hyperglycemia
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and dyslipidemia, providing rationale for apple pomace consumption to reduce NAFLD [14,15].
However, a potential concern is apple pomace’s fructose content. Excessive fructose
consumption has been shown to promote NAFLD development and progression [16].
Previously, we reported growing female Sprague-Dawley rats consuming different fructose
containing drinks for eight weeks promoted NAFLD, but had no significant effect on body weight
when compared to the water control [17]. Therefore, the objectives of this study were to
determine the effects of caloric substitution with apple pomace in a normal (standard diet) or
Western diet on expression of genes regulating hepatic lipid metabolism and NAFLD risk in a rat
model. Our study followed the suggested dietary advice of replacing calories in the diet with
healthier food choices instead of dietary supplementation with a purified isolated nutrient [18].
Study results showed that apple pomace had no detrimental effects on hepatic lipid metabolism
and liver health in rats consuming normal diets and attenuate features in the NAFLD spectrum
of upregulated gene expression of triglyceride synthesis as well as liver steatosis induced in rats
consuming a Western diet. Investigating whether apple pomace, a byproduct generated from
apple processing, can be re-purposed as a functional food for human consumption has the
potential to improve public health and food sustainability by providing an economical solution for
reducing environmental pollution and costly waste disposal.
3.3. Materials and Methods
Animals and Diets
Weanling (age 22–29 days) female Sprague-Dawley rats (n = 32) were purchased from
Harlan-Teklad (Indianapolis, IN, USA). Female rats were selected on the basis of their greater
susceptibility to hepatic effects with increased carbohydrate consumption [19]. All animal
procedures were approved by the Animal Care and Use Committee at West Virginia University
and were conducted in accordance with the guidelines of the National Research Council for the
Care of Laboratory Animals [20]. Rats were individually housed with cages kept in a room at
constant temperature of 21 ± 2 °C with a 12 h light/dark cycle throughout the study.
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Following seven-days acclimation, rats were randomly assigned (n = 8 rats/group) to
four dietary groups consisting of: (1) AIN-93G, a standard purified rodent diet (AIN), (2) AIN-93G
with 10% (g/kg) calorically substituted with apple pomace (AIN/AP), (3) Western diet (45% fat,
33% sucrose by kcals), or (4) Western diet with 10% (g/kg) calorically substituted with apple
pomace (Western/AP). AIN diets were adjusted to be isocaloric (3.7–3.8 kcal/g) and Western
diets were adjusted to be isocaloric (4.7 kcal/g), resulting in different types rather than amounts
of simple and complex carbohydrates. Detailed ingredient composition of experimental diets is
provided in Table 1. Locally sourced apple pomace was provided by Swilled Dog Hard Cider
Company (Franklin, WV, USA) and nutrient composition analysis was performed by Medallion
Laboratories (Minneapolis, MN, USA) (Table 2). Total polyphenols in apple pomace and
treatment diets were determined while using the Folin-Ciocalteu method [21]. Diets were stored
at −20 °C until fed. Rats were provided ad libitum access to their assigned diets and deionized
distilled water (ddH2O) throughout the eight weeks study duration. At baseline (day 1) and final
(end of eight weeks), rats were individually housed in a metabolic cage for 24 h to collect feces.
Feces was weighed and dried. Food intake was measured and assigned diets were replaced
every other day while ddH2O was replaced weekly. Rats were fasted overnight then euthanized
by carbon dioxide inhalation. The liver was excised, perfused with 0.7% saline solution,
weighed, and then flash frozen in liquid nitrogen. Rat livers were stored at −80 °C until
analyzed.

Liver total lipid and triglyceride content
Lipid extraction was performed according to Bligh and Dyer [22]. Briefly, 1g of liver tissue
was homogenized in Tris/EDTA buffer (pH 7.4). To quantify fatty acids, 50 µL of nonadecanoic
acid (19:0) was added as a standard during the initial weighing of the samples. A chloroform:
methanol:acetic acid (2:1:0.15, v/v/v) solution was added to liver samples, centrifuged at 900× g
for 10 min at 10 °C, and the bottom chloroform layer collected. The collected chloroform layer
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was mixed with chloroform: methanol (4:1, v/v) and centrifuged at 900× g at 10 °C for 10 min.
The chloroform layer was then collected and filtered. Extracted lipids were dried under nitrogen
gas. Total lipid content in the liver was gravimetrically determined.
Liver triglyceride content was determined using a commercially available triglyceride
colorimetric assay kit (Cayman Chemicals, Ann Arbor, MI, USA). Briefly, liver tissue (400 mg)
was homogenized using assay standard diluent (2 mL). Tissue homogenate was centrifuged at
10,000× g for 10 min at 4 °C. Supernatant was collected and diluted 1:5 in assay standard
diluent. Hepatic samples (10 µL) and lipase enzyme solution (150 µL) were added to a 96-well
cell culture plate and then incubated for 15 min. Hepatic sample absorbance was measured at
540 nm using a BioTek Epoch microplate spectrophotometer (Winooski, VT, USA). All samples
were performed in duplicate. The inter-assay coefficient of variation was 15.16%.

Diet and liver fatty acid composition
Following lipid extraction, diet and liver tissue samples were transmethylated according
to the method described by Fritsche and Johnston [23]. Briefly, fatty acids were methylated by
adding 4% sulfuric acid in anhydrous methanol to the extracted lipid samples followed by
incubation in a 90 °C water bath for 60 min. Samples were cooled to room temperature and
ddH2O was added. Chloroform was then added to the methylated samples and centrifuged at
900× g for 10 min at 10 °C. The collected chloroform layer was filtered through anhydrous
sodium sulfate to remove any remaining water. Fatty acid methyl esters (FAMEs) were dried
under nitrogen gas and re-suspended in iso-octane.
FAMEs were analyzed by gas liquid chromatography (CP-3800; Varian, Walnut Creek,
CA, USA) using an initial temperature of 140 °C held for 5 min and then increased 1 °C per min
to a final temperature of 220 °C. A wall-coated open tubular fused silica capillary column
(Varian, Walnut Creek, CA) was used to separate FAME with CP-Sil 88 at the stationary phase.
Nitrogen was used as the carrier gas and the total separation time was 56 min. Quantitative 37
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Component FAMEs Sigma Mix (Supelco, Bellefonte, PA, USA) was used to identify fatty acids.
Fatty acids were determined by retention time and quantified using peak ultra-counts. All
samples were performed in duplicate and reported as % of total fatty acids.

Liver histology
The left lateral liver lobe (n = 7–8) was removed and immediately fixed in 10% buffered
formalin solution for histological evaluation. Tissues were dehydrated through a series of
increasing ethanol concentrations (70–100% in ddH2O), then placed in xylene and embedded in
paraffin. Sections (8 µm) from each block were stained with hematoxylin and eosin. All slides
were analyzed under a Nikon TE 2000-S light microscope (Nikon Instruments, Melville, NY,
USA) by three trained individuals who were blinded to diet treatments. Liver fat accumulation
was graded using the classification described by Brunt, et al., where grade 0 is no evidence of
fat vacuoles, grade 1 is evidence of fat vacuoles in <33% of hepatocytes, grade 2 is evidence of
fat vacuoles in 33–66% of hepatocytes, and grade 3 is evidence of fat vacuoles in >66% of
hepatocytes [24]. Images were captured using a PC interface with Q-Capture imaging software
(Quantitative imaging Corporation, BC, Canada).

RNA isolation and gene expression
Total RNA was extracted from frozen tissue (50 mg) using the Zymo Research mRNA
Isolation Kit (Irvine, CA, USA) according to the manufacturer’s instruction for total RNA isolation.
Isolated RNA integrity was visualized on a 1.5% agarose gel and then quantified by
spectrophotometry (NanoDrop 100; Thermo Scientific, Waltham, MA, USA). Following DNase I
treatment with TURBO DNA-free kit (Applied Biosystems, Foster City, CA, USA), total mRNA
was amplified using the Superscript III First-Strand Synthesis System with oligo dT primers
(Invitrogen, Carlsbad, CA, USA).

84

Real-time quantitative polymerase chain reaction (RT-qPCR) consisted of 2.5 µL of
SYBR Green Master Mix (Applied Biosystems, Foster City, CA, USA ), 1 µL of cDNA (diluted
1:10), 1 µL of forward and reverse primer solutions (10 µM each), and 0.5 µL of deionized
distilled water for a total reaction volume of 5 µL. The thermal profile consisted of 50 °C for 2
min, 95 °C for 10 min, and then 40 cycles of 95 °C for 15 s and 60 °C for 1 min. A melt curve
analysis was applied at the end of cycling. Primers were designed for ChREBP, SREBP-1c,
sterol regulatory binding protein 2 (SREBP2), FAS, SCD-1, peroxisome proliferator-activated
receptor-α (PPARα), peroxisome proliferator-activated receptor-γ (PPARγ), hormone sensitive
lipase (HSL), microsomal triglyceride transfer protein (MTTP), and DGAT2, as well as for
housekeeping genes, β-actin and glyceraldehyde 2-phosphate dehydrogenase (GAPDH) using
the Primer3 program (Howard Hughes Medical Institute) and respective mRNA sequences that
were obtained from the NCBI database. Forward and reverse primers for gene transcriptions
can be found in Appendix A.

Serum biochemical measurements
Rats were fasted overnight and euthanized by carbon dioxide inhalation. Blood was
collected by aorta puncture. Collected blood was centrifuged at 1500× g for 10 min at 4 °C to
obtain serum. Serum samples were stored at −80 °C until analyzed. Serum measures of liver
function included: alanine aminotransferase (ALT) and aspartate aminotransferase (AST).
Values were determined enzymatically using a commercially available Vet-16 rotor and were
quantified by a Hemagen Analyst automated spectrophotometer (Hemagen Diagnostics Inc.,
Columbia, MD, USA). AST: ALT ratio was determined by dividing AST values by ALT values.
Serum cholesterol, low-density lipoprotein-cholesterol (LDL-C)/VLDL, and high-density
lipoprotein-cholesterol (HDL-C) were determined by commercially available fluorometric assay
(Cell Biolabs, San Diego, CA, USA). Briefly, 200 µL precipitation reagent was added to 200 µL
of serum and then centrifuged at 2000× g for 20 min. The supernatant containing HDL-C was
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removed and diluted to a final volume of 1:50. Pelleted portion containing LDL-C/VLDL was
resuspended in reaction buffer and diluted to a final volume of 1:50. Serum samples were
aliquoted onto a 96-well plate, incubated for 45 min, and measured at excitation of 570 nm and
emission at 590 nm using a BioTek Epoch microplate spectrophotometer.
Serum triglycerides were determined by commercially available colorimetric assay
(Cayman Chemical, Ann Arbor, MI, USA). Briefly, 10 µL of serum was aliquoted onto a 96-well
plate and reaction was initiated with 150 µL of diluted enzyme mixture solution. The plate was
incubated at room temperature for 15 min and measured at a wavelength of 540 nm using a
BioTek Epoch microplate spectrophotometer. All of the samples were performed in duplicate.
The intra-assay coefficient of variation was 15.6%.

Serum total bile acid concentration
Serum total bile acid content was determined using a commercially available bile acid
colorimetric assay kit (Crystal Chem Inc., Elk Grove, IL). Briefly, 20 µl of serum and 150 µl of
standard reagent were added to a 96-well plate and incubated for 5 min at 37°C. Absorbance
was measured at 540 nm on a BioTek Epoch microplate spectrophotometer. A second standard
reagent (30 µl) was then added to all wells followed by a 5 min incubation at 37°C and
absorbance read again at 540 nm. Differences between absorbance were measured to
determine total serum bile acid concentration. All samples were performed in duplicate. The
intra-assay coefficient of variation was 38.5%.

Statistics
Results are expressed as mean ± standard error of the mean (SEM). Gene expression was
determined as a function of mRNA abundance (A), where A = 1/(gene of interest primer
efficiency × ΔCT (g.o.i.) —average housekeeping primer efficiency × ΔCT (h.k.), where the
product of efficiency and average of expression of β-actin was averaged with the product of
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efficiency and average of expression of GAPDH to determine the overall expression of the two
housekeeping genes [25]. For gene expression data, each treatment group was log-transformed
prior to statistical analysis.
Data was analyzed for normal distribution and homogeneity of variance prior to
conducting a one-way analysis of variance (ANOVA) to determine the differences among dietary
groups. Post hoc multiple comparison tests were performed on parametric data using Tukey’s
test with differences considered to be significant at p = 0.05 and a tendency at p = 0.08.
Histological scoring was analyzed using the chi-square test. All statistical analyses were
performed using JMP 12.2 statistical software package (SAS Institute, Cary, NC, USA).
3.4 Results
Fatty acid composition of diets
As shown in Table 1, dietary fat content was higher in Western diets than standard AIN
diets. Fatty acid analysis (Table 3) showed Western/AP diet had the highest palmitic acid (16:0).
Both Western diets contained significantly higher palmitic acid, stearic acid (18:0), palmitoleic
acid (16:1n 7), and oleic acid (18:1n 9) compared to AIN diets. Essential fatty acids, linoleic acid
(18:2n-6) and α-linoleic acid (18:3n-3) content were approximately seven-fold lower (p<0.0001)
in Western diets compared to AIN diets. Arachidonic acid was higher (p<0.0001) in Western
diets compared to AIN diets which contained negligible amounts.

Food intake, body weight and tissue weights
Figure 1 shows there was no significant differences in body weight among diet groups
over 8 weeks. Shown in Table 4, there was a tendency (p=0.08) for higher final body weights for
rats fed Western diets compared to AIN diets. Growing female rat fed Western diets consumed
significantly more carbohydrates, fat, and total calories than rats fed standard rodent AIN diets.
There were no statistically significant differences in amount of carbohydrates, fat, and total
calories consumed by rats fed Western diet compared to Western/AP diet. There was a
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tendency (p=0.08) for higher initial wet and dry fecal weights in rats fed Western compared to
AIN diets, but no significant differences in final fecal output among diet groups. There were no
statistical differences observed in feed efficiency ratio among diet groups. Rats consuming
Western diets had increased (p<0.001) gonadal fat pad weights compared to rats fed AIN diets.
There were no statistically significant differences in gonadal fat pad weight in rats fed Western
diet compared to Western/AP diet. There were no statistically significant differences in absolute
or relative liver weights among diet groups.

Liver total lipid and triglyceride content
Total lipids and triglyceride content in the liver were within the value range reported in
previous studies of NAFLD [169]. There were no statistically significant differences in hepatic
total lipid content among diet groups (Figure 2A). Rats fed Western diet had the highest
(p=0.01) hepatic triglyceride content. Rats fed Western/AP diet showed no significant
differences in liver triglyceride content compared to rats fed AIN diets (Figure 2B).

Liver Histology
Based on liver histology 14% of rats fed AIN diet had fat vacuoles in <33% of
hepatocytes (Figure 3 panel A) and 43% of rats fed AIN/AP diet had fat vacuoles in <33% of
hepatocytes (Figure 3, panel B). Higher hepatic fat infiltration was indicated by 25% of rats fed
Western diet having fat vacuoles in 33-66% hepatocytes (Figure 3, panel C) while 13% of rats
fed Western/AP diet had fat vacuoles in 33-66% of hepatocytes (Figure 3, panel D). There was
an overall significant (p<0.0001) difference among histology scores.

Liver fatty acid composition
As shown in Table 5, rats fed Western diet had significantly higher hepatic palmitic acid
content than rats fed AIN diets. While Western/AP diet contained the highest amount of palmitic
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acid, liver content in rats fed Western/AP diet was only significantly higher compared to rats fed
AIN/AP diet. Western diets contained higher amounts of stearic acid and showed a tendency
(p=0.08) for higher hepatic stearic acid content than rats fed AIN diets. Both Western diets also
contained higher amounts of palmitoleic and oleic acid than AIN diets. However, rats consuming
Western diet had the highest hepatic palmitoleic acid content (p=0.05). Rats fed Western diet,
but not Western/AP diet had higher hepatic oleic acid content (p=0.0005) compared to rats fed
AIN diets. Rats consuming Western diets had significantly lower (p<0.0001) hepatic linoleic and
α-linolenic acid content compared to rats consuming AIN diets, however no difference in hepatic
arachidonic acid content was observed among all groups despite negligible amounts in the AIN
diets.

Hepatic lipogenic gene expression
As shown in Table 6, hepatic DGAT2 gene expression was up-regulated (p<0.01) in rats
consuming Western diet compared to all diet groups. Western/AP diet reverted hepatic DGAT2
gene expression to that found in rats fed AIN diets. There were no statistically significant
differences in hepatic gene expression of ChREBP, SREBP-1c, SREBP-2, SCD-1, FAS,
PPARα, PPARγ, HSL or MTTP among diet groups.

Serum liver enzymes, cholesterol, triglyceride, and bile acid measurements
As shown in Table 7 there were no statistical significant differences in serum AST, ALT,
AST:ALT ratio among diet groups. Serum triglycerides, VLDL/LDL-C, HDL-C, and total
cholesterol were not significantly different among diet groups. Serum bile acid concentration
was significantly higher in rats fed Western diet, but not Western/AP compared to rats fed AIN
diets.
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3.5 Discussion
Rats that were provided Western diets ingested more (p<0.0001) calories than rats
provided standard AIN rodent diets and had greater (p<0.0001) gonadal fat pad weight,
although not heavier body weight. In addition to being associated with obesity, diets that are
high in saturated fats and simple carbohydrates typified by Western diets have been associated
with the development of NAFLD [26,27]. Liver steatosis has also been diagnosed in non-obese
patients [8]. Replacing sugars in the diet, as well as increasing fruit consumption, is
recommended [28]. However, studies have reported high fructose consumption induces NAFLD
by stimulating hepatic DNL [17,26]. Among fruits popularly consumed in the USA, apples are
considered to be particularly concentrated in fructose [2,29]. In the present study, nutrient
analysis of apple pomace showed the major sugar was fructose (>30%).
Histological evaluation of liver tissue showed low fat infiltration (fat vacuoles in <33% of
hepatocytes), with no significant increase in total lipid or triglyceride content in rats consuming
AIN/AP as compared to AIN diet. Hepatic gene expression of DNL transcription factors and
enzymes were not upregulated and there were no increases in end products: palmitic, stearic,
palmitoleic, or oleic acid content in the liver of rats fed AIN/AP when compared to the AIN diet.
Furthermore, there were no significant differences in serum ALT, AST, and ALT/AST ratio to
indicate liver damage and dysfunction. Conversely, rats fed Western diets showed greater
hepatic lipid accumulation, as indicated by fat vacuoles in 33–66% of hepatocytes. Rats fed
Western diet showed 25% when compared to 14% of animals fed Western/AP having fat
vacuoles in 33–66% of hepatocytes. Rats fed Western/AP had decreased (p=0.04) hepatic
triglyceride content as compared to rats fed Western diet, suggesting that substituting calories in
the Western diet with 10% apple pomace attenuates hepatic triglyceride deposition.
Hepatic DNL is stimulated by FAS catalyzing synthesis of SFAs (i.e., palmitic and stearic
acid). Our results showed no dietary effects on hepatic FAS gene expression. Yet, rats that
were fed Western diet had higher (p=0.0007) hepatic palmitic acid content when compared to
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rats fed either AIN diets. This may be explained by higher palmitic content of Western diets.
Replacement with apple pomace in the Western/AP diet resulted in similar hepatic palmitic acid
content to rats fed the AIN diet, but was higher than rats fed AIN/AP diet. In DNL, palmitic acid
and stearic acid can be desaturated by the enzyme SCD-1 to MUFAs and palmitoleic and oleic
acid, respectively. Despite no significant differences in dietary MUFA content between the
Western and Western/AP diets, rats consuming Western diet had the highest (p=0.05) liver
palmitoleic acid content. Serum palmitoleic acid has been shown to be to be elevated in patients
with liver disease and high serum VLDL [30,31]. Additionally, rats consuming a Western diet,
but not Western/AP diet, had higher (p=0.0005) hepatic oleic acid content as compared to rats
consuming AIN diets. Studies have suggested that high oleic acid stimulates hepatic fat
deposition, since oleic acid is the preferred substrate for hepatic triglyceride synthesis [32]. In a
human clinical study, higher serum oleic acid was positively correlated to NAFLD [33]. In the
present study, despite differences in liver MUFA content, gene expression of SCD-1 was not
significantly different among diet groups. Differences in hepatic fat infiltration and fatty acid
composition in the absence of changes in DNL gene expression may be due instead to diet
influencing genes regulating lipolysis.
HSL catalyzes the conversion of diacylglycerols to monoacylglycerols in lipolysis [31].
PPARα and PPARγ have been suggested as a potential therapeutic target for NAFLD, as the
upregulation of these transcription factors results in increased use of lipids for metabolism
[34,35]. Therefore, gene expression of HSL, as well as transcription factors PPARα and PPARγ,
were determined to assess whether increased lipolysis was responsible for the observed
hepatoprotective effects of apple pomace. In the current study, the expression of genes
regulating lipolysis were not significantly different among diet groups. Besides imbalanced DNL
and lipolysis, altered hepatic lipid storage and transport has been suggested to be key to
NAFLD [31,36] . Increased gene expression of DGAT2 has been reported to promote hepatic
steatosis [37,38]. Reducing DGAT2 has also been identified as a therapeutic target for NAFLD
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[39]. In the current study, hepatic DGAT2 gene expression was upregulated (p=0.002) nearly
three-fold in rats that were fed a Western diet. The mechanism for higher triglyceride content in
the liver of rats fed Western diet might be explained by the combination of upregulation of
DGAT2 gene expression and increased MUFAs and palmitoleic and oleic acid content in the
liver, since MUFAs have been shown to be preferentially used for triglyceride synthesis [32,40].
On the other hand, polyunsaturated fatty acids (PUFAs) have been reported to have antisteatosis effects [33]. In our study, rats fed both Western diets had significantly lower hepatic
PUFA (e.g., linoleic acid and α-linolenic acid) content than rats that were fed AIN diets. There
was no difference in hepatic PUFA content in rats fed Western diet as compared to the
Western/AP diet. Based on our results, MUFAs appeared to be the bioactive fatty acids inducing
NAFLD in the Western diet.
Once synthesized triglycerides enter storage or secretory pools, hepatic MTTP regulates
the packaging of triglycerides into VLDLs for transport into the circulation [41–43]. In our study,
hepatic gene expression of MTTP was not significantly different among the diet groups. This
was indicated by no significant changes in serum triglycerides and LDL-C/VLDL among diet
groups. Overexpression of DGAT2 in mouse liver has been shown to increase liver triglyceride
content, but not VLDL secretion [44]. Based on the results, greater total triglyceride
accumulation in the liver of rats that were fed Western diet was due to increased triglyceride
synthesis without a concomitant increase in the transport of triglycerides out of the liver.
Accumulation of hepatic triglycerides without increasing circulating VLDLs may be due to the
physical limitations of liver to export triglyceride-rich VLDL particles that exceed the diameter of
the sinusoidal endothelia pores [45].
On the other hand, DGAT2 gene expression in the liver was not significantly upregulated
in rats fed Western/AP diet, suggesting a potential therapeutic role of apple pomace in
ameliorating Western diet induced NAFLD. Studies have suggested that bile represses hepatic
triglyceride secretion, therefore reducing triglyceride accumulation [46]. Individuals with NAFLD
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have been reported to have higher serum bile acid [47]. Dietary fiber has been reported to
decrease serum bile acids [48]. Individuals with NAFLD have been shown to consume less
dietary fiber than healthy individuals [49]. Apple pomace contains a substantial amount of nondigestible carbohydrates, including: dietary fibers, pectin, and oligosaccharides [2]. In our study,
serum bile acid concentration was higher in rats fed Western diet (p < 0.05), but not Western/AP
diet as compared to rats fed AIN diets. Western diet was adjusted to remain isocaloric after
substitution with apple pomace. All diets were adjusted to have 5% total fiber. No significant
differences in body weight, fecal weights, and feed efficiency ratio suggested no differences in
digestible energy among diet. However, differences in fiber type may be a potential mechanism.
Studies have reported that dietary oligofructose decreases intra-hepatic triglycerides [50].
Hepatocytes that were isolated from non-digestible carbohydrate oligofructose-fed rats showed
a reduced capacity to esterify palmitic acid [51]. In our study, rats fed Western diet, but not
Western/AP, had higher (p=0.0007) palmitic acid content in the liver when compared to rats fed
the AIN diet. Consumption of fruits and dietary fiber have been shown to improve liver steatosis
[49,52]. Therefore, as a fruit-based product that is high in dietary fiber, apple pomace could
potentially improve dietary fiber consumption in individuals with hepatic steatosis and the risk of
NAFLD.
A study of fiber-rich colloids that were isolated from apple pomace reported increased
fecal excretion of bile acids with dietary fiber by fiber acting as a bile sequestrant to improve
serum lipoproteins [53]. Another potential mechanism is the effect of soluble fibers on
microbiota. Mice fed a 30% fat diet supplemented with 4% pectin modulated microbiota and
increased short-chain fatty acid (SCFA) production resulting in a reduction in NAFLD [54].
However, extraction and purification of isolated ingredients from food can be technologically
challenging and costly. Also, nutrients in foods often act synergistically. Young male rats that
were fed a standard diet supplemented with 5 or 15% apple pomace for four weeks increased
cecal SCFAs [55,56]. However, there has been a dearth of studies investigating the effects of
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apple pomace on lipid metabolism. Bobek, et al., focusing specifically on cholesterol metabolism
in the liver, reported the beneficial effects of a 5% (w/w) apple pomace supplementation [57].
Another study reported diet-induced obese male Sprague-Dawley rats fed a high-fat diet (15%
w/w) that was substituted with 10% (w/w) apple pomace for five weeks as compared to rats fed
a high-fat diet resulted in significantly reduced liver triglyceride content, serum total triglycerides,
total cholesterol, and LDL-C due to higher fecal triglyceride and cholesterol excretion [5]. In the
present study, healthy growing female Sprague-Dawley rats fed the Western/AP diet attenuated
hepatic fat infiltration and also attenuated elevated MUFA and triglyceride content induced by
the Western diet. Additionally, elevated circulating bile acids was attenuated by apple pomace
consumption. In contrast to the study on diet-induced obese male rats fed apple pomace, our
study using female rats showed no improvement in serum lipoproteins [5]. Studies have shown
that various types of diets that are used for developing NAFLD in experimental animals produce
different effects [58]. In our study, Western diet induced hepatic steatosis was due to the
dysregulation of hepatic triglyceride synthesis without changes in circulating lipoproteins. Similar
hepatic effects were observed in other studies where the DGAT2 gene was overexpressed [44].
In summary, substituting calories with 10% apple pomace, despite added dietary
fructose, did not promote liver steatosis in rats that were fed a standard AIN diet. Caloric
substitution with fiber-rich apple pomace attenuated hepatic steatosis due to elevated hepatic
MUFA content, higher circulating bile acids, and upregulated hepatic DGAT2 gene expression
induced by a Western (high fat/high sugar) diet. Using a rat model, apple pomace consumption
attenuated liver steatosis and had no detrimental effects on liver health. The abundance of
apple pomace, currently a food processing waste by-product, has the potential to be repurposed into a sustainable food product with beneficial health properties. Further mechanistic
studies, preclinical, and human clinical research investigating apple pomace for human
consumption and health can offer an environmental and economical solution for fruit waste that
is generated by the industrial processing of apples.
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Table 1. Composition of rodent diets substituted with apple pomace (10% g/kg) fed to
growing female rats.
Diet Groups 1
AIN
AIN/AP

Western Western/AP
Ingredients (g/kg) 1
Apple pomace
0.0
100.0
0.0
100.0
Corn Starch
397.486 392.086
63.36
57.96
Maltodextrin
132.0
132.0
60.0
60.0
Sucrose
100.0
43.9
340.0
283.9
Total Dietary Fiber
50.0
50.0
50.0
50.0
Insoluble Fiber 2
50.0
39.0
50.0
39.0
Soluble Fiber 3
0.0
11.0
0.0
11.0
Anhydrous Milkfat
0.0
0.0
210.0
210.0
Soybean Oil
70.0
68.7
20.0
18.7
Casein
200.0
196.0
195.0
191.0
L-Cystine
3.0
3.0
3.0
3.0
Vitamin Mix
10.0
10.0
12.5
12.5
Mineral Mix
35.0
35.0
43.0
43.0
Choline Bitartrate
2.5
2.5
3.1
3.1
TBHQ, antioxidant
0.014
0.014
0.04
0.04
Polyphenols
0.0015
0.0029
0.0008
0.0032
Macronutrients (% kcal)
Protein
18.8
18.9
14.8
14.8
Fat
17.2
17.3
44.6
44.8
Carbohydrate
63.9
63.7
40.6
40.4
Calories (kcal/g)
3.8
3.7
4.7
4.7
1
Abbreviations: AIN, the American Institute of Nutrition; AP, apple pomace; TBHQ, tertbutylhydroquinone. 2 Insoluble fiber is cellulose. 3 Soluble fiber is mainly pectin [2].
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Table 2. Composition of freeze-dried apple pomace substituted (10% g/kg) into diets fed to
growing female rats.
Macronutrients (%)
Protein

3.56

Fat

1.3

Carbohydrates

68.1

Sugars (%)
Fructose

32.5

Glucose

9.77

Sucrose

13.9

Maltose

<0.1

Lactose

<0.1

Dietary Fiber (%)
Insoluble Dietary Fiber 22.2
Soluble Dietary Fiber

11.0

Polyphenols (g/kg)

0.029

Calories (kcal/100 g)

387
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Table 3. Fatty acid analysis of rodent diets substituted with apple pomace (10% g/kg).
Treatments 1
Measurements
AIN

AIN/AP

Western

Western/AP

p-Value

Palmitic acid (16:0)

11.36 ± 0.09c

11.14 ± 0.15c

32.19 ± 0.03 b 32.92 ± 0.30 a <0.0001

Stearic acid (18:0)

3.56 ± 0.25 b

3.72 ± 0.06 b

9.94 ± 0.11 a

10.24 ± 0.06 a <0.0001

Palmitoleic acid (16:1n-7)

0 ± 0.00 b

0 ± 0.00 b

1.44 ± 0.01 a

1.44 ± 0.02 a

Oleic acid (18:1n-9)

19.09 ± 0.10 b 18.35 ± 0.33 b 22.96 ± 0.11 a 22.95 ± 0.17 a <0.0001

SFAs

MUFAs
<0.0001

PUFAs
Linoleic acid (18:2 n-6)

50.12 ± 0.55 a 51.41 ± 2.41 a 6.99 ± 0.09 b

7.04 ± 0.06 b

<0.0001

α-linolenic acid (18:3 n-3)

7.08 ± 0.13 a

Arachidonic acid (20:4 n-6) 0 ± 0.00 b

7.13 ± 0.70 a

1.04 ± 0.01 b

1.05 ± 0.02 b

<0.0001

0 ± 0.00 b

0.13 ± 0.00 a

0.14 ± 0.00 a

<0.0001

Values expressed as mean ± standard error of the mean (SEM, n = 5 samples/group). Different superscript letters a, b, and c within.
The same row indicates significant difference at p < 0.05 by one-way ANOVA followed by Tukey’s test. Abbreviations: MUFAs,
monounsaturated fatty acids; PUFAs, polyunsaturated fatty, acids; SFAs, saturated fatty acids.
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Table 4. Effect of consumption of different diets substituted with apple pomace (10% g/kg) by growing female rats on caloric intake,
body weight, and liver weight following eight weeks of feeding.
Treatments 1
Measurements
AIN

AIN/AP

Western

Western/AP

p-Value

Caloric intake (kcal)

2946 ± 85 b

2757 ± 62 b

3373 ± 71 a

3443 ± 134 a

<0.0001

CHO intake (kcal)

1769 ± 54 a

1708 ± 39 a

1354 ± 29 b

1347 ± 54 b

<0.0001

Fat intake(kcal)

476 ± 15 b

464 ± 11 b

1487 ± 32 a

1494 ± 60 a

<0.0001

Initial bwt (g)

95 ± 3

92 ± 3

95 ± 3

95 ± 3

0.80

Final bwt (g)

216 ± 4

216 ± 8

228 ± 5

234 ± 5

0.08

Total bwt gain (g)

121 ± 4

124 ± 7

133 ± 6

138 ± 6

0.17

Wet Initial Fecal Weight (g)

0.82 ± 0.06 b 0.75 ± 0.11 b 1.30 ± 0.23 a 1.14 ± 0.13 a,b 0.06

Dry Initial Fecal Weight (g)

0.67 ± 0.06

Wet Final Fecal Weight (g)

0.30 ± 0.18 b 0.28 ± 0.16 b 0.91 ± 0.34 a 0.63 ± 0.23 a,b 0.03

Dry Final Fecal Weight (g)

0.23 ± 0.13

0.19 ± 0.10

0.78 ± 0.27

0.50 ± 0.16

0.13

Feed Efficiency Ratio

0.17 ± 0.01

0.17 ± 0.01

0.18 ± 0.01

0.18 ± 0.01

0.13

Gonadal fat pad weight (g)

4.12 ± 0.26 b 3.46 ± 0.44 b 5.87 ± 0.24 a 5.96 ± 0.23 a

<0.0001

Liver weight (g)

7.50 ± 0.24

Relative liver weight (mg/g bwt) 3.47 ± 0.078

0.54 ± 0.14

1.269 ± 0.27

0.75 ± 0.21

0.08

7.44 ± 0.37

8.05 ± 0.30

7.98 ± 0.24

0.35

3.45 ± 0.068

3.52 ± 0.067

3.41 ± 0.048

0.69

1

Values expressed as mean ± SEM (n = 6–8 rats/group). Different superscript letters a and b within the same row. Indicate
significant difference at p < 0.05 by one-way ANOVA followed by Tukey’s test. Abbreviations: Bwt, body weight; CHO, carbohydrate.
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Table 5. Effect of consumption of different diets substituted with apple pomace (10% g/kg) by growing female rats on hepatic fatty
acid composition following 8 weeks of feeding.
Treatments 1
Measurements (%)
AIN

AIN/AP

Western

Western/AP

p-Value

18.40 ± 0.53 c

21.44 ± 0.53 a

21.08 ± 0.53 a,b

0.0007

14.46 ± 0.65

14.06 ± 0.60

14.83 ± 0.83

16.28 ± 0.60

0.08

Palmitoleic acid (16:1n-7)

0.57 ± 0.25 b

0.81 ± 0.25 b

1.61 ± 0.23 a

0.76 ± 0.25 b

0.05

Oleic acid (18:1n-9)

11.25 ± 1.65 b

10.72 ± 1.39 b

19.55 ± 1.39 a

15.95 ± 1.30 a,b

0.0005

Linoleic acid (18:2n-6)

22.44 ± 1.09 a

25.12 ± 1.09 a

9.28 ± 1.09 b

8.38 ± 1.09 b

<0.0001

α-linoleic acid (18:3n-3)

1.04 ± 0.14 a

1.28 ± 0.15 a

0.23 ± 0.14 b

0.22 ± 0.14 b

<0.0001

Arachidonic acid (20:4n-6)

13.26 ± 1.00

11.99 ± 1.61

13.20 ± 1.00

14.56 ± 1.00

0.37

SFAs
19.10 ± 0.57
Palmitic acid (16:0)
b,c

Stearic acid (18:0)
MUFAs

PUFAs
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1

Values expressed as mean ± SEM (n = 6–8 rats/group). Different superscript letters a, b, and c within the same row indicate
significant difference at p < 0.05 by one-way ANOVA followed by Tukey’s test. Abbreviations: MUFAs, monounsaturated fatty acids;
PUFAs, polyunsaturated fatty acids; SFAs, saturated fatty acids.

109

Table 6. Effect of consumption of different diets substituted with apple pomace (10% g/kg) by growing female rats on hepatic lipid
metabolism gene expression following 8 weeks of feeding.
Treatments 1
Measurements
AIN

AIN/AP

Western

Western/AP

p-Value

ChREBP

0.074 ± 0.004

0.069 ± 0.006

0.078 ± 0.006

0.077 ± 0.009

0.76

SREBP-1c

0.118 ± 0.027

0.132 ± 0.041

0.136 ± 0.038

0.117 ± 0.031

0.11

SREBP-2

0.088 ± 0.020

0.080 ± 0.012

0.083 ± 0.017

0.092 ± 0.026

0.92

FAS

0.116 ± 0.034

0.096 ± 0.015

0.121 ± 0.028

0.156 ± 0.075

0.15

SCD-1

0.234 ± 0.084

0.216 ± 0.036

0.223 ± 0.073

0.309 ± 0.080

0.13

PPARα

0.088 ± 0.016

0.099 ± 0.013

0.098 ± 0.027

0.076 ± 0.012

0.74

PPARγ

0.054 ± 0.021

0.053 ± 0.013

0.053 ± 0.016

0.052 ± 0.026

0.99

HSL

0.085 ± 0.019

0.087 ± 0.011

0.084 ± 0.023

0.074 ± 0.027

0.89

Lipogenesis

Lipolysis

Storage and Transport
DGAT2

0.171 ± 0.020 b 0.151 ± 0.025 b 0.617 ± 0.161 a 0.213 ± 0.039 b 0.002

MTTP

0.145 ± 0.026

0.090 ± 0.008

0.164 ± 0.044

0.151 ± 0.035

0.43

1

Values expressed as mean ± SEM (n = 6–8 rats/group) of transcript abundance (A) of gene of interest relative to housekeeping
genes β-actin and GAPDH. aDifferent superscript letters a and b within the same row indicate significant difference at p < 0.05 by
one-way ANOVA followed by Tukey’s test. Abbreviations: ChREBP, carbohydrate element response binding protein; DGAT2,
diacylglycerol O-acyltransferase 2; FAS, fatty acid synthase; HSL, hormone sensitive lipase; MTTP, microsomal triglyceride transfer
protein; PPARα, peroxisome proliferator-activated receptor alpha; PPARγ, peroxisome proliferator-activated receptor gamma; SCD1, stearoyl-CoA desaturase-1; SREBP-1c, sterol regulatory binding protein-1c; SREBP-2, sterol regulatory binding protein-2.
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Table 7. Effect of consumption of different diets substituted with apple pomace (10% g/kg) by growing female rats on serum
measurements of liver function enzymes, cholesterol, and bile acids following 8 weeks of feeding.
Serum Measurements

AIN

AIN/AP

Western

Western/AP

p-Value

AST (U/L)

129.48 ± 52.86 212.50 ± 37.86 283.63 ± 45.30 259.67 ± 48.96

0.69

ALT (U/L)

107.63 ± 19.59 118.71 ± 43.60 94.5 ± 12.58

133.5 ± 30.59

0.78

AST:ALT ratio

3.16 ± 0.45

2.79 ± 0.28

2.97 ± 0.26

2.84 ± 0.17

0.83

VLDL/LDL-C (mg/dl)

41.59 ± 4.17

41.74 ± 2.38

40.42 ± 6.44

41.29 ± 6.74

0.99

HDL-C (mg/dl)

17.29 ± 2.18

18.95 ± 1.97

18.21 ± 2.13

21.85 ± 1.82

0.43

Total Cholesterol (mg/dl) 58.89 ± 3.43

60.38 ± 3.38

59.80 ± 5.69

57.98 ± 7.85

0.99

Triglyceride (mg/dl)

55.81 ± 8.17

47.39 ± 9.04

58.64 ± 9.38

50.04 ± 8.81

0.84

Total Bile Acids (µmol/L)

30.00 ± 3.13 b

28.80 ± 7.69 b

54.13 ± 7.96 a

31.52 ± 3.69 a,b 0.02

1

Values expressed as mean ± SEM of n = 6–8 rats/group. Different superscript letters a and b within the same row indicate
significant difference at p < 0.05 by one-way ANOVA followed by Tukey’s test. Abbreviations: AST, aspartate aminotransferase; ALT,
alanine aminotransferase; VLDL, very-low density lipoprotein, LDL-C, low density lipoprotein-cholesterol; HDL-C, high density
lipoprotein-cholesterol.

111

Figure Legend
Figure 1. Growth curve of growing female rats consuming different diets including apple
pomace over 8 weeks.
Figure 2. (A) Total hepatic lipid percentage of rodents consuming different diets including apple
pomace. (B) Total hepatic triglyceride content of rodents consuming different diets including
apple pomace. Different letters a and b indicate significant difference at p<0.05 by one-way
ANOVA followed by Tukey’s test
Figure 3. Representative histological staining images of livers of growing female rats
consuming different diets including apple pomace.
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Figure 1. Growth curve of rats fed different diets containing apple pomace.
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Figure 2. (A) Total hepatic lipid content (mg/g) and (B) Total hepatic triglyceride content (mg/g)
of growing female rats consuming different diets substituted with apple pomace (10% w/w)
following eight weeks of feeding. Different letters a and b indicate significant difference at p <
0.05 by one-way ANOVA followed by Tukey’s test.
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Histological steatosis scores for diet groups.
Measurement

AIN AIN/AP Western Western/AP p-Value

Steatosis Grade

<0.0001

0

6

4

-

-

1

1

3

6

7

2

-

-

2

1

3

-

-

-

-

Figure 3. Representative histological staining images of livers of growing female rats
consuming (A) AIN, (B) AIN/AP, (C) Western, or (D) Western/AP following eight weeks of
feeding. Arrow indicates fat deposition. Scores analyzed by chi-square test at p < 0.05.
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4.1 Abstract
Non-alcoholic fatty liver disease, the most prevalent liver condition, can progress to more
severe non-alcoholic steatohepatitis (NASH). NASH is characterized by inflammation and
dysregulation of liver-adipose crosstalk with diet being a major factor in its disease etiology and
treatment. Apple pomace, an apple processing byproduct, is polyphenol-rich, suggesting
potential as a functional food to alleviate features of NASH. Growing (age 22-29 days) female
Sprague-Dawley rats were randomly assigned (n=8 rats/group) to consume purified AIN-93G,
AIN-93G/10% g/kg caloric substitution with apple pomace (AIN/AP), Western diet, or
Western/10% apple pomace (Western/AP) diets for 8 weeks. Rats consuming Western diet had
the highest histological evidence inflammation. Hepatic palmitic, palmitoleic, and oleic acid were
higher in rats consuming Western diet (p<0.05); whereas with adipose palmitic, stearic, and
oleic acid lower (p<0.01) compared to rats consuming Western/AP. Hepatic and adipose gene
expression of nuclear transcription factor kappa B (NFκB) was significantly upregulated in rats
fed a Western diet compared to all groups and interlekin-6 (IL-6) was significantly upregulated
compared to rats consuming AIN diets. Adipose tumor-necrosis factor-α (TNF-α) was
significantly upregulated in rats fed Western diet compared to all diet groups. Apple pomace
consumption upregulated (p<0.01) hepatic expression of glutathione peroxidase (GPx). Serum
total antioxidants were highest (p<0.04) in rats fed Western/AP, and apple pomace attenuated
decreased urinary total antioxidants in rats consuming Western diet. Based on the study results,
apple pomace attenuated Western-diet induced changes to NASH by attenuating increased
fatty acid crosstalk, upregulated proinflammatory gene expression, and decreased in antioxidant
status. The results provide evidence that apple pomace has the potential to be a sustainable
functional food.

Keywords: apple pomace, NAFLD, NASH, inflammation, antioxidant, sustainability, fatty acid

117

4.2 Introduction
Apples are the most widely consumed fruit in the United States with over half of
harvested apples processed into juice, resulting in discarding of pulp, skin, seeds, calyx and
stem, collectively referred to as apple pomace [1]. Apple pomace disposal is costly and is an
industrial waste product that contributes to environmental pollution [2]. Yet, apple pomace
contains nutrients and bioactive compounds that may be used as a nutritional aid for dietinduced metabolic complications [2,3]. Liver manifestation of metabolic syndrome, non-alcoholic
fatty liver disease (NAFLD), has become the most prevalent liver disease worldwide and is
increasing in children [4-6].
Progression of NAFLD to non-alcoholic steatohepatitis (NASH), a more severe
manifestation of NAFLD, is proposed to be a multiple-hit pathogenesis. Contributions to NASH
are increased de novo lipogenesis (DNL) leading to lipid oxidation, resulting in formation of
reactive oxygen species (ROS) and inflammatory cytokines [7,8]. Studies show adipose tissue
play a role in the NAFLD progression. Cytokines produced in adipose tissue circulate to the liver
and contribute to increased hepatic inflammation [9-12]. Also contributing to NASH are altered
adipose triglyceride metabolism and free fatty acid released by adipose acting as stimulators of
inflammation and oxidative stress [13-20].
Major dietary contributors to the NAFLD cascade of disease progression to NASH are
increased consumption of simple carbohydrates and saturated fat [21]. Additionally, high
consumption of omega-6 polyunsaturated fatty acids (n-6 PUFAs) has been reported to
exacerbate liver disease through increased inflammation and oxidative stress [22]. The n-6
PUFA, linoleic acid (LA) can be metabolized to arachidonic acid (ARA) and is also a major fatty
acid found in Western diets. ARA provides a substrate for cyclooxygenase synthesis of
proinflammatory 2-series eicosanoids that can exacerbate NAFLD through increased
inflammation [23].
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Currently, dietary interventions are the main treatment for NASH, with diets high in
antioxidants recommended [24]. Apple pomace is a rich source of antioxidant polyphenols
indicating potential to attenuate NASH [2]. However, apple pomace also contains fructose,
which can increase uric acid, with subsequent increases in inflammation and oxidative stress
[2,25-27].
Therefore, it is important to evaluate the potential of apple pomace to be a safe,
nutritious, and beneficial food for human consumption. Apple pomace can be a sustainable food
source for a growing population by repurposing processing waste as a functional food which
decreases costs associated with disposal and reduces environmental pollution. Previously, we
showed Western diet induced NAFLD and apple pomace to attenuate indices of NAFLD [28].
The aim of this study was to determine whether apple pomace can attenuate Western diet
induced progression from NAFLD to NASH. Additionally, the study determines whether the
fructose content of apple pomace affected liver health in animals consuming a standard ‘normal’
diet. We hypothesize no detrimental effects on the liver due to fructose content in apple pomace
in rats fed normal diet, while changes to hepatic-adipose fatty acid profiles, proinflammatory
gene expression, and antioxidant status in rats consuming a Western diet are attenuated by the
addition of apple pomace

4.3 Materials and Methods
Animals and Diets
Weanling (age 22-29 days) female Sprague-Dawley rats (n=32) were purchased from
Harlan-Teklad (Indianapolis, IN). Female rats were used on the basis of their greater
susceptibility to liver dysfunction with increased carbohydrate consumption [29]. All animal
procedures were approved by the Animal Care and Use Committee at West Virginia University
and conducted in accordance with the guidelines of the National Research Council for the Care
of Laboratory Animals [30]. Rats were individually caged to measure food intake. Rats were
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housed in cages kept in a room at constant temperature of 21+2°C with a 12 h light/dark cycle
throughout acclimation and the study duration.
Following a 7-day acclimation, rats were randomly assigned (n=8 rats/group) to four
dietary groups consisting of: 1) standard purified rodent diet, AIN-93G, 2) AIN-93G with 10%
(g/kg) calorically substituted with freeze-dried apple pomace (AIN/AP), 3) Western diet (45% fat,
33% sucrose by kcals), or 4) Western diet with 10% (g/kg) calorically substituted with freezedried apple pomace (Western/AP). Locally sourced apple pomace (varieties Gala and Honey
Crisp) was provided by Swilled Dog Hard Cider Company (Franklin, WV) and nutrient
composition analysis was performed by Medallion Laboratories (Minneapolis, MN). Total
polyphenol content in apple pomace and treatment diets were determined using the FolinCiocalteu method [31]. Formulation of AIN diet after apple pomace addition was adjusted to be
isocaloric (3.7-3.8 kcal/g) and Western diet after apple pomace addition was adjusted to be
isocaloric (4.7 kcal/g). Detailed ingredient composition of experimental diets and apple pomace
is provided in Supplementary Table 1. Diets were stored at -20°C until fed.
Rats were provided ad libitum access to their assigned diets and to deionized distilled
water (ddH2O) throughout the eight weeks study duration. Food intake was measured, and diets
replaced every other day while ddH2O was replaced weekly. At the end of eight weeks, rats
were fasted overnight then euthanized by carbon dioxide inhalation. The liver was excised,
perfused, weighed, and then flash frozen in liquid nitrogen and stored at -80°C until analyzed.

Liver Histology
The left lateral liver lobe (n=7-8) was removed and immediately fixed in 10% buffered
formalin solution for histological evaluation. Dissected tissues were dehydrated through a series
of increasing ethanol concentrations (70-100% in ddH2O) then placed in xylene and embedded
in paraffin. Sections (8 µm) from each block were stained with hematoxylin and eosin. Liver
inflammation was determined using a modification of the method described by Kleiner et al [32].
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An inflammation grade of 0 indicated no inflammation present, where a grade of 1 indicated
presence of inflammation. All slides were analyzed using a Nikon TE 2000-S light microscope
(Nikon Instruments, New York, NY) at magnification x 100 by a trained investigator blinded to
the identity of the groups. Images were captured using a PC interface with Q-Capture imaging
software (Quantitative Imaging Corporation, BC, Canada).

Diet and tissue fatty acid composition
Diet, liver tissue, and gonadal adipose tissue samples were extracted according to Bligh
and Dyer [33]. Briefly, liver tissue (1 g), diet (1 g), and adipose tissue (0.1 g) were homogenized
in Tris/EDTA buffer (pH=7.4). Quantification of fatty acids was determined by adding 50 μL of
nonadecanoic acid (19:0) as a standard during the initial weigh of the samples. A
chloroform:methanol:acetic acid (2:1:0.15 v/v/v) solution was added to all samples and
centrifuged at 900 x g for 10 min at 10°C. The bottom chloroform layer was collected and mixed
with a chloroform:methanol (4:1 v/v) solution and centrifugation repeated. The chloroform layer
was collected, filtered, and dried under nitrogen gas.
Extracted lipids were transmethylated according to the method described by Fritsche
and Johnston [34]. Briefly, fatty acids were methylated by adding 4% sulfuric acid in anhydrous
methanol to the extracted lipid samples followed by incubation in a 90°C water bath for 60 min.
Samples were cooled to room temperature, and ddH2O added. Chloroform was then added to
the methylated samples and centrifuged at 900 x g for 10 min at 10°C. The collected chloroform
layer was filtered through anhydrous sodium sulfate to remove any remaining water. Fatty acid
methyl esters (FAMEs) were dried under nitrogen gas and re-suspended in iso-octane.
FAMEs were analyzed by gas liquid chromatography (CP-3800; Varian, Walnut Creek,
CA) using an initial temperature of 140°C held for 5 min and then increased 1°C per min to a
final temperature of 220°C. A wall-coated open tubular fused silica capillary column (Varian)
was used to separate FAME with CP-Sil 88 at the stationary phase. Nitrogen was used as the
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carrier gas, and total separation time was 85 min. Quantitative 37 Component FAMEs Sigma
Mix (Supelco, Bellefonte, PA) was used to identify fatty acids. Fatty acids were determined by
retention time and quantified using peak ultra-counts. All samples are performed in duplicates
and reported as mg/g of total fatty acids.

Liver and Adipose Oxidative Stress and Inflammatory Gene Expression
Liver and gonadal adipose tissue total RNA was extracted from -80°C frozen samples
(50 mg) using the Zymo Research Direct-zol RNA Miniprep Plus Isolation Kit (Irvine, CA,
catalog #R2071) and the Qiagen RNeasy Tissue Mini Kit (Venlo, Netherlands, catalog # 74804),
respectively, according to the manufacturer’s instruction for total RNA isolation. Isolated RNA
integrity was visualized on a 1.5% agarose gel and quantified by spectrophotometry (NanoDrop
100; Thermo Fisher Scientific, Waltham, MA). Following DNase I treatment with TURBO DNAfree kit (Thermo Fisher Scientific), total mRNA was amplified using the Superscript IV FirstStrand Synthesis System with oligo dT primers (Thermo Fisher Scientific).
Real-time quantitative polymerase chain reaction (RT-qPCR) consisted of 2.5 µl of
SYBR Green Master Mix (Thermo Fisher), 1 µL of cDNA (diluted 1:10), 1 µL of respective
forward and reverse primers (10 μM) and 0.5 µl of deionized distilled water for a total reaction
volume of 5 µl. The reactions were performed in a 7500 ABI Real-Time PCR System (Thermo
Fisher Scientific). The thermal profile consisted of 50°C for 2 min, 95°C for 10 min then 40
cycles of 95°C for 15 sec and 60°C for 1 min. A melt curve analysis was applied at the end of
cycling. Primers that were designed for transcription factor and genes regulating inflammation
included: nuclear factor kappa-light chain enhancer of B cells (NFκB), tumor necrosis factoralpha (TNF-α), interleukin-6 (IL-6), interleukin-10 (IL-10). Genes regulating PUFA
metabolism/inflammation included: cyclooxygenase 1 (COX1), cyclooxygenase 2 (COX2),
arachidonate 5-lipoxygnease (5LOX). Genes regulating oxidation and antioxidants included:
NADPH oxidase 4 (NOX4), transforming growth factor beta-3 (TGFβ3), chemokine (CC-motif)
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ligand-2 (CCL-2), nuclear factor-like 2 (Nrf-2), superoxide dismutase 1 (SOD-1), superoxide
dismutase 2 (SOD-2), catalase, and glutathione peroxidase (GPx), as well as for housekeeping
genes β-actin and glyceraldehyde 2-phosphate dehydrogenase (GAPDH). Primers were
designed using the Primer3 online program (Howard Hughes Medical Institute) and respective
mRNA sequences were obtained at the NCBI RefSeq RNAs catalog through gene ID numbers.
Forward and reverse primers for gene transcriptions are listed in Supplementary Table 2.

Tissue oxidation and antioxidant measurements
Hydrogen peroxide content in the liver was determined using a commercially available
assay kit (Abcam, Cambridge, MA). Briefly, liver samples (50 mg) were homogenized,
centrifuged at 10,000 x g for 2 min at 4°C, and supernatant collected. Deproteinization was
performed by addition of 4M perchloric acid (PCA), followed by precipitation of excess PCA with
2M potassium hydroxide. Liver samples were adjusted to pH 6.5-8. Absorbance was read at
570 nm using a BioTek Epoch microplate spectrophotometer (Walooski, VT). Inter-assay
coefficient of variation was 12.7%.
Thiobarbituric acid reactive substances (TBARS) content in the liver was determined by
measuring malondialdehyde (MDA) using a commercially available assay (Cayman Chemical,
Ann Arbor, MI). Briefly, liver samples (25 mg) were homogenized, centrifuged at 1600 x g for 10
min at 4°C, and supernatant collected. Liver samples were boiled at 100°C for one hour and
placed on ice for 10 min to stop the reaction. Absorbance was read at 535 nm using a BioTek
Epoch microplate spectrophotometer. Inter-assay coefficient of variation was 15.2%.
Total polyphenol content in the liver was determined according to the Folin-Ciocalteu method
(Blainski et al. 2013). The inter-assay coefficient of variation was 11.2%.

Serum and urinary total antioxidant measurements
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Serum and urinary total antioxidant capacity was determined by commercially available
antioxidant assay kit (Cayman Chemical, Ann Arbor, MI). At the end of the feeding study, rats
were individually housed for 24 h in metabolic cages to collect urine. Ascorbic acid (0.1%) was
added to the urine collection tube as a preservative along with 1 ml of mineral oil to prevent
evaporation. Collected urine samples were centrifuged for 10 min at 1500 x g at 4°C to remove
debris. Fasted blood was collected by aorta puncture. Collected blood was centrifuged at 1500 x
g for 10 min at 4°C to obtain serum. Serum and urine samples were stored at -80°C until
assayed for total antioxidant capacity. Briefly, serum and urinary samples were diluted 1:20 and
40 μL hydrogen peroxide (441 μM) working solution added. Absorbance was read at 750 nm
using a BioTek Epoch microplate spectrophotometer. Inter-assay coefficient of variation was
14.5% for serum samples and 21.1% for urine samples.

Serum and urinary biochemical measurements
Serum measurement of liver function and damage included: alanine aminotransferase
(ALT), aspartate aminotransferase (AST), total bilirubin, and albumin were determined
enzymatically using a commercially available Vet-16 rotor and quantified by a Hemagen Analyst
automated spectrophotometer (Hemagen Diagnostics Inc., Columbia, MD). AST:ALT ratio was
determined by dividing AST values by ALT values.
Serum and urine uric acid was determined by commercially available enzymatic assay
(Cayman Chemical). Briefly, serum and urine samples were aliquoted onto a 96-well plate and
incubated for 15 minutes. Reaction was initiated by adding 15 μL of uricase and horseradish
peroxidase enzyme mixture, and read at an excitation of 535 nm and an emission of 590 nm
using a BioTek Synergy H1 microplate reader (Winooski, VT). Inter-assay coefficient of variation
was 32.1% for both serum and urine.

Statistics
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Results are expressed as mean ± standard error of the mean (SEM). Gene expression
was determined as a function of mRNA abundance (A), where A= 1/(gene of interest’s primer
efficiency x ΔCT (g.o.i.))– (average housekeeping’s primer efficiency x ΔCT (h.k.)), where the
product of efficiency and average of expression of β-actin was averaged with the product of
efficiency and average of expression of GAPDH to determine the overall expression of the two
housekeeping genes [28,35,36]. Gene expression data for each treatment group were logtransformed prior to statistical analysis. One-way ANOVA was used to determine differences
among diet groups. Post hoc multiple comparison tests were performed using Tukey’s test with
treatment differences considered significant at p<0.05 and a tendency at p<0.08. All statistical
analyses were performed using JMP 12.2 statistical software package (SAS Institute, Cary,
NC).

4.4 Results
Diet Analysis
As shown in Supplementary Table 1, caloric replacement with apple pomace in AIN
and Western diets resulted in higher total polyphenols. Fat content was higher in the Western
diets than standard AIN diets. Shown in Table 1, Western diets had significantly higher
saturated fatty acids (SFAs), palmitic (16:0) and stearic acid (18:0) than AIN diets. Western/AP
diet had the highest (p<0.0001) palmitic acid. Western diets were also significantly higher in
monounsaturated fatty acids (MUFAs), palmitoleic acid (16:1n 7), and oleic acid (18:1n 9), than
AIN diets.
Essential fatty acids, n-6 PUFA, LA (18:2n-6), and n-3 PUFA, α-linoleic acid (ALA,
18:3n-3) content were lower (p<0.0001) in Western diets than AIN diets. Long chain n-6 PUFA,
ARA was higher (p<0.0001) in Western diets as compared to AIN diets, which contained
negligible amounts. There were no detectable levels of long chain n-3 PUFAs, eicosapentaenoic
acid (EPA, 20:5n-3) or docosahexaenoic acid (DHA, 22:6n-3) in any of the diets.
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Caloric intake, body weight, and tissue weights
Shown in Table 2, rats consuming the Western diets consumed more (p<0.0001) fat
than rats consuming AIN diets. But, rats fed the AIN diets consumed more (p<0.0001)
carbohydrates. Overall, rats fed the Western diets consumed significantly more calories than
rats fed the AIN diets. No significant differences were observed in body weight gain, but a
tendency (p=0.08) for heavier final body weight in rats fed Western diets. Rats fed the Western
diets had heavier (p<0.0001) gonadal adipose tissue than rats fed the AIN diets.

Liver histological evaluation
As shown in Figure 1, 88% of rats fed Western diet and 63% of rats fed Western/AP diet
had evidence of hepatic inflammation. AIN and AIN/AP diet groups each showed 15% of
animals having hepatic inflammation.

Liver and gonadal adipose fatty acid composition
Western/AP diet contained the highest amount of dietary palmitic acid (Table 1), but
hepatic palmitic acid content was not significantly different than rats consuming the AIN diet
(Table 3). Both Western diets contained higher amounts of stearic acid but only showed a
tendency (p=0.08) for higher hepatic stearic acid content compared to rats fed AIN diets.
Western diets also contained higher amounts of palmitoleic and oleic acid than AIN diets. Rats
consuming Western diet had the highest (p=0.05) hepatic palmitoleic acid content. Rats fed
Western diet, but not Western/AP diet, had higher hepatic oleic acid content (p=0.0005)
compared to rats fed the AIN diets. Rats consuming Western diets had lower (p<0.0001)
hepatic n-6 PUFAs, LA and ALA content when compared to rats consuming the AIN diets, but
no difference in hepatic ARA content was observed among diet groups. No EPA or DHA was
found in diet or the liver of any of the diet groups.
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Gonadal adipose tissue palmitic and stearic acids were higher (p<0.0008) in rats
consuming AIN/AP and Western/AP diets than rats consuming AIN and Western diets. Although
no differences in gonadal adipose tissue palmitoleic acid content were observed among diet
groups, substitution of diets with apple pomace resulted in higher (p=0.01) gonadal adipose
tissue oleic acid. Gonadal adipose tissue LA was higher (p<0.0001) in rats consuming AIN/AP
than the Western diets. Additionally, gonadal adipose tissue ALA was highest (p<0.0001) in rats
fed AIN/AP diet. ARA and EPA were below detected in the gonadal adipose tissue in any diet
group. However, gonadal adipose tissue contained more DHA (p=0.008) in rats fed AIN/AP than
Western diets.

Hepatic and gonadal adipose gene markers for inflammation and oxidative stress
As shown in Figure 2A, rats consuming Western diet, but not Western/AP diet
significantly upregulated hepatic transcription factor, NFκB and inflammatory cytokine, IL-6
compared to rats fed the AIN diets. No significant differences were observed in hepatic gene
expression of inflammatory cytokines, TNF-α and IL-10, among diet groups
As shown in Figure 2B, gonadal adipose tissue NFκB, TNFα and IL-6 gene expression
was upregulated (p<0.05) in rats consuming Western diet, but not Western/AP diet compared to
rats fed the AIN diets. No significant differences were observed in gonadal adipose tissue gene
expression of IL-10 among diet groups.

Measurements of PUFA metabolism, inflammation and ROS
As shown in Figure 3A, no significant differences were observed in hepatic gene
expression of COX1, COX2, 5-LOX, or NOX4 among diet groups. As shown in Figure 3B, no
significant differences were observed in gonadal adipose tissue gene expression of COX1,
COX2, 5LOX, or NOX4 among diet groups. As shown in Figure 4, there were no significant
differences in hepatic expression of genes promoting progression of NAFLD to NASH, TGFβ3
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or CCL-2. There were no significant differences in hepatic gene expression of antioxidant
defense transcription factor, Nrf2 or endogenous antioxidant enzymes, SOD1, SOD2, or
catalase among diet groups. However, rats consuming diets substituted with apple pomace
showed upregulation (p<0.0001) hepatic GPx gene expression.

Oxidative Stress and Antioxidant Status Measurements
No significant differences were observed among diet groups for liver oxidation products,
hydrogen peroxide (Figure 5A) or MDA (Figure 5B). For antioxidants, there were no significant
differences in total polyphenols in the liver among diet groups despite higher diet content with
apple pomace caloric replacement (Figure 5C). However, rats consuming Western/AP diet had
the highest (p<0.05) serum total antioxidants (Figure 5D) while rats consuming Western diet
had (p<0.0004) the lowest urinary total antioxidants (Figure 5E).

Serum and urine biochemical measurements
As shown in Table 4, there were no significant differences for serum markers of liver
function and damage: ALT, AST, AST:ALT ratio, bilirubin, or albumin among diet groups. Also,
there were no significant differences in serum or urine uric acid among diet groups.

4.5 Discussion
Previously, we showed caloric substitution with 10% apple pomace in rats consuming a
Western diet attenuated increased histological evidence of steatosis, hepatic triglyceride
content, and hepatic expression of the enzyme DGAT2, which catalyzes the terminal step in
triglyceride synthesis [28]. To extend this study, we evaluated the effects of apple pomace
consumption on diet-induced progression of NAFLD to NASH. The current study showed apple
pomace attenuated histological evidence of inflammation in the liver of rats consuming a
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Western diet. Previous studies showed adipose tissue can alter liver fatty acid composition and
in turn, gene expression of inflammatory cytokines. Additionally, fatty acids released from the
adipose can contribute to hepatic inflammation [37,38]. In our study, rats consuming Western
diets had higher (p<0.0001) gonadal adipose weight compared to rats consuming standard AIN
diets. Further, lipidomic analysis of individuals with NASH-associated hepatocellular carcinoma
showed a significant increase in hepatic MUFA content [39].
In this study, both Western diets contained more MUFAs; however, rats consuming
Western diet, but not Western/AP, had higher hepatic MUFAs, palmitoleic acid (p=0.05) and
oleic acid (p=0.0005) content compared to rats consuming AIN diets. Additionally, gonadal
adipose tissue of rats consuming Western diet, but not Western/AP diet had reduced (p=0.01)
oleic acid content compared to AIN/AP diet. High hepatic oleic acid content, and low adipose
oleic acid content suggests liver-adipose crosstalk, where oleic acid released from adipose
tissue was deposed in the liver. MUFA crosstalk between liver and adipose tissue has been
shown to regulate DNL and inflammation [40-42]. In our study, higher MUFA transport from
gonadal adipose to the liver in rats consuming Western diet was attenuated by caloric
substitution with 10% apple pomace. Increased MUFAs influence triglyceride synthesis and liver
steatosis, promoting NAFLD, where increased SFAs stimulate inflammation, promoting
progression to NASH [16,43].
Rats consuming Western diet, but not Western/AP had higher (p=0.0007) hepatic SFA,
palmitic acid, content compared to rats consuming AIN diets, despite Western/AP diet
containing the highest dietary amount of SFA. Additionally, gonadal adipose tissue of rats
consuming Western diet had lower (p<0.0008) palmitic and stearic acid content than rats
consuming Western/AP diets. The results suggest rats consuming the Western diet had
increased SFA crosstalk, where palmitic acid released from gonadal adipose was transported to
the liver, with apple pomace once again attenuating this increase in the liver. Studies have
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implicated SFAs in NASH due to increased SFA content promoting gene expression of
proinflammatory cytokines [44,45].
Transcription factor, NFκB is a key regulator of numerous inflammatory cytokines [46].
Upregulated gene expression of NFκB and cytokine, IL-6, are major factors in the progression of
NAFLD to NASH [21,47,48]. In the current study, rats fed Western diet had the highest
upregulated (p<0.05) gene expression of NFκB and IL-6 in liver and gonadal adipose tissue.
Additionally, rats consuming a Western diet also had the highest upregulation (p=0.001) of gene
expression of TNF-α in gonadal adipose tissue. According to Hotamisligil, et al [49]., adipose
tissue is a major production site for TNF-α. Studies have shown free fatty acids alter gene
expression of cytokines resulting in progression liver disease [16,41,44,50]. Caloric substitution
with 10% apple pomace attenuated liver deposition of MUFAs and SFAs released from gonadal
adipose tissue and upregulation of gene expression of inflammatory cytokines induced by
Western diet resulting in the absence of development of NAFLD and progression to NASH in
rats fed Western/AP diet.
PUFAs also regulate inflammatory gene expression and in turn, influence liver disease
progression [22,51]. AIN diets contained more n-6 PUFA, LA, than Western diets, which in turn
increased (p<0.0001) hepatic and gonadal adipose tissue LA content. Long-chain n-6 PUFA,
ARA, content was higher in Western diets compared to AIN diets, but no significant differences
were observed in hepatic ARA content. This may be due to higher LA content in AIN diets
undergoing metabolism in the liver to ARA [52]. ARA was not detectable in gonadal adipose
tissue, which was expected since ARA is primarily stored in muscle and liver [53]. ALA, a n-3
PUFA, content was significantly higher In AIN diets than Western diets. Rats fed AIN/AP had
the highest (p<0.001) adipose tissue ALA. Additionally, gonadal adipose tissue of rats
consuming AIN/AP had higher (p=0.0078) DHA content compared to rats consuming Western
diets. In the absence of dietary DHA in any of the diets, this was likely due to higher dietary ALA
in AIN/AP diet being metabolized in adipose tissue to long-chain n-3 PUFA, DHA (Table 3) [54].
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ARA tissue composition influences inflammation by acting as a substrate for COX- and LOXmediated pathways, producing proinflammatory eicosanoids and leukotrienes, respectively
[22,55]. n-3 PUFAs compete for the same COX and LOX enzymes to produce less inflammatory
eicosanoids and leukotrienes [56]. Despite changes in tissue fatty acid composition, there were
no significant differences in COX1, COX2, or 5LOX gene expression in liver or gonadal adipose
tissue among diet groups.
Alterations in tissue fatty acid composition can also promote lipid peroxidation and
increased oxidative stress, which are suggested to promote NASH [17,57,58]. In the present
study, no significant differences were observed in hepatic prooxidants hydrogen peroxide and
MDA content among diet groups. Upregulated gene expression of NOX4, TGFβ3, and CCL-2
are associated with NASH and increased oxidative stress [59-62]. Our study also showed no
significant differences in gene expression of hepatic or adipose NOX4, or hepatic TGFβ3 or
CCL-2 among diet groups (Figure 4). Oxidative stress occurs due to an imbalance of ROS and
antioxidants, indicating antioxidant status as critical in attenuation of NASH [63]. Our study
showed no significant differences in hepatic gene expression of transcription factor, Nrf2, a key
regulator of endogenous antioxidant enzymes, SOD1, SOD2, or catalase among diet groups.
However, rats consuming AIN and Western diets containing apple pomace had upregulated
(p<0.0001) hepatic expression of GPx. Endogenous antioxidant, GPx defends against
increased oxidative stress due to lipid peroxidation [64]. Diets with apple pomace contained
more polyphenols. Increased dietary antioxidants have been shown to increase GPx gene
expression [65]. Decreases in antioxidant enzyme activity, specifically glutathione enzymes, and
diminished antioxidant response has been reported in subjects with NASH. [66,67]. In the
present study, there were no significant differences in liver polyphenol content among diet
groups, which was expected, as polyphenols circulate in the blood with excess polyphenols
being excreted, rather than depose in tissues [68,69]. Higher antioxidant status with apple
pomace caloric consumption was indicated by highest (p=0.0001) serum total antioxidants in
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rats consuming Western/AP and lowest (p=0.0004) urinary total antioxidant excretion in rats
consuming Western diet. These results showed apple pomace increased antioxidant
bioavailability, which can result in attenuation of NASH [70].
Bobek, et al [71]. reported rats fed cholesterol diets (0.3%) supplemented with 5% apple
pomace for 10 weeks reduced erythrocyte SOD, catalase, and GPx. Another study reported
feeding rats a standard diet with 14-15% apple pomace for 4 weeks decreased hepatic MDA
and increase erythrocyte SOD and serum antioxidant capacity [72]. However, neither feeding
study investigated apple pomace’s ability to attenuate diet-induced NASH. Most studies
investigating antioxidant effects of apple pomace used polyphenols isolated from apple pomace.
Consuming isolated bioactive isolated from apple pomace versus whole apple pomace avoids
fructose intake. Fructose overconsumption has been shown to increase uric acid resulting in
increases in proinflammatory cytokine and oxidative stress [25,73]. Our study showed no
significant effect of caloric substation of AIN diet with apple pomace on serum or urinary uric
acid, expression of proinflammatory cytokines, or indices of oxidative stress. Additionally, caloric
substitution of Western diet with apple pomace attenuated progression to NASH. The results
indicate the fructose content in 10% apple pomace to be safe for consumption. Apple pomace
also contains a substantial amount of dietary fiber, which has been shown to produce
synergistic effects when consumed with polyphenols [74-77]. Purification of bioactive
components from pomace is both time consuming and costly, providing further rationale for
consuming whole apple pomace [78-80].
In conclusion, Western diet containing apple pomace ameliorated palmitic and oleic acid
transport from adipose and deposition in the liver, upregulation of inflammatory genes in liver
and gonadal adipose, and improved antioxidant status. Further, caloric substitution of standard
AIN diet with 10% apple pomace rats showed the fructose content of apple pomace did not
promote detrimental liver effects. Based on the current animal study, absence of detrimental
effect on liver health while attenuating NAFLD progression to NASH induced by Western diet
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consumption indicates apple pomace is a potential safe, beneficial, and sustainable functional
food for human consumption.

Conflicts of interest
There are no conflicts to declare.

Acknowledgments
The authors would like to thank Swilled Dog Hard Cider Company for the donation of apple
pomace used in this study. This research was funded by Hatch WVA 1017641 and the Davis
College Dean’s discretionary fund.

133

4.6 References
1.
USDA ERS - Food Availability and Consumption. USDA Economic Research Service .
https://www.ers.usda.gov/data-products/ag-and-food-statistics-charting-the-essentials/foodavailability-and-consumption/. Published 2017. Accessed June 1, 2018.
2.

Bhushan S, Kalia K, Sharma M, Singh B, Ahuja PS. Processing of apple pomace for

bioactive molecules. Crit Rev Biotechnol. 2008;28(4):285-296.
doi:10.1080/07388550802368895
3.

Grigoras C, Destandau E, Fougere L, Elfakir C. Evaluation of apple pomace extracts as

a source of bioactive compounds. Ind Crops Prod. 2013;49:794-804.
doi:10.1016/J.INDCROP.2013.06.026
4.

Kleiner DE, Behling C, Brunt EM, et al. Comparison of adult and pediatric NAFLD-

confirmation of a second pattern of progressive fatty liver disease in children: 189. Hepatology.
2006;44:259A–260A. https://insights.ovid.com/hepatology/hepa/2006/10/001/comparison-adultpediatric-nafld-confirmation/189/01515467.
5.

Loomba R, Sanyal AJ. The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol.

2013;10(11):686-690. doi:10.1038/nrgastro.2013.171
6.

Anderson EL, Howe LD, Jones HE, Higgins JPT, Lawlor DA, Fraser A. The prevalence

of non-alcoholic fatty liver disease in children and adolescents: a systematic review and metaanalysis. Wong V, ed. PLoS One. 2015;10(10):e0140908. doi:10.1371/journal.pone.0140908
7.

Suzuki A, Diehl AM. Nonalcoholic Steatohepatitis. Annu Rev Med. 2017;68(1):85-98.

doi:10.1146/annurev-med-051215-031109
8.

Basaranoglu M, Basaranoglu G, Bugianesi E. Carbohydrate intake and nonalcoholic

fatty liver disease: fructose as a weapon of mass destruction. Hepatobiliary Surg Nutr.
2015;4(2):109-116. doi:0.3978/j.issn.2304-3881.2014.11.05
134

9.

Qureshi K, Abrams GA. Metabolic liver disease of obesity and role of adipose tissue in

the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol. 2007;13(26):35403553. doi:10.1002/hep.25539
10.

Sampey BP, Vanhoose AM, Winfield HM, et al. Cafeteria Diet Is a Robust Model of

Human Metabolic Syndrome With Liver and Adipose Inflammation: Comparison to High-Fat
Diet. Obesity. 2011;19(6):1109-1117. doi:10.1038/oby.2011.18
11.

Lallukka S, Sevastianova K, Perttilä J, et al. Adipose tissue is inflamed in NAFLD due to

obesity but not in NAFLD due to genetic variation in PNPLA3. Diabetologia. 2013;56(4):886892. doi:10.1007/s00125-013-2829-9
12.

Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: The

multiple parallel hits hypothesis. Hepatology. 2010;52(5):1836-1846. doi:10.1002/hep.24001
13.

James MJ, Gibson RA, Cleland LG. Dietary polyunsaturated fatty acids and

inflammatory mediator production. Am J Clin Nutr. 2000;71(1):343s-348s.
doi:10.1093/ajcn/71.1.343s
14.

Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: From steatosis to cirrhosis.

Hepatology. 2006;43(S1):S99-S112. doi:10.1002/hep.20973
15.

Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: The

multiple parallel hits hypothesis. Hepatology. 2010;52(5):1836-1846. doi:10.1002/hep.24001
16.

Milanski M, Degasperi G, Coope A, et al. Saturated fatty acids produce an inflammatory

response predominantly through the activation of TLR4 signaling in hypothalamus: implications
for the pathogenesis of obesity. J Neurosci. 2009;29(2):359-370.
doi:10.1523/JNEUROSCI.2760-08.2009

135

17.

Day CP, James OFW. Steatohepatitis: A tale of two “hits”? Gastroenterology.

1998;114(4):842-845. doi:10.1016/S0016-5085(98)70599-2
18.

Piro S, Anello M, Di Pietro C, et al. Chronic exposure to free fatty acids or high glucose

induces apoptosis in rat pancreatic islets: possible role of oxidative stress. Metabolism.
2002;51(10):1340-1347. doi:10.1053/META.2002.35200
19.

Anitha Nandhini AT, Balakrishnan SD, Anuradha C V. Taurine modulates antioxidant

potential and controls lipid peroxidation in the aorta of high fructose-fed rats. J Biochem Mol Biol
Biophys. 2002;6(2):129-133. doi:10.1080/10258140290027261
20.

Videla LA, Rodrigo R, Araya J, Poniachik J. Oxidative stress and depletion of hepatic

long-chain polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease. Free
Radic Biol Med. 2004;37(9):1499-1507. doi:10.1016/J.FREERADBIOMED.2004.06.033
21.

Buzzetti E, Pinzani M, Tsochatzis EA. The multiple-hit pathogenesis of non-alcoholic

fatty liver disease (NAFLD). Metabolism. 2016;65(8):1038-1048.
doi:10.1016/J.METABOL.2015.12.012
22.

Simopoulos AP. An increase in the omega-6/omega-3 fatty acid ratio increases the risk

for obesity. Nutrients. 2016;8(3):128. doi:10.3390/nu8030128
23.

French SW, Morimoto M, Reitz RC, et al. Lipid Peroxidation, CYP2E1 and Arachidonic

Acid Metabolism in Alcoholic Liver Disease in Rats. J Nutr. 1997;127(5):907S-911S.
doi:10.1093/jn/127.5.907S
24.

Adams LA, Angulo P. Treatment of non-alcoholic fatty liver disease. Postgrad Med J.

2006;82(967):315-322. doi:10.1055/s-2001-12931

136

25.

Nakagawa T, Hu H, Zharikov S, et al. A causal role for uric acid in fructose-induced

metabolic syndrome. Am J Physiol Physiol. 2006;290(3):F625-F631.
doi:10.1152/ajprenal.00140.2005
26.

Mosca A, Nobili V, De Vito R, et al. Serum uric acid concentrations and fructose

consumption are independently associated with NASH in children and adolescents. J Hepatol.
2017;66(5):1031-1036. doi:10.1016/J.JHEP.2016.12.025
27.

Lim JS, Mietus-Snyder M, Valente A, Schwarz J-M, Lustig RH. The role of fructose in the

pathogenesis of NAFLD and the metabolic syndrome. Nat Rev Gastroenterol Hepatol.
2010;7(5):251-264. doi:10.1038/nrgastro.2010.41
28.

Skinner R, Warren D, Lateef S, et al. Apple Pomace Consumption Favorably Alters

Hepatic Lipid Metabolism in Young Female Sprague-Dawley Rats Fed a Western Diet.
Nutrients. 2018;10(12):1882. doi:10.3390/nu10121882
29.

Vilà L, Roglans N, Perna V, et al. Liver AMP/ATP ratio and fructokinase expression are

related to gender differences in AMPK activity and glucose intolerance in rats ingesting liquid
fructose. J Nutr Biochem. 2011;22(8):741-751. doi:10.1016/J.JNUTBIO.2010.06.005
30.

National Research Council. Guide for the Care and Use of Laboratory Animals: Eighth

Edition - National Research Council, Division on Earth and Life Studies, Institute for Laboratory
Animal Research, Committee for the Update of the Guide for the Care and Use of Laboratory
Animals - Google Books. 8th ed. Washington D.C.; 2010.
https://books.google.com/books?hl=en&lr=&id=Vp5mgXtxYdQC&oi=fnd&pg=PP2&dq=national+
research+council+2010+rats&ots=FrTgd1JCl5&sig=eZ_vGWk36QfLScXnMbS__BgT8XU#v=on
epage&q=national research council 2010 rats&f=false. Accessed February 27, 2018.

137

31.

Blainski A, Lopes G, de Mello J, Blainski A, Lopes GC, de Mello JCP. Application and

Analysis of the Folin Ciocalteu Method for the Determination of the Total Phenolic Content from
Limonium Brasiliense L. Molecules. 2013;18(6):6852-6865. doi:10.3390/molecules18066852
32.

Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring

system for nonalcoholic fatty liver disease. Hepatology. 2005;41(6):1313-1321.
doi:10.1002/hep.20701
33.

Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J

Biochem Physiol. 1959;37(1):911-917. doi:10.1139/o59-099
34.

Fritsche KL, Johnston P V. Effect of dietary a-linolenic acid on growth, metastasis, fatty

acid profile and prostaglandin production of two murine mammary adenocarcinomas. J Nutr.
1990;120(12):1601-1609. doi:10.1093/jn/120.12.1601
35.

Jacometo CB, Schmitt E, Pfeifer LFM, et al. Linoleic and α-linolenic fatty acid

consumption over three generations exert cumulative regulation of hepatic expression of genes
related to lipid metabolism. Genes Nutr. 2014;9(4):405. doi:10.1007/s12263-014-0405-7
36.

Maditz KH, Benedito VA, Oldaker C, et al. Feeding Soy Protein Isolate and n-3 PUFA

Affects Polycystic Liver Disease Progression in a PCK Rat Model of Autosomal Polycystic
Kidney Disease. J Pediatr Gastroenterol Nutr. 2015;60(4):467-473.
doi:10.1097/MPG.0000000000000649
37.

Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of

fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver
disease. J Clin Invest. 2005;115(5):1343-1351. doi:10.1172/JCI23621

138

38.

Roberts AA, Hebbard LW. Molecular cross-talk between the liver and white adipose

tissue links excessive noURIshment to hepatocellular carcinoma. Transl Cancer Res.
2016;5(6):S1222-S1226. doi:10.21037/10460
39.

Muir K, Hazim A, He Y, et al. Proteomic and lipidomic signatures of lipid metabolism in

NASH-associated hepatocellular carcinoma. Cancer Res. 2013;73(15):4722-4731.
doi:10.1158/0008-5472.CAN-12-3797
40.

Burhans MS, Ntambi JM. Monounsaturated Fatty Acid Mediated Liver-Adipose Tissue

Crosstalk and Metabolic Regulation. In: Hepatic De Novo Lipogenesis and Regulation of
Metabolism. Cham: Springer International Publishing; 2016:255-265. doi:10.1007/978-3-31925065-6_12
41.

Malhi H, Gores GJ. Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver

disease. Semin Liver Dis. 2008;28(4):360-369. doi:10.1055/s-0028-1091980
42.

Saponaro C, Gaggini M, Carli F, et al. The Subtle Balance between Lipolysis and

Lipogenesis: A Critical Point in Metabolic Homeostasis. Nutrients. 2015;7(11):9453-9474.
doi:10.3390/nu7115475
43.

Miyazaki M, Kim YC, Ntambi JM. A lipogenic diet in mice with a disruption of the

stearoyl-CoA desaturase 1 gene reveals a stringent requirement of endogenous
monounsaturated fatty acids for triglyceride synthesis. J Lipid Res. 2001;42(7):1018-1024.
44.

Leamy AK, Egnatchik RA, Young JD. Molecular mechanisms and the role of saturated

fatty acids in the progression of non-alcoholic fatty liver disease. Prog Lipid Res.
2013;52(1):165-174. doi:10.1016/J.PLIPRES.2012.10.004

139

45.

Nestel P, Clifton P, Noakes M. Effects of increasing dietary palmitoleic acid compared

with palmitic and oleic acids on plasma lipids of hypercholesterolemic men. J Lipid Res.
1994;35(4):656-662. http://www.ncbi.nlm.nih.gov/pubmed/8006520.
46.

Tak PP, Firestein GS. NF-kappaB: a key role in inflammatory diseases. J Clin Invest.

2001;107(1):7-11. doi:10.1172/JCI11830
47.

Michelotti GA, Machado M V., Diehl AM. NAFLD, NASH and liver cancer. Nat Rev

Gastroenterol Hepatol. 2013;10(11):656-665. doi:10.1038/nrgastro.2013.183
48.

Wieckowska A, Papouchado BG, Li Z, Lopez R, Zein NN, Feldstein AE. Increased

Hepatic and Circulating Interleukin-6 Levels in Human Nonalcoholic Steatohepatitis. Am J
Gastroenterol. 2008;103(6):1372-1379. doi:10.1111/j.1572-0241.2007.01774.x
49.

Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose

tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin
Invest. 1995;95(5):2409-2415. doi:10.1172/JCI117936
50.

van Dijk SJ, Feskens EJ, Bos MB, et al. A saturated fatty acid–rich diet induces an

obesity-linked proinflammatory gene expression profile in adipose tissue of subjects at risk of
metabolic syndrome. Am J Clin Nutr. 2009;90(6):1656-1664. doi:10.3945/ajcn.2009.27792
51.

Wang X, Cao Y, Fu Y, Guo G, Zhang X. Liver fatty acid composition in mice with or

without nonalcoholic fatty liver disease. Lipids Health Dis. 2011;10:234. doi:10.1186/1476-511X10-234
52.

Salem N, Pawlosky R, Wegher B, Hibbeln J. In vivo conversion of linoleic acid to

arachidonic acid in human adults. Prostaglandins, Leukot Essent Fat Acids. 1999;60(5-6):407410. doi:10.1016/S0952-3278(99)80021-0

140

53.

Smith GI, Atherton P, Reeds DN, et al. Omega-3 polyunsaturated fatty acids augment

the muscle protein anabolic response to hyperinsulinaemia-hyperaminoacidaemia in healthy
young and middle-aged men and women. Clin Sci (Lond). 2011;121(6):267-278.
doi:10.1042/CS20100597
54.

Todorčević M, Hodson L. The Effect of Marine Derived n-3 Fatty Acids on Adipose

Tissue Metabolism and Function. J Clin Med. 2015;5(1). doi:10.3390/jcm5010003
55.

Nanji A, Miao L, Thomas P, et al. Enhanced cyclooxygenase-2 gene expression in

alcoholic liver disease in the rat. Gastroenterology. 1997;112(3):943-951.
doi:10.1053/gast.1997.v112.pm9041257
56.

Martinez-Rubio L, Morais S, Evensen Ø, et al. Effect of functional feeds on fatty acid and

eicosanoid metabolism in liver and head kidney of Atlantic salmon (Salmo salar L.) with
experimentally induced Heart and Skeletal Muscle Inflammation. Fish Shellfish Immunol.
2013;34(6):1533-1545. doi:10.1016/J.FSI.2013.03.363
57.

Reddy JK, Sambasiva Rao M. Lipid Metabolism and Liver Inflammation. II. Fatty liver

disease and fatty acid oxidation. Am J Physiol Liver Physiol. 2006;290(5):G852-G858.
doi:10.1152/ajpgi.00521.2005
58.

Narasimhan S, Gokulakrishnan K, Sampathkumar R, et al. Oxidative stress is

independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and
without type 2 diabetes. Clin Biochem. 2010;43(10-11):815-821.
doi:10.1016/J.CLINBIOCHEM.2010.04.003
59.

Kuroda J, Ago T, Matsushima S, Zhai P, Schneider MD, Sadoshima J. NADPH oxidase

4 (Nox4) is a major source of oxidative stress in the failing heart. Proc Natl Acad Sci U S A.
2010;107(35):15565-15570. doi:10.1073/pnas.1002178107

141

60.

Mas E, Danjoux M, Garcia V, Carpentier S, Ségui B, Levade T. IL-6 Deficiency

Attenuates Murine Diet-Induced Non-Alcoholic Steatohepatitis. Ng IO-L, ed. PLoS One.
2009;4(11):e7929. doi:10.1371/journal.pone.0007929
61.

Ix JH, Sharma K. Mechanisms linking obesity, chronic kidney disease, and fatty liver

disease: the roles of fetuin-A, adiponectin, and AMPK. J Am Soc Nephrol. 2010;21(3):406-412.
doi:10.1681/ASN.2009080820
62.

Rossary A, Arab K, Steghens J-P. Polyunsaturated fatty acids modulate NOX 4 anion

superoxide production in human fibroblasts. Biochem J. 2007;406(1):77-83.
doi:10.1042/BJ20061009
63.

Willcox JK, Ash SL, Catigani GL. Antioxidants and prevention of chronic disease. Crit

Rev Food Sci Nutr. 2004;44(4):275-295.
64.

Aykaç G, Uysal M, Süha Yalçin A, Koçak-Toker N, Sivas A, Öz H. The effect of chronic

ethanol ingestion on hepatic lipid peroxide, glutathione, glutathione peroxidase and glutathione
transferase in rats. Toxicology. 1985;36(1):71-76. doi:10.1016/0300-483X(85)90008-3
65.

Sen CK. Glutathione homeostasis in response to exercise training and nutritional

supplements. In: Stress Adaptation, Prophylaxis and Treatment. Boston, MA: Springer US;
1999:31-42. doi:10.1007/978-1-4615-5097-6_4
66.

Koruk M, Taysi S, Savas MC, Yilmaz O, Akcay F, Karakok M. Oxidative stress and

enzymatic antioxidant status in patients with nonalcoholic steatohepatitis. Ann Clin Lab Sci.
2004;34(1):57-62. http://www.ncbi.nlm.nih.gov/pubmed/15038668. Accessed January 28, 2019.
67.

Nobili V, Pastore A, Gaeta LM, et al. Glutathione metabolism and antioxidant enzymes in

patients affected by nonalcoholic steatohepatitis. Clin Chim Acta. 2005;355(1-2):105-111.
doi:10.1016/J.CCCN.2004.12.022

142

68.

D’Archivio M, Filesi C, Varì R, Scazzocchio B, Masella R. Bioavailability of the

polyphenols: status and controversies. Int J Mol Sci. 2010;11(4):1321-1342.
doi:10.3390/ijms11041321
69.

de Vries JH, Hollman PC, Meyboom S, et al. Plasma concentrations and urinary

excretion of the antioxidant flavonols quercetin and kaempferol as biomarkers for dietary intake.
Am J Clin Nutr. 1998;68(1):60-65. doi:10.1093/ajcn/68.1.60
70.

Chang CY, Argo CK, Al-Osaimi AMS, Caldwell SH. Therapy of NAFLD: antioxidants and

cytoprotective agents. J Clin Gastroenterol. 2006;40 Suppl 1:S51-60.
doi:10.1097/01.mcg.0000168648.79034.67
71.

Bobek P, Ozdín L, Hromadová M. The effect of dried tomato, grape and apple pomace

on the cholesterol metabolism and antioxidative enzymatic system in rats with
hypercholesterolemia. Mol Nutr Food Res. 1998;42(5):317-320. doi:10.1002/(SICI)15213803(199810)42:05<317::AID-FOOD317>3.0.CO;2-Y
72.

Juśkiewicz J, Żary-Sikorska E, Zduńczyk Z, Król B, Jarosławska J, Jurgoński A. Effect of

dietary supplementation with unprocessed and ethanol-extracted apple pomaces on caecal
fermentation, antioxidant and blood biomarkers in rats. Br J Nutr. 2012;107(8):1138-1146.
doi:10.1017/S0007114511004144
73.

Lyngdoh T, Marques-Vidal P, Paccaud F, et al. Elevated Serum Uric Acid Is Associated

with High Circulating Inflammatory Cytokines in the Population-Based Colaus Study. Means T,
ed. PLoS One. 2011;6(5):e19901. doi:10.1371/journal.pone.0019901
74.

Hyson DA. A comprehensive review of apples and apple components and their

relationship to human health. Adv Nutr. 2011;2(5):408-420. doi:10.3945/an.111.000513

143

75.

Devi PB, Vijayabharathi R, Sathyabama S, Malleshi NG, Priyadarisini VB. Health

benefits of finger millet (Eleusine coracana L.) polyphenols and dietary fiber: a review. J Food
Sci Technol. 2014;51(6):1021-1040. doi:10.1007/s13197-011-0584-9
76.

Saura-Calixto F. Antioxidant Dietary Fiber Product: A New Concept and a Potential Food

Ingredient. 1998. doi:10.1021/JF9803841
77.

Sudha ML, Baskaran V, Leelavathi K. Apple pomace as a source of dietary fiber and

polyphenols and its effect on the rheological characteristics and cake making. Food Chem.
2007;104(2):686-692. doi:1016/J.FOODCHEM.2006.12.016
78.

Sembries S, Dongowski G, Jacobasch G, Mehrländer K, Will F, Dietrich H. Effects of

dietary fibre-rich juice colloids from apple pomace extraction juices on intestinal fermentation
products and microbiota in rats. Br J Nutr. 2003;90(3):607-615. doi:10.1079/BJN2003925
79.

Sembries S, Dongowski G, Mehrländer K, Will F, Dietrich H. Dietary fiber–rich colloids

from apple pomace extraction juices do not affect food intake and blood serum lipid levels, but
enhance fecal excretion of steroids in rats. J Nutr Biochem. 2004;15(5):296-302.
doi:10.1016/J.JNUTBIO.2003.12.005
80.

Chen L, Liu L, Li C, et al. A mix of apple pomace polysaccharide improves mitochondrial

function and reduces oxidative stress in the liver of high-fat diet-induced obese mice. Mol Nutr
Food Res. 2017;61(3). doi:10.1002/mnfr.201600433

144

Table 1. Fatty acid analysis of rodent diets substituted with apple pomace (10% g/kg).
Measurements (mg/g)

AIN

AIN/AP

Treatments
Western

Western/AP p-Value
SFAs
Palmitic acid (16:0)
113.6 ± 0.9c 111.4 ± 1.5c 321.9 ± 0.3b 329.2 ± 3.0a <0.0001
Stearic acid (18:0)
35.6 ± 2.5b
37.2 ± 0.6b
99.4 ± 1.1a 102.4 ± 0.6a <0.0001
MUFAs
Palmitoleic acid (16:1n-7)
0 ± 0.00b
0 ± 0.00b
14.4 ± 0.1a
14.4 ± 0.2a <0.0001
b
b
a
Oleic acid (18:1n-9)
190.9 ± 1.0
183.5 ± 3.3
229.6 ± 1.1 229.5 ± 1.7a <0.0001
PUFAs
Linoleic acid (18:2 n-6)
501.2 ± 5.5a 514.1 ± 24.1a 69.9 ± 0.9b
70.4 ± 0.6b <0.0001
a
a
b
α-linolenic acid (18:3 n-3)
70.8 ± 1.3
71.3 ± 7.0
10.4 ± 0.1
10.5 ± 0.2b <0.0001
b
b
a
Arachidonic acid (20:4 n-6)
0 ± 0.00
0 ± 0.00
0.13 ± 0.00 0.14 ± 0.00a <0.0001
EPA (20:5n-3)
0 ± 0.00
0 ± 0.00
0 ± 0.00
0 ± 0.00
1.00
DHA (22:6n-3)
0 ± 0.00
0 ± 0.00
0 ± 0.00
0 ± 0.00
1.00
Values expressed as mean ± standard error of the mean (SEM, n = 5 samples/group). Different superscript letters a, b, and c within.
The same row indicates significant difference at p<0.05 by one-way ANOVA followed by Tukey’s test. Abbreviations: DHA,
docosahexaenoic acid; EPA, eicosapentaenoic acid; MUFAs, monounsaturated fatty acids; PUFAs, polyunsaturated fatty, acids;
SFAs, saturated fatty acids.
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Table 2. Daily caloric and macronutrient intake, total body weight gain, liver and gonadal fat pad weights, and liver triglyceride
content of growing female rats consuming different diets substituted with apple pomace (10% g/kg) for 8 weeks.
Treatments
AIN
AIN/AP
Western
Western/AP
p-Value
Caloric intake (kcal/d)
53 ± 2b
49 ± 1b
60 ± 1a
61 ± 2a
<0.0001
CHO intake (kcal/d)
32 ± 1a
31 ± 1a
24 ± 1b
24 ± 1b
<0.0001
b
b
a
a
Fat intake(kcal/d)
9 ± 0.3
8 ± 0.2
27 ± 1
27 ± 1
<0.0001
Bwt gain (g/d)
2.2 ± 0.1
2.2 ± 0.1
2.4 ± 0.1
2.5 ± 0.1
0.17
Final Body Weight (g)
215 ± 4
216 ± 8
229 ± 5
234 ± 5
0.08
b
b
a
a
Gonadal fat pad weight (g)
4.12 ± 0.26
3.46 ± 0.44
5.87 ± 0.24
5.96 ± 0.23
<0.0001
Relative gonadal fat pad weight (mg/g bwt)
1.90 ± 0.14b
1.59 ± 0.17b
2.37 ± 0.20a
2.56 ± 0.11a
<0.0001
Liver weight (g)
7.50 ± 0.24
7.44 ± 0.37
8.05 ± 0.30
7.98 ± 0.24
0.35
Relative liver weight (mg/g bwt)
3.47 ± 0.08
3.45 ± 0.07
3.52 ± 0.07
3.41 ± 0.05
0.69
Values expressed as mean ± SEM (n = 6–8 rats/group). Different superscript letters a and b within the same row. Indicate
significant difference at p<0.05 by one-way ANOVA followed by Tukey’s test. Abbreviations: Bwt, body weight; CHO,
carbohydrate.
Measurements
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Table 3. Liver and gonadal adipose tissue fatty acid content of young female rats consuming different diets substituted with apple
pomace (10% g/kg).
Liver
Measurement
(mg/g)
SFAs
Palmitic Acid
(16:0)
Stearic Acid
(18:0)
MUFAs
Palmitoleic
Acid (16:1)
Oleic Acid
(18:1)
PUFAs
LA (18:3n-6)

AIN

Adipose

AIN/AP

Western

Western/AP

p-value

AIN

AIN/AP

Western

Western/AP

p-value

191.0 ± 5.7bc

184.0 ± 5.33c

214.4 ± 5.3a

210.8 ± 5.3ab

0.0007

132.1 ± 27.3b

282.6 ± 25.6a

123.2 ± 29.5b

241.8 ± 25.6a

0.0004

144.6 ± 6.5

140.6 ± 6.0

148.3 ± 8.3

162.8 ± 6.0

0.08

18.3 ± 3.1b

32.9 ± 3.3a

20.2 ± 3.10b

35.5 ± 3.1a

0.0008

57.0 ± 25.0b

81.0 ± 25.0b

161.0 ± 23.0a

76.0 ± 25.0b

0.05

14.7 ± 7.3

b

b

a

ab

24.2 ± 10.4
b

112.5 ± 16.5

107.2 ± 13.9

195.5 ± 13.9

159.5 ± 13.0

0.0005

185.8 ± 39.9

224.4 ± 10.9a

251.2 ± 10.9a

92.8 ± 10.9b

83.8 ± 10.9b

<0.0001

193.8 ± 65.0ab

a

a

b

b

b

17.8 ± 7.0
a

313.7 ± 39.9

142.4 ± 46.1

376.1 ± 51.0a

53.5 ± 19.0b

a

b

23.6 ± 8.8
b

314.9 ± 42.6

0.84
a

0.01

64.6 ± 6.7b

<0.0001

5.2 ± 1.6b

<0.0001

ALA (18:3n-3)

10.4 ± 1.4

12.8 ± 1.5

2.3 ± 1.4

2.2 ± 1.4

<0.0001

11.3 ± 3.5

38.4 ± 5.0

3.8 ± 2.2

ARA (20:4)

132.6 ± 10.0

119.9 ± 16.1

132.0 ± 10.0

145.6 ± 10.0

0.37

0 ± 0.00

0 ± 0.00

0 ± 0.00

0 ± 0.00

1.00

EPA (20:5n-3)

0 ± 0.00

0 ± 0.00

0 ± 0.00

0 ± 0.00

1.00

0 ± 0.00

0 ± 0.00

0 ± 0.00

0 ± 0.00

1.00

DHA (22:6n-3)

0 ± 0.00

0 ± 0.00

0 ± 0.00

0 ± 0.00

1.00

0.1 ± 0.1b

1.3 ± 0.3a

0 ± 0.00b

0.1 ± 0.1b

0.0078

Values expressed as mean ± SEM (n = 6–8 rats/group). Different superscript letters a and b within the same column
indicate significant difference at p<0.05 by one-way ANOVA followed by Tukey’s test. Abbreviations: ALA, α-linolenic acid;
ARA, arachidonic acid; DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; LA, linoleic acid; MUFA,
monounsaturated
fatty
acids;
PUFA,
polyunsaturated
fatty
acids;
SFAs,
saturated
fatty
acids
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Table 4. Effect of consumption of different diets substituted with apple pomace (10% g/kg) by growing female rats on serum
and urine measurements of liver function enzymes, and uric acid following 8 weeks of feeding.
Measurements
AIN
AIN/AP
Western
Western/AP
p-Value
Serum ALT (U/L)
107.63 ± 19.59 118.71 ± 43.60
94.5 ± 12.58
133.5 ± 30.59
0.78
Serum AST (U/L)
129.48 ± 52.86 212.50 ± 37.86 283.63 ± 45.30 259.67 ± 48.96
0.69
Serum AST:ALT ratio
3.16 ± 0.45
2.79 ± 0.28
2.97 ± 0.26
2.84 ± 0.17
0.83
Serum Bilirubin
0.21 ± 0.01
0.21 ± 0.01
0.21 ± 0.01
0.21 ± 0.01
1.00
Serum Albumin
4.06 ± 0.24
4.28 ± 0.36
4.93 ± 0.21
4.1 ± 0.36
0.21
Serum Uric Acid (μM)
7.24 ± 0.31
6.27 ± 1.61
7.19 ± 0.86
7.57 ± 1.25
0.86
Urine Uric Acid (μM)
5.94 ± 2.26
10.35 ± 2.11
10.40 ± 1.12
6.79 ± 1.41
0.23
Values expressed as mean ± SEM (n=4-8 animals/group). Different superscript letters a and b within the same figure indicates
significant difference at p<0.05 by one-way ANOVA followed by Tukey’s test. Abbreviations: AST, aspartate aminotransferase; ALT,
alanine aminotransferase.
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Figure Legend
Figure 1. Representative histological staining images of the liver of growing female rats
consuming (A) AIN, (B) AIN/AP, (C) Western, or (D) Western/AP following 8 weeks of feeding.
Black arrows indicate fat deposition. White arrows indicate inflammation.
Figure 2. Relative expression of genes involved in inflammation in (A) liver tissue and (B)
gonadal adipose tissue of young female rats consuming different diets substituted with apple
pomace (10% g/kg) for 8 weeks. Values expressed as mean ± SEM (n=6-8 animals/group).
Different superscript letters a and b within the same figure indicates significant difference at
p<0.05 by one-way ANOVA followed by Tukey’s test. Abbreviations: AU, arbitrary units, IL-6,
interleukin-6, IL-10, interleukin-10; NFκB, nuclear factor kappa-light-chain enhancer of activated
B cells; TNF-α, tumor necrosis factor alpha.
Figure 3. Relative expression of genes involved in polyunsaturated fatty acid metabolism,
inflammation, and oxidative stress in (A) liver tissue and (B) gonadal adipose tissue of young
female rats consuming different diets substituted with apple pomace (10% g/kg) for 8 weeks.
Values expressed as mean ± SEM (n=6-8 animals/group). Different superscript letters a and b
within the same figure indicates significant difference at p<0.05 by one-way ANOVA followed by
Tukey’s test. Abbreviations: 5LOX, arachidonate 5-lipoxygenase; AU, arbitrary units; COX1,
cyclooxygenase 1; COX2, cyclooxygenase 2; NOX4, NADPH oxidase 4.
Figure 4. Relative expression of genes involved in oxidative stress and antioxidant function in
liver tissue of young female rats consuming different diets substituted with apple pomace (10%
g/kg) for 8 weeks. Values expressed as mean ± SEM (n=6-8 animals/group). Different
superscript letters a and b within the same figure indicates significant difference at p<0.05 by
one-way ANOVA followed by Tukey’s test. Abbreviations: AU, arbitrary units; CAT, catalase;
CCL-2, chemokine (C-C motif) ligand 2; GPx, glutathione peroxidase; Nrf2, nuclear factor-like 2;
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SOD1, superoxide dismutase 1; SOD2, superoxide dismutase 2, TGFβ3, transforming growth
factor beta-3.
Figure 5. Oxidative stress and antioxidant status measured by (A) hepatic hydrogen peroxide,
(B) hepatic MDA, (C) hepatic total polyphenols, (D) serum total antioxidants, and (E) urine total
antioxidants in young female rats consuming different diets substituted with apple pomace (10%
g/kg) for 8 weeks. Values expressed as mean ± SEM (n=6-8 animals/group). Different
superscript letters a and b within the same panel indicates significant difference at p<0.05 by
one-way ANOVA followed by Tukey’s test. Abbreviations: MDA, malondialdehyde.
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Inflammation Grades
AIN

AIN/AP

Western

Western/AP

0

85%

85%

12%

37%

1

15%

15%

88%

63%
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152

153

154
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4.7 Supplementary Material
Supplementary Table 1. Composition of rodent diets substituted with apple pomace (10% g/kg)
fed to growing female rats.
Diet Groups *
AIN

AIN/AP

Western Western/AP

Apple
Pomace
(g/100g)
100
13.9
33.5
33.2
22.2
11.0
0.29

Ingredients (g/kg) *
Apple pomace
0.0
100.0
0.0
100.0
Corn Starch
397.486 392.086
63.36
57.96
Maltodextrin
132.0
132.0
60.0
60.0
Sucrose
100.0
43.9
340.0
283.9
Fructose
50
54.45
170
174.45
Total Dietary Fiber
50.0
50.0
50.0
50.0
Insoluble Fiber †
50.0
39.0
50.0
39.0
Soluble Fiber ‡
0.0
11.0
0.0
11.0
Anhydrous Milkfat
0.0
0.0
210.0
210.0
Soybean Oil
70.0
68.7
20.0
18.7
Casein
200.0
196.0
195.0
191.0
L-Cystine
3.0
3.0
3.0
3.0
Vitamin Mix
10.0
10.0
12.5
12.5
Mineral Mix
35.0
35.0
43.0
43.0
Choline Bitartrate
2.5
2.5
3.1
3.1
TBHQ, antioxidant
0.014
0.014
0.04
0.04
Polyphenols
0.0015
0.0029
0.0008
0.0032
Macronutrients (% kcal)
Protein
18.8
18.9
14.8
14.8
3.6
Fat
17.2
17.3
44.6
44.8
1.3
Carbohydrate
63.9
63.7
40.6
40.4
68.1
Calories (kcal/g)
3.8
3.7
4.7
4.7
3.9
*
Abbreviations: AIN, the American Institute of Nutrition; AP, apple pomace; TBHQ, tertbutylhydroquinone. † Insoluble fiber is cellulose. ‡ Soluble fiber is mainly pectin 2.
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Supplementary Table 2. List of primers used for RT-qPCR analysis.
Gene

NCBI Gene ID

Forward Primer

Reverse Primer

NFκB

81736

5’ TTATGGGCAGGATGGACCTA 3’

5’ CCTTTCAGGGCTTTGGTTTA 3’

TNFα

24835

5’ CACAAGGCTGCTGAAGATGT 3’

5’ GAGGGAAGGAAGGAAGGAAG 3’

IL-6

24498

5’ TGGCTAAGGACC AAGACCAT 3’

5’ TTGCCGAGTAGACCTCATAGTG 3’

IL-10

25325

5’ CACTGCTATGTTGCCTGCTC 3’

5’ GCCTTTGCTGGTCTTCACTC 3’

PUFA
Metabolism/
Inflammation
COX-1

24693

5’ CTGCCTCAACACCAAGACC 3’

5’ CCGTCATCTCCAGGGTAATC 3

COX-2

29527

5’ CGGAGGAGAAGTGGGTTTTAG 3’

5’ TGAAAGAGGCAAAGGGACAC 3’

5LOX

25290

5’ CCATCAAGAGCAGGGAGAAA 3’

5’ CATAGTTGGAGGAGCGTTGG 3’

Inflammation

Oxidative
Stress
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NOX4

85431

5’ CCTCCATCAAGCCAAGATTC 3’

5’ CTCCAGCCACACACAGACTAAC 3’

TGFβ3

25717

5’ AACTGCTGTGTGCGCCCC 3’

5’ TAGTCCAAGCACCGTGCTGTGG 3’

CCL-2

24770

5’ CCACAACCACCTCAAGCAC 3’

5’ AGGCATCACATTCCAAATCAC 3’

Nrf2

83619

5’ TGACTCGGAAATGGAAGAGC 3’

5’ TGTGTTGGCTGTGCTTTAGG 3’

SOD1

24786

5' GGTCCACGAGAAACAAG TGA 3'

5' CAATCACACCACAAGCCAAG 3'

SOD2

24787

5' GAAAGTGCTCAAGATGGACAAAG 3'

5' CTGAATGGCTTCCCTGAATG 3'

Catalase

24248

5' TGTTGAATGAGGAGAGGA 3'

5' TTCTTAGGC TTCTGGGAGTTG 3'

GPx

24404

5' GATACGCCGAGTGTGGTT T 3'

5' TCTTGATTACTTCCTGGCTCCT 3'

β-actin

81822

5’ TTGCTGACAGGATGCACAAG 3’

5’ CAGTGAGGCCAGGATAGAGC 3’

GAPDH

24383

5’ TCAAGAAGGTGGTGAAGCAG 3’

5’ CCTCAGTGTAGCCCAGGATG 3’

Antioxidant
Status

Housekeeping
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5.1 Abstract
Apple pomace, a “waste” byproduct of apple processing has a favorable nutritional profile
indicating potential for repurposing for human consumption. However, the high fructose content
of apple pomace when added to a healthy diet or Western diet, typified by high sugar and high
fat, may result in detriments to kidney and bone health. Therefore, the objectives of this study
were to determine the safety of caloric substitution with 10% apple pomace substitution (g/kg) to
a healthy or Western diet. Growing (age 22-29 days) female Sprague-Dawley rats were
randomly assigned (n=8 rats/group) to consume a purified standard rodent diet (AIN-93G), AIN93G/10% g/kg apple pomace (AIN/AP), Western diet, or Western/10% g/kg apple pomace
(Western/AP) diets for 8 weeks. Histological evaluation showed renal interstitial hypercellularity
in rats fed AIN/AP, Western, and Western/AP diets. However, there was no effects on renal
expression of oxidative stress and inflammatory genes or serum measures of kidney damage
and function among diet groups. Apple pomace is also high in calcium which can affect calcium
balance. Dietary calcium consumption was highest (p<0.0001) in rats consuming Western/AP.
However, there was no significant differences in calcium absorption and retention among diet
groups. Further, there was no evidence of renal calcification. There were also impact on femoral
calcium and total mineral content, size, and strength. Based on the results, apple pomace
consumption was safe for renal and bone health, regardless of diet quality.
Keywords: apple pomace, safety, minerals, Western diet, bone, kidney
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5.2 Introduction
Apple processing generates waste, consisting of skin, stem, seeds, and calyx,
collectively known as apple pomace. The environmental pollution and burden of waste disposal
costs to apple farmers and producers can be decreased by re-purposing apple pomace as a
product for human consumption [1-3]. However, among popular consumed fruits, apples had the
highest fructose content [1]. Muir, et al. [4] reported apples to have 10.5 g of fructose/serving
compared to 3.2 g/serving for bananas, 6.4 g/serving for blueberries, and 2.5 g/serving for
oranges. Further, apple pomace contains 44.7% fructose compared to 5.8-6.0% fructose in
whole apple [5]. This is a health concern because fructose overconsumption has been reported
to contribute to renal disease and to produce deleterious effects on bone [6,7]. Apple pomace
contains a higher mineral content than whole apples, particularly calcium which is required for
bone health [1,8]. However, over-consumption of calcium can increase nephrocalcinosis and
reduced kidney function [9,10]. In turn, renal dysfunction can lead to bone loss due to mineral
imbalance, resulting in increased risk of osteoporosis and other bone-mineral disorders [11].
Diets typical of Western countries are characterized by high fat and high sucrose.
Western diet consumption has been shown to increase the risk of chronic kidney disease by
inducing renal steatosis, inflammation, and oxidative stress. Western diet consumption has also
been reported to increase risk of kidney stones due to the high sugar content [12,13].
Additionally, consuming a Western diet can result in early onset of osteoporosis by promoting
mineral balance and inflammation leading to decreased bone mineral density [14,15].
Dietary advice suggests replacing calories in the diet with healthier food choices instead of
dietary supplementation with a purified isolated nutrient [16].
Previously, our laboratory reported caloric substitution of a Western diet with 10% g/kg
apple pomace attenuating features of NAFLD [17]. However, the effects of apple pomace on
renal and bone was not assessed in this study. To our knowledge no studies have evaluated the
safety of apple pomace consumption on renal and bone health. Therefore, the objectives of this
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study were to determine the safety of apple pomace, due to its high fructose content and
increased calcium content, in growing rats consuming a standard diet or Western diet. Female
rats were used due to their increased susceptibility to nephrocalcinosis, and growing rats
because kidney disease has been shown to have more severe bone effects in a pediatric
population [18,19]. We hypothesize apple pomace will not have detriment to kidney or bone
health in growing female rats consuming “healthy” or Western diets.

5.3 Materials and Methods
Diets
Locally sourced apple pomace was provided by Swilled Dog Hard Cider Company
(Franklin, WV). Apple pomace was freeze dried in a VirTis Genesis 25 XL Pilot Freeze Drier (SP
Scientific, Warminster, PA) Nutrient composition analysis of apple pomace was performed by
Medallion Laboratories (Minneapolis, MN). Apple pomace contains 32.5% fructose compared to
the published average of 5.9% fructose for whole apples. Dietary calcium and phosphorus were
determined by inductively coupled plasma mass spectrometry (ICP) (model P400, Perkin Elmer,
Shelton, CT). Apple pomace contained 1.47 mg/g calcium and 1.97 mg/g phosphorous
compared to published values of 0.06 mg/g calcium and 0.11 mg/g phosphorous in whole
apples [17] (Table 1).
The ‘healthy’ diet was the standard purified American Institute of Nutrition (AIN-93G) for
growing rats [20] while a Western diet consisting of 45% fat and 34% sucrose was used to typify
the high fat, high sugar diet consumed by Western countries [21,22]. AIN-93G and Western diet
were calorically substituted with 10% g/kg freeze-dried apple pomace. AIN diets were adjusted
to be isocaloric (3.7-3.8 kcal/g) and Western diets were adjusted to be isocaloric (4.7 kcal/g).
Table 2 shows diet formulation for macronutrients, sugars, total minerals, calcium, and
phosphorous. The complete ingredient composition of experimental diets is provided in
Supplemental Table 1. Diets were stored at -20°C until fed to animals.
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Animals
Weanling (age 22-29 days) female Sprague-Dawley rats (n=32) were purchased from
Harlan-Tekald (Indianapolis, IN). All animal procedures were approved by the Animal Care and
Use Committee at West Virginia University and conducted in accordance with the guidelines of
the National Research Council for the Care and Use of Laboratory Animals [23]. Rats were
individually housed and kept in a room at constant temperature of 21+2°C with a 12 h light/dark
cycle throughout the study duration. Following 7-days acclimation period, rats were randomly
assigned (n=8 rats/group) to four dietary groups consisting of: 1) AIN-93G, 2) AIN-93G with
10% weight (g/kg) substituted with apple pomace (AIN/AP), 3) Western diet (45% fat, 33%
sucrose by kcals), or 4) Western diet with10% of weight (g/kg) substituted with apple pomace
(Western/AP). Rats were provided ad libitum access to their assigned diets and deionized
distilled water (ddH2O) throughout the eight weeks study duration. Food intake was measured
and assigned diets replaced every other day while ddH2O was replaced weekly. At the end of
the study, rats were fasted overnight then euthanized by carbon dioxide inhalation. The kidney
was excised, weighed, and then flash frozen in liquid nitrogen and stored at -80°C until
analyzed. Both femurs were removed, cleaned, and stored at -20°C.

Kidney histology
The left kidney was removed, weighed, flash frozen in liquid nitrogen, and stored at 80°C until analysis. A center sagittal section was cut from each frozen tissue (n=6-8) and stored
in 10% neutral buffered formalin for 48 hours (fixation). After fixation, samples underwent a
dehydration protocol consisting of 10-15 minutes incubation in increasing ethanol
concentrations (50-to-100%) followed by two 20-minute incubations in xylenes. Following xylene
incubation, samples were incubated in molten paraffin wax for 20 minutes (infiltration) and
embedded into blocks. 5-7μm sections were cut and mounted on charged slides and sections
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stained with hematoxylin and eosin. Histological evaluation included gross morphological
assessment which included the following: glomerular hypercellularity and matrix deposition,
interstitial hypercellularity, tubulointerstitial calcification, inflammation, and fibrosis. All slides
were analyzed using a Nikon Labophot 2 microscope (Nikon Instruments, New York, NY) at
magnification 10X by a trained investigator blinded to the identity of the groups. Images were
captured using a LCL-500-LHD digital camera with a PC Method Capture Imaging software
(Ludesco, Parkville, MD).

Renal RNA isolation and inflammatory gene expression
Total RNA was extracted from frozen kidney tissue (50 mg) using the Zymo Research
Direct-zol RNA Miniprep Plus Isolation Kit (Irvine, CA, catalog #R2071) according to the
manufacturer’s instruction for total RNA isolation. Isolated RNA integrity was visualized on a
1.5% agarose gel and quantified by spectrophotometry (NanoDrop 100; Thermo Fisher
Scientific, Waltham, MA). Following DNase I treatment with TURBO DNA-free kit (Thermo
Fisher Scientific), total mRNA was amplified using the Superscript IV First-Strand Synthesis
System with oligo dT primers (Thermo Fisher Scientific).
Real-time quantitative polymerase chain reaction (RT-qPCR) consisted of 2.5 µl of
SYBR Green Master Mix (Thermo Fisher Scientific), 1 µL of cDNA (diluted 1:10), 1 µL of
respective forward and reverse primers (10 μM) and 0.5 µl of deionized distilled water for a total
reaction volume of 5 µl. The reactions were performed in a 7500 ABI Real-Time PCR System
(Thermo Fisher Scientific). The thermal profile consisted of 50°C for 2 min, 95°C for 10 min then
40 cycles of 95°C for 15 sec and 60°C for 1 min. A melt curve analysis was applied at the end of
cycling. Primers that were designed for transcription factors, nuclear factor kappa-light chain
enhancer of B cells (NFκB) and NADPH oxidase 4 (NOX4) and for inflammatory cytokines,
tumor necrosis factor-alpha (TNF-α), and interleukin-6 (IL-6) as well as for housekeeping genes,
β-actin and glyceraldehyde 2-phosphate dehydrogenase (GAPDH) using the Primer3 program
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(Howard Hughes Medical Institute) and respective mRNA sequences obtained by NCBI.
Forward and reverse primers for genes of interest are listed below:
Gene

NCBI Gene ID

Forward Primer

Reverse Primer

NFκB

81736

TNFα

24835

IL-6

24498

5’
TTATGGGCAGGAT
GGACCTA 3’
5’
CACAAGGCTGCTG
AAGATGT 3’
5’ TGGCTAAGGACC
AAGACCAT 3’

NOX4

85431

β-actin

81822

GAPDH

24383

5’
CCTTTCAGGGCTTT
GGTTTA 3’
5’
GAGGGAAGGAAGG
AAGGAAG 3’
5’
TTGCCGAGTAGAC
CTCATAGTG 3’
5’
CTCCAGCCACACA
CAGACTAAC 3’
5’
CAGTGAGGCCAGG
ATAGAGC 3’
5’
CCTCAGTGTAGCC
CAGGATG 3’

5’
CCTCCATCAAGCC
AAGATTC 3’
5’
TTGCTGACAGGAT
GCACAAG 3’
5’
TCAAGAAGGTGGT
GAAGCAG 3’

Serum and urinary measures of renal function and health
Serum measures of kidney function included: blood urea nitrogen (BUN), creatinine, total
protein, calcium, phosphorous, alanine aminotransferase (ALT). Additionally, serum glucose
and amylase were measured. Values were determined enzymatically using a commercially
available Vet-16 rotor and quantified by a Hemagen Analyst automated spectrophotometer
(Hemagen Diagnostics Inc., Columbia, MD).
Serum and urine uric acid was determined by commercially available enzymatic assay
(Cayman Chemical). Briefly, serum and urine samples were aliquoted onto a 96-well plate and
incubated for 15 minutes. Reaction was initiated by adding 15 μl of uricase and horseradish
peroxidase enzyme mixture, and read at an excitation of 535 nm and an emission of 590 nm
using a BioTek Synergy H1 microplate reader (Winooski, VT). Inter-assay coefficient of variation
was 32.1% for both serum and urine.
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Calcium balance and retention
Rats were fasted overnight and euthanized by carbon dioxide inhalation. Blood was
collected by aorta puncture. Collected blood was centrifuged at 1,500 g for 10 min at 4°C to
obtain serum. Serum samples were stored at -80°C until analyzed. Serum calcium was
determined enzymatically using a commercially available Vet-16 rotor and quantified by a
Hemagen Analyst automated spectrophotometer.
During the initial and final weeks of the feeding study, rats were individually housed in
metabolic cages to collect urine and feces for 24 h. Initial and final day urine samples were
collected, centrifuged at 1,500 g for 10 min at 4°C, filtered through Whatman no. 1 paper, and
then diluted 1:10 in ddH2O. Initial and final feces were collected and dried for 48 h, then ashed
in a muffle furnace (model CP18210, Thermolyne, Dubuque, IA) at 550°C for 24 h. Fecal
samples were then acidified in 70% nitric acid, neutralized in ddH2O, filtered through Whatman
no. 1 paper, and further diluted (1:50 v/v) in ddH2O. Ca content of feces and urine was
determined by ICP.
Urinary calcium excretion was calculated as urinary calcium concentration/urine volume.
Calcium apparent absorption was calculated as [(calcium intake-fecal calcium
excretion)/(calcium intake)] x 100. Calcium retention was calculated as [(calcium intake – (fecal
calcium excretion + urinary calcium excretion)] [24].

Femur morphometry and mineralization
Following CO2 inhalation, the left and right femur were collected, and then defleshed.
After no bilateral differences were determined using a t-test with significance set at p<0.05, the
left femurs were used for all analyses. Femoral morphometry measurements consisting of
depth, width, and length were determined using a Vernier caliper (Bel-Art Products,
Pequannock, NJ, USA). Length was measured from the medial condyle to the greater
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trochanter. Femurs were weighed using an analytical balance (Mettler Toledo, Columbus, OH,
USA).
Total bone mineral was determined by ashing in a muffle furnace at 600°C for 24 hours,
then weighed ash. To measure specific minerals, bone ash was dissolved in 2 mL of 70% nitric
acid. Acidified samples were filtered through Whatman no. 1 paper and diluted (1:50 v/v) to
volume with ddH2O and Ca determined using ICP.

Femur biomechanical strength
Femoral strength indices were assessed using a TA,XT2i Texture Analyzer (Texture
Technologies, Scarsdale, NY, USA) fitted with a three point bending apparatus. Femora were
placed on supports and force applied to the midshaft marked at a position halfway between the
greater trochanter and the distal medical condyle. Bone was broken by lowering a centrally
placed blade (1 mm width) at a constant crosshead speed (0.1 mm/s). The load cell was 50 kg.
The load-deflection data were collected by a PC interfaced with the TA,XT2i. Sample test
distance was set at 10 mm with a signal collection rate of 100 points per second. Peak force,
ultimate stiffness, ultimate bending stress and Young’s modulus were calculated according to
Yuan and Kitts [25].

Statistics
Results are expressed as mean ± standard error of the mean (SEM). Gene expression
was determined as a function of mRNA abundance (A), where A=1/(gene of interest primer
efficiency x ΔCT (g.o.i.) – (average housekeeping primer efficiency x ΔCT (h.k.)), where the
product of efficiency and average of expression of β-actin was averaged with the product of
efficiency and average of expression of GAPDH to determine the overall expression of the two
housekeeping gene [17,26,27]. Gene expression data for each treatment group were logtransformed prior to statistical analysis. One-way ANOVA was used to determine differences
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among dietary groups. Post hoc multiple comparison tests were performed using Tukey’s test
with treatment differences considered significant at p<0.05 and a tendency at p=0.08. All
statistical analyses were performed using JMP 12.2 statistical software package (SAS Institute,
Cary, NC).

5.4 Results and Discussion
Rats are susceptible to renal disease and diets high in fructose and high in calcium have
been shown to be detrimental to renal health. Also, and high-fructose diets can detriment bone
health [7,28,29]. In the current study, histological analysis of the kidneys showed no evidence of
fibrosis, glomerular hypercellularity, glomerular matrix deposition, or amyloidosis. However, rats
consuming Western diet and diets containing apple pomace showed renal interstitial
hypercellularity (Figure 1), suggesting renal inflammation. To further investigate, gene
expression of inflammatory transcription factor, NFκB and proinflammatory cytokines, TNF-α
and IL-6 as well as NOX4, a highly expressed enzyme regulating generation of reactive oxygen
species, were measured in the kidneys. No significant differences were found in renal
expression of any of the genes of interest among diet groups (Figure 2). Serum clinical
measures of kidney damage and function were also measured [12,30-32]. Serum creatinine,
BUN, ALT, and total protein also showed no significant differences among diet groups,
collectively indicating absence of inflammation and oxidative stress (Table 4).
Increased fructose consumption and elevated uric acid may play a role in renal
inflammation [33-35]. Elevations in uric acid levels have been shown to change the fundamental
architecture of renal histology and has been implicated in acute and chronic renal failure [36].
The current study results showed no significant difference in serum or urine uric acid among diet
groups (Table 4). Interstitial hypercellularity was observed in 13-29% of animals, but there were
no significant differences in oxidative stress and inflammatory gene expression or serum and
urine measurements of renal dysfunction and injury were observed among diet groups. These
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results indicate renal interstitial hypercellularity was unlikely to be of biological significance.
Collectively, the results indicate the fructose content of apple pomace was not a risk for renal
injury and development of chronic kidney disease in either ‘healthy’ or Western diet.
In our study, Western diets were high in calcium with Western/AP diet having the highest
calcium content (Table 2). Differences in calcium content in diets can have significant effects on
calcium excretion, absorption, and retention [37]. Increased calcium excretion can induce
nephrocalcinosis through accumulation of calcium in the kidney [38]. Initial urinary and fecal
calcium excretion, calcium retention, and calcium absorption showed no significant differences
among diet groups (Table 5). At final week, no differences were observed in rats urinary
calcium excretion among all groups, but an increase (p=0.04) in fecal calcium excretion by rats
consuming a Western/AP diet compared to AIN diet was observed. This was also likely due to a
combination of the high insoluble dietary fiber content in apple pomace possibly binding to
calcium and the increased dietary calcium in the Western/AP diet. This higher dietary calcium
also explains the lack of change in apparent calcium absorption among all diet groups. No
differences were observed in calcium retention among all diet groups. Further, renal histological
evaluation showed no evidence of calcium deposition in any of the diet groups, further indicating
apple pomace consumption to be safe (Figure 2).
While Western diet (high fat and high sugar) and fructose consumption have also been
reported to detriment bone health, whole apples have been shown to favorably alter bone
health, through increased bone mineral density, decreased calcium loss, and decreased
inflammation due to antioxidants present in apples [39-42]. Apple pomace has been shown to
contain more calcium than apples [5]. Increasing dietary calcium has been shown to prevent
osteoporosis and to lower the risk of bone fractures [43,44]. Further, children with adequate
calcium consumption have increased bone mineral density [45,46]. The present study showed
no significant differences in femoral calcium content among diet groups. Additionally, there were
no significant differences in femur size or bone strength measurements among diet groups.
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These measures included peak force, ultimate stiffness, ultimate bending stress, and Young’s
modulus which measures the stiffness and strength of the bones (Table 5).
Another concern is rats consuming Western/AP diets had significantly increased gonadal
fat pad weights than rats consuming AIN diets [data not shown, 17]. Obesity and diabetes have
been reported to be causal factors in diet-induced kidney disease progression [6,47]. Despite
higher adiposity in rats fed Western/AP diet there were no significant differences in fasting
serum glucose or amylase among diet groups (data not shown). Our study provides evidence
that high fructose and high calcium content of apple pomace was not sufficient to effect renal or
bone health in rats, regardless of diet. Studies on apple pomace have reported numerous health
benefits including decreases in body weight, as well improvements in serum lipid, insulin,
glucose, antioxidant status, and digestion [48-54]. Yet, few studies have evaluated the safety of
apple pomace consumption. Devrajan, et al. [55] fed rats unfermented or fermented apple
pomace for 2 weeks showed a nonsignificant increase serum BUN, but found no indication of
kidney damage [56].
In conclusion, caloric substitution of a healthy or Western diet with 10% apple pomace
had no impact on renal or bone health in growing female rodents. Based on our results apple
pomace is safe for consumption, despite its high fructose content combined with a high calcium
content, regardless of diet quality. The study provides evidence for apple pomace, a “waste”
byproduct of apple processing has a favorable nutritional profile and is safe and therefore has
potential to be repurposed as a sustainable food source for human consumption.
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Table 1. Composition of locally sourced freeze-dried apple pomace.
Macronutrients (%)
Protein
Fat
Carbohydrates
Sugars (%)
Fructose
Glucose
Sucrose
Maltose
Lactose
Dietary Fiber (%)
Insoluble Dietary Fiber
Soluble Dietary Fiber
Polyphenols (g/kg)
Minerals (mg/g)
Total Minerals
Calcium
Phosphorous
Calories (kcal/100 g)

3.56
1.3
68.1
32.5
9.77
13.9
<0.1
<0.1
22.2
11.0
0.029
15.5
1.47
1.97
387
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Table 2. Ingredient composition of rodent diets substituted with apple pomace (10% g/kg) fed to growing female rats.
AIN

Diet Groups 1
AIN/AP

Western

Western/AP

1

Key Ingredients
Apple pomace (g/kg)
0.0
100.0
0.0
100.0
Sucrose (g/kg)
100.0
43.9
340.0
283.9
Fructose (g/kg)
50
54.5
170
174.5
Total Minerals (mg/g)
22.1
24.2
26.4
28.0
Calcium (mg/g)
10.4
10.8
12.8
14.6
Phosphorus (mg/g)
7.2
7.5
7.6
7.5
Macronutrients (% kcal)
Protein
18.8
18.9
14.8
14.8
Fat
17.2
17.3
44.6
44.8
Carbohydrate
63.9
63.7
40.6
40.4
Calories (kcal/g)
3.8
3.7
4.7
4.7
1
Abbreviations: AIN, the American Institute of Nutrition; AP, apple pomace. A complete list of ingredients can be found in
Supplemental Table 1.
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Table 3. Weekly caloric and macronutrient intake, weekly body weight gain, and kidney and bone weights of growing female rats
consuming different diets substituted with apple pomace (10% g/kg) for 8 weeks.
Treatments 1
AIN
AIN/AP
Western
Western/AP p-Value
b
b
a
Caloric intake (kcal/week)
368 ± 11
345 ± 8
422 ± 9
430 ± 17a
<0.0001
Initial bwt (g)
95 ± 3
92 ± 3
95 ± 3
95 ± 3
0.80
Final bwt (g)
216 ± 4
216 ± 8
229 ± 5
234 ± 5
0.08
Average weekly bwt gain (g)
16 ± 3
16 ± 3
18 ± 3
18 ± 3
0.94
Average mineral intake (mg/d)
304.0 ± 9.3b 318.8 ± 7.3b 368.9 ± 7.8a 374.7 ± 15.0a <0.0001
Right kidney weight (g)
0.69 ± 0.02 0.68 ± 0.02 0.71 ± 0.02
0.73 ± 0.02
0.28
Left kidney weight (g)
0.69 ± 0.02 0.67 ± 0.02 0.74 ± 0.03
0.74 ± 0.02
0.07
Relative right kidney weight (mg/g) 0.32 ± 0.01 0.31 ± 0.01 0.32 ± 0.01
0.31 ± 0.01
0.86
Relative left kidney weight (mg/g)
0.31 ± 0.01 0.31 ± 0.01 0.31 ± 0.01
0.32 ± 0.00
0.70
Left kidney ash (mg/g)
9.86 ± 0.56 10.07 ± 0.54 9.14 ± 1.09 10.34 ± 0.67
0.71
1
Values expressed as mean ± SEM (n = 6–8 rats/group). Different superscript letters a and b within the same row. Indicate
significant difference at p<0.05 by one-way ANOVA followed by Tukey’s test. Abbreviations: AIN, American Institute of Nutrition;
AP, apple pomace; Bwt, body weight; CHO, carbohydrate.
Measurements
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Table 4. Effect of consumption of different diets substituted with apple pomace (10% g/kg) by growing female rats on serum and
urine measurements of liver function enzymes, and uric acid following 8 weeks of feeding.
Treatments1
Measurements
AIN
AIN/AP
Western
Western/AP p-Value
Serum Creatinine (U/L)
1.46 ± 0.08
1.45 ± 0.11
1.38 ± 0.09
1.43 ± 0.04
0.90
Serum BUN (mg/dl)
17.84 ± 1.59
19.63 ± 1.41
20.25 ± 2.32 16.00 ± 0.94
0.27
Serum ALT (U/L)
107.63 ± 19.59 118.71 ± 43.60 94.5 ± 12.58 133.5 ± 30.59
0.78
Serum Total Protein (g/dl)
3.9 ± 0.25
4.62 ± 0.34
4.08 ± 0.67
4.19 ± 0.34
0.79
Serum Phosphorous (mg/dl)
14.18 ± 0.54
13.46 ± 1.72
15.68 ± 0.53 13.09 ± 1.02
0.35
Serum Calcium (mg/dl)
9.56 ± 0.80
11.10 ± 1.09
11.49 ± 0.54 10.51 ± 1.00
0.48
Serum Uric Acid (μM)
7.24 ± 0.31
6.27 ± 1.61
7.19 ± 0.86
7.57 ± 1.25
0.86
Urine Uric Acid (μM)
5.94 ± 2.26
10.35 ± 2.11
10.40 ± 1.12
6.79 ± 1.41
0.23
1
Values expressed as mean ± SEM (n=4-8 animals/group). Different superscript letters a and b within the same figure indicates
significant difference at p<0.05 by one-way ANOVA followed by Tukey’s test. Abbreviations: ALT, alanine aminotransferase; BUN,
blood urea nitrogen.
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Table 5. Calcium content of serum, feces, urine, and femurs of rats fed different diets substituted with 10% (g/kg) apple pomace.
Calcium Balance

AIN
12.8 ± 0.4
135.6 ± 4.2c

Treatments 1
AIN/AP
Western
Western/AP p-Value
13.3 ± 0.3
12.8 ± 0.3
13.1 ± 0.5
0.88
140.1 ± 3.2c 162.4 ± 3.5b 184.9 ± 7.4a <0.0001

Ca intake (g/d)
Intake (mg/d)
Initial
Urine Ca excretion (mg/dl) 0.16 ± 0.04 0.19 ± 0.04
0.17 ± 0.04 0.18 ± 0.04
0.96
Fecal Ca excretion (mg/d)
25.9 ± 3.6
22.9 ± 3.5
31.3 ± 3.7
34.7 ± 2.7
0.12
Ca retention (mg/d)
89.3 ± 9.4
94.9 ± 5.9
96.4 ± 5.8
109.8 ± 6.2
0.32
Ca absorption (%)
62.5 ± 4.6
68.0 ± 4.7
61.4 ± 4.2
63.3 ± 3.0
0.70
Final
Urine Ca excretion (mg/ml) 0.15 ± 0.02 0.16 ± 0.04
0.16 ± 0.04 0.10 ± 0.01
0.25
b
ab
ab
a
Fecal Ca excretion (mg/d)
60.9 ± 2.9
79.4 ± 11.6
81.2 ± 3.9
99.3 ± 7.1
0.04
Ca retention (mg/d)
77.7 ± 5.3
66.7 ± 5.3
80.8 ± 5.0
78.9 ± 5.3
0.25
Ca absorption (%)
54.2 ± 4.1
41.8 ± 11.8
49.7 ± 3.2
46.3 ± 5.3
0.65
1
Values expressed as mean ± SEM (n=4-8 animals/group). Different superscript letters a and b within the same figure indicates
significant difference at p<0.05 by one-way ANOVA followed by Tukey’s test. Abbreviations: Ca, calcium.
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Table 6. Femoral morphometry and strength measurements of rats fed different diets substituted with 10% (g/kg) apple pomace.
Treatments 1
Measurement

AIN

AIN/AP

Western

Western/AP

p-value

Femur morphometry
29.71 ± 0.53
29.09 ± 0.78
30.52 ± 0.56
29.36 ± 0.78
Length (mm)
Medial lateral width (mm)
2.98 ± 0.04
3.12 ± 0.12
3.06 ± 0.08
3.15 ± 0.10
Depth (mm)
2.78 ± 0.07
2.73 ± 0.12
2.60 ± 0.09
3.06 ± 0.17
Wet wt (g)
0.77 ± 0.02
0.74 ± 0.05
0.73 ± 0.03
0.74 ± 0.04
Dry wt (g)
0.48 ± 0.01
0.46 ± 0.03
0.45 ± 0.02
0.47 ± 0.02
Femur mineralization
Ash (mg/g of bone)
407.92 ± 11.42
407.75 ± 9.26
399.66 ± 7.40
396.94 ± 6.46
Calcium (mg/g of bone)
37.99 ± 0.78
39.09 ± 4.41
40.09 ± 2.26
38.28 ± 2.08
Femur biomechanical strength
Peak force (N)
1.74 ± 0.18
1.99 ± 0.25
1.55 ± 0.11
1.23 ± 0.23
Ultimate stiffness (N/S)
382.03 ± 16.28
399.49 ± 27.07
397.55 ± 38.73
347.15 ± 14.01
Ultimate bending stress (N/S)
42.32 ± 1.57
38.21 ± 2.19
40.12 ± 3.46
42.19 ± 2.59
Young’s Modulus (N/mm2)
1604.92 ± 76.18
1484.85 ± 284.92
1549.57 ± 90.13
1275.92 ± 200.17
1
Values expressed as mean ± SEM (n=6-8 animals/group). Different superscript letters a and b within the same figure indicates
significant difference at p<0.05 by one-way ANOVA followed by Tukey’s test.

0.09
0.13
0.43
0.89
0.77
0.80
0.75
0.07
0.60
0.48
0.75
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Figure Legend
Figure 1. Representative histological staining images of the left kidney of growing female rats
consuming (A) AIN, (B) AIN/AP, (C) Western, or (D) Western/AP following 8 weeks of feeding.
Black arrows indicate interstitial hypercellularity.

Figure 2. Relative expression of genes involved in inflammation in kidney tissue of young
female rats consuming different diets substituted with 10% g/kg apple pomace for 8 weeks.
Values expressed as mean ± SEM (n=5-7 animals/group). Abbreviations: AU, arbitrary units, IL6, interleukin-6; NFκB, nuclear factor kappa-light-chain enhancer of activated B cells; NOX4,
NADPH oxidase 4; TNF-α, tumor necrosis factor alpha.
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Supplemental Material
Supplementary Table 1. Composition of rodent diets substituted with apple pomace
(10% g/kg) fed to growing female rats.
Diet Groups *
AIN
AIN/AP

Western
Western/AP
Ingredients (g/kg) *
Apple pomace
0.0
100.0
0.0
100.0
Corn Starch
397.486
392.086
63.36
57.96
Maltodextrin
132.0
132.0
60.0
60.0
Sucrose
100.0
43.9
340.0
283.9
Fructose
50
54.45
170
174.45
Total Dietary Fiber
50.0
50.0
50.0
50.0
Insoluble Fiber †
50.0
39.0
50.0
39.0
Soluble Fiber ‡
0.0
11.0
0.0
11.0
Anhydrous Milkfat
0.0
0.0
210.0
210.0
Soybean Oil
70.0
68.7
20.0
18.7
Casein
200.0
196.0
195.0
191.0
L-Cystine
3.0
3.0
3.0
3.0
Vitamin Mix
10.0
10.0
12.5
12.5
Mineral Mix
35.0
35.0
43.0
43.0
Total Minerals
22.1
24.2
26.4
28.0
Calcium
10.4
10.8
12.8
14.6
Phosphorous
7.2
7.5
7.6
7.5
Choline Bitartrate
2.5
2.5
3.1
3.1
TBHQ, antioxidant
0.014
0.014
0.04
0.04
Polyphenols
0.0015
0.0029
0.0008
0.0032
Macronutrients (% kcal)
Protein
18.8
18.9
14.8
14.8
Fat
17.2
17.3
44.6
44.8
Carbohydrate
63.9
63.7
40.6
40.4
Calories (kcal/g)
3.8
3.7
4.7
4.7
*
Abbreviations: AIN, the American Institute of Nutrition; AP, apple pomace; TBHQ, tertbutylhydroquinone. † Insoluble fiber is cellulose. ‡ Soluble fiber is mainly pectin 1.
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6.0

Chapter 4
Dissertation Discussion, Conclusions, and Future Directions

6.1 Discussion and Conclusions
This dissertation investigated the health benefits and safety of apple pomace
consumption using a rat model. Rats consumed a standard ‘healthy” diet or a high-fat, highsugar diet typical of most Americans. The Western diet is low in fruits and vegetables, which
provide dietary fiber and antioxidants. Finding sustainable food sources with potential to provide
increases in these critical nutrients is important for improving diet quality. Study 1 results
showed caloric substitution with apple pomace attenuated Western diet-induced NAFLD. Rats
consuming Western/AP had decreased histological evidence of steatosis, hepatic triglyceride
content, SFA and MUFA content, and hepatic DGAT2 gene expression compared to rats
consuming a Western diet. This was attributed to the high fiber content of apple pomace
attenuating bile acids.
NAFLD progression to NASH is proposed to be a multiple-hit disease with the onset of
the disease due to alteration in hepatic lipid metabolism and subsequent increases in severity
due to increased inflammation and oxidative stress. Study 2 results showed apple pomace
reduced histological evidence of hepatic inflammation, modulated adipose release of SFA and
MUFA and deposition in the liver of rats consuming the Western diet. Caloric substitution with
10% apple pomace also downregulated gene expression of inflammatory NFκB, IL-6, and TNFα
in liver and adipose tissue in rats consuming a Western diet. This was due to increased serum
and urine total antioxidants in the Western/AP diet group compared to the Western diet group,
attributed to the polyphenol content of apple pomace.
Progression of liver disease can result in systemic damage to the kidneys and bone.
Study 3 showed Western diet consumption resulted in NAFLD and progression to NASH but
this did not produce detrimental effects in the kidney and bone. Caloric substitution with apple
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pomace, which is high in calcium but also high in fructose, did not produce any significant
changes in kidney or bone health, regardless of diet quality. Based on the three studies, we
conclude:
1) apple pomace consumption can attenuate diet-induced NAFLD in rats consuming a
Western diet,
2) apple pomace consumption can prevent progression of NAFLD to NASH in rats
consuming a Western diet,
3) apple pomace consumption is safe for renal or bone health in rats consuming a healthy
or Western diet.

Collectively, the study results indicate apple pomace’s potential to be a sustainable
functional food and nutritional aid for human consumption. The current environmental pollution
and costs associated with apple pomace wastage and disposal are unnecessary. Repurposing
apple pomace for human consumption provides a solution to a multifaceted problem. Utilizing
apple pomace as a functional food can improve health while generating revenue. Methods of
utilizing “waste products” is an expanding field as sustainability moves to the forefront of science
and society due to a growing population. By providing a better understanding of the
physiological effects of consuming products such as apple pomace the public can move towards
a more sustainable and healthier world.

6.2 Potential Future Studies
Repurposing apple pomace for human consumption is an apparent solution to the
increasing waste due to processing of apples for juices, ciders, sauces, and other products.
Future studies should address long-term consequences of apple pomace consumption using
animal models and human subjects. Human studies should address biological effects of apple
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pomace and investigate consumer acceptability. Marketing and product development studies
should be conducted to determine the best method for consumer delivery of apple pomace.
Lastly, methods for quick storage must be addressed due to rapid spoilage of apple pomace.
Although large scale apple producers may have access to industrial freeze-driers, small apple
farmers do not. Addressing ways to improve apple pomace drying affordability will be
paramount for enabling apple farmers to effectively repurpose apple pomace, currently a waste
byproduct of apple processing, for human consumption.
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